text stringlengths 46 525k | url stringlengths 24 420 | crawl_date timestamp[us, tz=UTC]date 2022-04-01 00:01:42 2022-09-25 07:27:13 | id stringlengths 24 420 | label bool 2
classes |
|---|---|---|---|---|
High
Frequently used
We're seeing significant engagement with this asset.
Stock Photo ID: 57000980
Important information
Release information: Signed model release on file with Shutterstock, Inc.
Photo Formats
2000 × 3000 pixels • 6.7 × 10 in • DPI 300 • JPG
667 × 1000 pixels • 2.2 × 3.3 in • DPI 300 • JPG
334 × 500 pixels • 1.1 × 1.7 in • DPI 300 • JPG
Photo Contributor | https://www.shutterstock.com/image-photo/fitness-woman-smiling-pilates-ball-isolated-57000980 | 2022-07-27T11:59:35Z | https://www.shutterstock.com/image-photo/fitness-woman-smiling-pilates-ball-isolated-57000980 | false |
Highlights:
- Located in South Texas, Burke Hollow's initial Production Area Authorization 1 ("PAA-1") is the newest and largest In-Situ Recovery ("ISR") wellfield being developed in the United States.
- Completing installation of the 106 monitor wells for PAA-1 marks a significant milestone achievement towards ISR uranium production at the Burke Hollow project (the "Project").
- This is a significant development for UEC and an important step in America's nuclear fuel supply chain to provide safe, clean and reliable carbon-free energy.
- Advancing Burke Hollow towards production is timely as the U.S. looks to reduce its imports of Russian uranium. The U.S. National Nuclear Security Administration (NNSA) has recently begun the process to acquire U.S. produced uranium for America's strategic Uranium Reserve. NNSA has issued an initial solicitation to purchase up to approximately one million pounds of domestically produced uranium.
- With the successful installation of the PAA-1 monitor well ring, UEC plans to transition into additional exploration and delineation drilling within the 19,336-acre Project to define additional production areas.
- UEC's South Texas hub-and-spoke strategy is anchored by its fully licensed Hobson Processing Plant and five ISR projects, including its fully permitted Palangana, Goliad and Burke Hollow projects.
- To learn more about the environmental, social and low-cost advantages of uranium In-Situ Recovery, visit https://www.uraniumenergy.com/projects/isr/
CORPUS CHRISTI, Tex., July 27, 2022 /PRNewswire/ - Uranium Energy Corp (NYSE American: UEC) "UEC" or the "Company") is pleased to announce that it has completed the installation of the 106 monitor wells necessary for its first Production Area Authorization at its Burke Hollow Project located in Bee County, Texas. The planned production area is approximately two miles in length and, once complete, will constitute the largest production area ever to be developed in South Texas.
Andy Kurrus, VP of Resource Development stated: "We are pleased to have completed the installation of the Burke Hollow PAA-1 monitor well ring, a critical step towards uranium extraction.
We have also defined resources outside of PAA-1 at the Project, including several exploration targets and anomalous areas that have only been lightly explored. We expect this to translate into an extensive Project pipeline with additional exploration drilling and production area development in the near future. The development of Burke Hollow, the only recent uranium discovery in the United States, is the largest Goliad Formation deposit ever discovered in the South Texas Uranium Trend."
In this stage of Project advancement, well development and baseline sampling are expected to be complete by mid-August followed by aquifer testing. Preparation for an authorization application which sits within the current mine permit for the Project, is planned for submittal prior to the end of the calendar year.
The mineralization in PAA-1 is hosted within the Pliocene aged Goliad Formation, in what the Company has termed the "Lower B Sand". This unit, positioned at approximately 390 to 450 feet in depth, is comprised of four sub-units of mineralization.
In 2017, UEC refocused and then concentrated its Burke Hollow efforts by specifically targeting this area with the delineation drilling necessary to expand the resources identified earlier in the Project. Commencement of the permitting phase began in 2019 with the conclusion of the delineation campaign that was immediately followed by the first round of monitor well installations.
Uranium Energy Corp is America's leading, fastest growing, uranium mining company listed on the NYSE American. UEC is a pure play uranium company and is advancing the next generation of low-cost, environmentally friendly In-Situ Recovery (ISR) mining uranium projects. The Company has two production ready ISR hub and spoke platforms in South Texas and Wyoming, anchored by fully licensed and operational processing capacity at the Hobson and Irigaray plants. UEC also has seven U.S. ISR uranium projects with all of their major permits in place. Additionally, the Company has other diversified holdings of uranium assets, including: (1) one of the largest physical uranium portfolios of U.S. warehoused U3O8; (2) a major equity stake in the only royalty company in the sector, Uranium Royalty Corp.; and (3) a pipeline of resource-stage uranium projects in Arizona, Colorado, New Mexico and Paraguay. The Company's operations are managed by professionals with a recognized profile for excellence in their industry, a profile based on many decades of hands-on experience in the key facets of uranium exploration, development and mining.
Stock Exchange Information:
NYSE American: UEC
WKN: AØJDRR
ISN: US916896103
Except for the statements of historical fact contained herein, the information presented in this news release constitutes "forward-looking statements" as such term is used in applicable United States and Canadian securities laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans, "estimates" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and should be viewed as "forward-looking statements". Such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the actual results of exploration activities, variations in the underlying assumptions associated with the estimation or realization of mineral resources, the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares, accidents, labor disputes and other risks of the mining industry including, without limitation, those associated with the environment, delays in obtaining governmental approvals, permits or financing or in the completion of development or construction activities, title disputes or claims limitations on insurance coverage. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Many of these factors are beyond the Company's ability to control or predict. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings with the Securities and Exchange Commission. For forward-looking statements in this news release, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities.
View original content:
SOURCE Uranium Energy Corp | https://www.valleynewslive.com/prnewswire/2022/07/27/uranium-energy-corp-achieves-key-milestone-burke-hollow-isr-project-with-installation-106-monitor-wells-first-production-area/ | 2022-07-27T11:59:46Z | https://www.valleynewslive.com/prnewswire/2022/07/27/uranium-energy-corp-achieves-key-milestone-burke-hollow-isr-project-with-installation-106-monitor-wells-first-production-area/ | false |
Maybe President Biden felt antsy after being cooped up for covid-19 isolation. Maybe the House Jan. 6 committee laid the groundwork by exposing Donald Trump’s dereliction of presidential duty when the U.S. Capitol was attacked. Whatever the reason, Biden came out swinging on Monday during a virtual speech to the National Organization of Black Law Enforcement Executives conference. He went out of his way to excoriate Trump, a possible preview of the midterm campaign season.
Referencing Trump’s 187 minutes of refusal to summon help for the besieged Capitol, Biden said, “And for three hours, the defeated former president of the United States watched it all happen as he sat in the comfort of the private dining room next to the Oval Office.” He added, “While he was doing that, brave law enforcement officers were subject to the medieval hell for three hours — dripping in blood, surrounded by carnage, face to face with a crazed mob that believed in the lies of the defeated president.”
Biden then turned to an attack that is as applicable to Trump’s GOP enablers as it is to Trump personally. “Donald Trump lacked the courage to act. The brave women and men in blue all across this nation should never forget that. You can’t be pro-insurrection and pro-cop. You can’t be pro-insurrection and pro-democracy. You can’t be pro-insurrection and pro-America.”
Many Democratic officials and operatives frustrated with Biden’s reticence no doubt whispered: It’s about time.
White House press secretary Karine Jean-Pierre, briefing reporters later in the day, left no doubt that these were no off-the-cuff remarks about Trump from Biden. “The former president had a choice to make,” she said. “The choice was, do you stand on the side of our law enforcement, or do you stand on the side of a mob?” Jean-Pierre then, for emphasis, repeated the president’s vivid description almost verbatim.
Biden and other Democrats can accomplish multiple goals by continuing to hammer away at Trump’s betrayal on Jan. 6. For starters, baiting Trump often results in more damaging, self-incriminating remarks. Consider Biden’s zingers a public service to provide the Jan. 6 committee and the Justice Department with still more ammunition. (Put differently, he is ratcheting up pressure on the department without needing to tell Attorney General Merrick Garland: Pick up the pace, pal.)
Second, the more Democrats focus on Jan. 6 and Republicans’ spineless adherence to the “big lie,” the easier it is for them to make the case in the midterms that Republicans are unfit to serve. Every Trump endorsee and every “big lie” spreader should have to defend Trump’s conduct. A Democratic candidate such as Josh Shapiro, who is running for Pennsylvania governor against Republican Doug Mastriano (a Jan. 6 attendee who helped transport Trump supporters to his “Stop the Steal” rally that day), certainly can push the theme that Mastriano was on the side of those bludgeoning the police.
Third, Biden’s invocation of Jan. 6 can be part of a broader effort to flip the script on Republicans and crime. The argument could go that many Republicans are not just on the side of those who attacked the police at the Capitol on Jan. 6, GOP lawmakers also unanimously opposed the American Rescue Plan, which contained funding to keep police and other first responders on state and local payrolls. Biden’s administration actually has been “funding the police” with the American Rescue Plan, and with this year’s generous law enforcement budget request.
Along similar lines, Democrats could point out that Republicans’ refusal to ban assault weapons threatens innocent teachers, children, shoppers, parade-goers — and the law enforcement personnel who protect them. In other words, you cannot be pro-AR-15 and be pro-police.
As Biden wraps up his legislative agenda for the year — perhaps with a robust list of accomplishments that defies the media’s excessively negative assessment of his presidency — Democrats might look forward to a more aggressive Biden willing to bind Republicans to the albatross around their necks, or even goad Trump into an early declaration of his candidacy. (That would be a welcome development for Democrats, who would like nothing better than to turn the midterms into a referendum on the insurrectionist in chief.)
Even if Biden’s own approval ratings worry fellow Democrats, his control of the bully pulpit and ability to direct attention to the violent debacle on Jan. 6, 2021, might come as a welcome midterm boost for the party on the side of the police, not the mob. | https://www.washingtonpost.com/opinions/2022/07/27/biden-trump-jan6/ | 2022-07-27T11:59:47Z | https://www.washingtonpost.com/opinions/2022/07/27/biden-trump-jan6/ | false |
GURUGRAM, India, July 27, 2022 /PRNewswire/ -- ReNew Energy Global Plc ("ReNew" or "the Company") (NASDAQ: RNW) (NASDAQ: RNWWW) announced that it has filed its annual report on form 20-F for the financial year ended March 31, 2022, with the Securities and Exchange Commission of the United States. The annual report on form 20-F can be accessed on the Investor Relations Section of ReNew's website at https://investor.renewpower.in/ and on the website of the U.S. Securities and Exchange Commission at www.sec.gov. ReNew will provide all shareholders, upon request, hard copies of these documents, free of charge.
About ReNew
ReNew is one of the largest renewable energy Independent Power Producers in India and globally. ReNew develops, builds, owns, and operates utility-scale wind energy, solar energy, and hydro projects. As of June 30, 2022, ReNew has a gross total portfolio of ~ 12.8 GW of renewable energy projects across India, including commissioned and committed projects. To know more, visit www.renewpower.in and follow us on Linked In, Facebook, Twitter and Instagram.
Press Enquiries
Kamil Zaheer
kamil.zaheer@renewpower.in
+ 91 9811538880
Shilpa Narani
shilpa.narani@renewpower.in
+91 9999384233
Investor Enquiries
Nathan Judge
Anunay Shahi
ir@renewpower.in
Logo: https://mma.prnewswire.com/media/653741/ReNew_Power_New_Logo.jpg
View original content:
SOURCE ReNew Energy Global Plc | https://www.wafb.com/prnewswire/2022/07/27/renew-energy-global-plc-files-its-annual-report-form-20-f-financial-year-ended-march-31-2022/ | 2022-07-27T12:01:08Z | https://www.wafb.com/prnewswire/2022/07/27/renew-energy-global-plc-files-its-annual-report-form-20-f-financial-year-ended-march-31-2022/ | false |
NEW YORK — Buzz Aldrin's jacket worn on his historic first mission to the moon's surface in 1969 has been auctioned off to a bidder for nearly $2.8 million.
The $2,772,500 paid for the Apollo 11 Inflight Coverall Jacket is the highest for any American space-flown artifact sold at auction, according to Sotheby's, which handled the sale. The unidentified winning bidder, who participated by phone, outlasted several others in a bidding that spanned almost 10 minutes.
The jacket displays Aldrin’s name tag on the left breast above the Apollo 11 mission emblem, and the American flag on the left shoulder. It is made of a fire-resistant material known as Beta cloth that was incorporated in spacesuits in response to the fire that killed three astronauts aboard Apollo 1 in 1967, according to Sotheby's.
Aldrin and Neil Armstrong became the first astronauts to walk on the moon on July 20, 1969.
"Neil Armstrong's complete in flight cover-all garment: jacket, trousers and boots are at the Smithsonian. Mike Collins jacket, trousers and boots are at the Smithsonian. Buzz's trousers and boots are at the Smithsonian. And that means that this jacket is the only garment worn on the Apollo 11 mission that can be owned privately," said Cassandra Hatton, Sotheby's Global Head of Science and Popular Culture.
Also on offer by Sotheby's is a pen used by Aldrin to fix a broken circuit breaker switch on the Apollo 11 mission. The company's presale estimate is $1 million to $2 million.
"By some kind of miracle, the diameter of (the pen's) plastic tip was the same as the diameter of the switch, and it fit perfectly in that hole and armed the engine and saved their lives," Hatton said.
Val Lick contributed. | https://www.kvue.com/article/tech/science/aerospace/buzz-aldrin-flight-to-moon-jacket-sells-at-auction/507-d0f7fa51-ab60-4fbf-ac3f-9c48071d8f6d | 2022-07-27T12:01:40Z | https://www.kvue.com/article/tech/science/aerospace/buzz-aldrin-flight-to-moon-jacket-sells-at-auction/507-d0f7fa51-ab60-4fbf-ac3f-9c48071d8f6d | false |
Dynamic capabilities and modular platform earn company top honors in newly-released report
MINNEAPOLIS, July 27, 2022 /PRNewswire/ -- MHC, a global enterprise automation software solutions provider, has been named as a Leader on the 2022 Aspire Leaderboard for Customer Communications Management (CCM) and Customer Experience Management (CXM) vendors. It's the second year MHC has been positioned as a Leader within the Aspire Leaderboard report for their customer communications platform EngageCX.
MHC EngageCX is packaged with several modules and business apps that enable organizations to configure end-to-end mass communication solutions in the cloud or deployed in a hybrid or on-premises model. The MHC EngageCX platform is cost-effective for customers given how it is built on open standards and comes with extensive integration capabilities out-of-the-box. The platform's capabilities are dynamic and modular, enabling solution teams to easily embed some or all of its communication services into a wider ecosystem of solutions.
MHC performed particularly well in the mid-market space within the report. With the comprehensive capabilities to compete among the most prominent CCM vendors, what sets MHC apart is their agility and personalized approach. In the 2022 report, Aspire noted "MHC's dynamic capabilities are second-to-none and its modular product portfolio makes it very adaptable to customer needs."
"Delivering effective communications reliably and efficiently is a critical part of any organization's operations, yet we also know organizations don't have one-size-fits-all requirements. The value and strength of EngageCX is its flexibility and scalability to fully support our customers' unique needs as they grow and evolve," says MHC CEO Gina Armada.
The Aspire Leaderboard is published by consulting firm Aspire Customer Communications Services. Assessment scores are generated by analyzing more than 1,200 data points relating to a company's platform strength, software capabilities, strategic direction, benefits, and other features.
"MHC's modern CCM platform has customer-centricity at its heart, enabling it to empower customers to meet their evolving business goals," commented Kaspar Roos, CEO & Founder of Aspire. "While EngageCX is a very rounded suite in itself, MHC has taken it even further by incorporating it within its newly developed MHC NorthStar platform, allowing it to serve as a versatile front-end CX layer to back-end automation processes. The new combination delivers a powerful and agile platform that is poised for exciting growth."
The full 2022 Aspire Leaderboard for CCM-CXM is available here.
MHC enables organizations to tackle digital transformation with speed and confidence, delivering solutions to automate the creation, capture, and distribution of documents and communications across core business processes. With the world's most flexible end-to-end automation platform, MHC empowers business users to eliminate manual interactions involving their organization's key stakeholders, increase efficiency and agility to achieve operational excellence goals, and strengthen the ever-important relationships with customers and suppliers to drive long-term growth. To learn more visit www.mhcautomation.com.
Aspire Customer Communications Services is a boutique consulting firm specializing in the Customer Communications Management (CCM), Customer Experience Management (CXM), and Customer Journey Mapping (CJM) industries. Through deep market expertise and global insights, Aspire works with Software, Services and Solution providers, and Business Advisories and Private Equity Firms to help them achieve their CCM goals. Find more information about how Aspire is helping organizations navigate the complexities of the customer communications world at http://www.aspireccs.com.
The Aspire Leaderboard™ is copyrighted by Aspire Customer Communications Services Ltd. and is based on the findings and opinions of Aspire's consultancy organization. Aspire does not endorse any vendor, product or service included in the Aspire Leaderboard. For tailored RFP support please contact the Aspire team here.
View original content to download multimedia:
SOURCE MHC Software | https://www.wkyt.com/prnewswire/2022/07/27/mhc-included-leader-quadrant-2022-ccm-cxm-aspire-leaderboard/ | 2022-07-27T12:02:26Z | https://www.wkyt.com/prnewswire/2022/07/27/mhc-included-leader-quadrant-2022-ccm-cxm-aspire-leaderboard/ | true |
Universal Credit payments will increase from April next year, it has been confirmed by the Department for Work & Pensions. The increase is decided based on inflation and wage levels, as well as the cost of living crisis.
The boost comes amid findings from the University of Sussex Business School which claimed the introduction of Universal Credit “imposed large societal costs”. Each April, all payments get an increase - with a 3.1 per cent increase in place for this financial year (2022/2023). This figure was based on inflation in September 2021 but is well below the current CPI rate of 9.3 per cent.
It comes as more than eight million households have started to receive the first of two payments totalling £650 to ease cost-of-living pressures. Even with the cost of living payments, the rising cost of gas, petrol and goods on the supermarket shelf is already making life difficult for many, reports the Mirror.
However, a government minister stated the increase of Universal Credit payments will not be confirmed until November. Parliamentary under-secretary at the DWP David Rutley MP was responding to a written question asking the government to review benefit payments, with the energy price cap in mind.
Currently at an eye-watering maximum of £1,971 per year, the price cap could increase to £3,000 by October. Mr Rutley said the government is "required to undertake an annual statutory review of benefits and pensions" but there were no plans to bring the review forward.
The "review will commence in the autumn and decisions will be announced to Parliament in November in the normal way," he stated.
Current DWP payment rates for 2022-2023
Below are all the DWP payment rates for 2022-2023, with the previous amount for 2021-2022 in brackets to show how much they went up. A much larger rise is expected for 2023-2024.
Weekly rates are shown, unless otherwise stated.
Attendance Allowance
- Higher rate: £92.40 (from £89.60)
- Lower rate: £61.85 (from £60.00)
Bereavement Benefit
For deaths between April 9, 2001 and April 5, 2017
- Widowed Parent's Allowance: £126.35 (from £122.55)
Bereavement Support Payment
For deaths occurring on or after April 6, 2017
- Standard rate (lump sum) £2,500 (no change)
- Standard rate monthly payments £100 (no change)
- Higher rate lump sum stays at £3,500 (no change)
- Higher rate monthly payments £350 (no change)
Carer’s Allowance
- £69.70 (from £67.60)
Disability Living Allowance
Care Component
- Highest: £92.40 (from £89.60)
- Middle: £61.85 (from £60.00)
- Lowest: £24.45 (from £23.70)
Mobility component
- Higher: £64.50 (from £62.55)
- Lower: £24.45 (from £23.70)
Employment and Support Allowance (ESA)
- Under 25: £61.05 (from £59.20)
- 25 or over: £77 (from £74.70)
Housing Benefit
- Under 25: £61.05 (from £59.20)
- 25 or over: £77.00 (from £74.70)
- Entitled to main phase ESA: £77.00 (from £74.70)
Incapacity Benefit
- Long-term: £118.25 (from £114.70)
Income Support
- Under 25: £61.05 (from £59.20)
- 25 or over: £77.00 from (£74.70)
Industrial death benefit
- Widow's pension higher rate: £141.85 (from £137.60)
- Widow's pension lower rate: £42.56 (from £41.28)
- Widower's pension: £141.85 (from £137.60)
Jobseeker's Allowance
Contribution-based JSA
- Under 25: £61.05 (from £59.20)
- 25 or over: £77.00 (from £74.70)
Income-based JSA
- Under 25: £61.05 (from £59.20)
- 25 or over: £77.00 (from £74.70)
Where to find help as the cost of living soars
The jump in the cost of living is putting household budgets under pressure, with some having to choose between heating and eating.
Here are some resources available if you need help.
Citizens Advice
Citizens Advice is an independent charity offering free, confidential support with legal, consumer, housing, debt and other problems. Its website details what help is available and where your nearest bureau is, for face-to-face advice.
Helpline: 0800 144 8848 in England / 0800 702 2020 in Wales (open 09.00 – 17.00 Monday-Friday)
The Trussell Trust
The Trussell Trust supports a national network of more than 1,200 food banks, providing emergency food for free to those who need it. You can use its website to locate support wherever you live.
Helpline: 0808 208 2138 (open 09.00 – 17.00 Monday-Friday)
Turn2us
Turn2us is a national charity providing practical support to people who are struggling financially. Its website includes a benefits calculator and details of schemes and grants in your area, including for energy and water bills.
Helpline: 0808 802 2000 (open 09.00 – 17.00 Monday-Friday)
Maternity/Paternity/Shared Parental Allowance/Statutory Parental Bereavement Pay
- Standard rate: £156.66 (from £151.97)
Pension Credit
- Single: £182.60 (from £177.10)
- Couple: £278.70 (from £270.30)
Personal Independence Payment (PIP)
Daily Living Component
- Enhanced: £92.40 (from £89.60)
- Standard: £61.85 (from £60.00)
Mobility Component
- Enhanced: £64.50 (from £62.55)
- Standard: £24.45 (from £23.70)
State Pension
New State Pension
- £185.15 (from £179.60)
Old State Pension
- Category A or B Basic: £141.85 (from £137.60)
Category B (lower) basic pension - spouse or civil partner's insurance: £85 (from £82.45)
Category C or D - non-contributory: £85 (from £82.45)
Widow's Pension
- Standard rate: £126.35 (from £122.55)
Universal Credit (monthly rates shown)
Standard allowance
Single
- Single under 25: £265.31 (from £257.33)
- Single 25 or over: £334.91 (from £324.84)
Couple
- Joint claimants both under 25: £416.45 (from £403.93)
- Joint claimants, one or both 25 or over: £525.72 (from £509.91)
Child amounts
- First child (born prior to 6 April 2017): £290.00 (from £282.60)
- First child (born on or after 6 April 2017) or second child and subsequent child (where an exception or transitional provision applies): £244.58 (from £237.08)
Disabled child additions
- Lower rate: £132.89 (from £128.89)
- Higher rate: £414.88 (from 402.41) | https://www.derbytelegraph.co.uk/news/cost-of-living/universal-credit-benefits-rise-millions-7386040 | 2022-07-27T12:04:30Z | https://www.derbytelegraph.co.uk/news/cost-of-living/universal-credit-benefits-rise-millions-7386040 | true |
MARLBOROUGH, Mass. (AP) _ Boston Scientific Corp. (BSX) on Wednesday reported second-quarter profit of $260 million.
On a per-share basis, the Marlborough, Massachusetts-based company said it had net income of 17 cents. Earnings, adjusted for amortization costs and costs related to mergers and acquisitions, came to 44 cents per share.
The results topped Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 42 cents per share.
The medical device manufacturer posted revenue of $3.24 billion in the period, also exceeding Street forecasts. Nine analysts surveyed by Zacks expected $3.21 billion.
For the current quarter ending in October, Boston Scientific expects its per-share earnings to range from 43 cents to 45 cents.
The company expects full-year earnings in the range of $1.74 to $1.77 per share.
Boston Scientific shares have fallen 11% since the beginning of the year, while the S&P's 500 index has declined 18%. The stock has declined 14% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BSX at https://www.zacks.com/ap/BSX | https://www.beaumontenterprise.com/business/article/Boston-Scientific-Q2-Earnings-Snapshot-17331716.php | 2022-07-27T12:05:41Z | https://www.beaumontenterprise.com/business/article/Boston-Scientific-Q2-Earnings-Snapshot-17331716.php | true |
MILWAUKEE (AP) _ Rockwell Automation Inc. (ROK) on Wednesday reported fiscal third-quarter net income of $297.9 million.
On a per-share basis, the Milwaukee-based company said it had net income of $2.55. Earnings, adjusted for non-recurring costs, came to $2.66 per share.
The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.31 per share.
The industrial equipment and software maker posted revenue of $1.97 billion in the period, also beating Street forecasts. Six analysts surveyed by Zacks expected $1.95 billion.
Rockwell Automation expects full-year earnings in the range of $9.30 to $9.70 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ROK at https://www.zacks.com/ap/ROK | https://www.beaumontenterprise.com/business/article/Rockwell-Automation-Fiscal-Q3-Earnings-Snapshot-17331795.php | 2022-07-27T12:08:51Z | https://www.beaumontenterprise.com/business/article/Rockwell-Automation-Fiscal-Q3-Earnings-Snapshot-17331795.php | true |
Phoenix remembers pilots, photojournalists killed in 2007 news helicopter crash
PHOENIX (3TV/CBS 5) — Phoenix news stations and the community are remembering the news helicopter crash that killed four people as Wednesday is the 15th anniversary. On July 27, 2007, two-man crews in helicopters for 3TV and Channel 15 were covering a police chase when they collided mid-air around 12:45 p.m. Both choppers came down in Steele Indian School Park in central Phoenix. 3TV’s pilot Scott Bowerbank and photographer Jim Cox died, along with Channel 15′s pilot Craig Smith and photographer Rick Krolak. No one on the ground was hurt.
A year later, a memorial was unveiled at the park to honor the four men who died. Every year, friends and family of the victims gather together to remember them and share stories. Flowers are also placed at the memorial, which has photos of the four men and a plaque about what happened.
To celebrate the lives of Jim Cox and his colleagues and make sure their legacy endures, Cox’s family has created The James Alan Cox Foundation for student photographers. It provides financial support to expand opportunities for young photojournalists. In honor of their memories, Arizona’s Family will make a donation to the foundation. During the last 15 years, Arizona’s Family has had 10 James Alan Cox Foundation interns, and there will be another one this fall. Cox’s family also donates cameras to high schoolers interested in journalism.
Cox graduated from Arizona State University and joined 3TV (KTVK) in 1993. He worked his way up to be a cameraman in the helicopter. Bowerbank started flying for KTVK in 2004 and was a longtime pilot who was also a certified flight instructor.
Smith started as a traffic reporter and then learned to fly. He got his helicopter pilot’s license in 1990. Krolak had spent nine years at Channel 15 and was known for his smile and bad jokes. At the time of the crash, five different news helicopters were covering the chase. Today, there is one helicopter that is shared across five stations.
Copyright 2022 KTVK/KPHO. All rights reserved. | https://www.azfamily.com/2022/07/27/phoenix-remembers-pilots-photojournalists-killed-2007-news-helicopter-crash/ | 2022-07-27T12:10:51Z | https://www.azfamily.com/2022/07/27/phoenix-remembers-pilots-photojournalists-killed-2007-news-helicopter-crash/ | false |
ET HealthWorld privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website.
You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website.
If you choose to ignore this message, we'll assume that you are happy to receive all cookies on ET HealthWorld.
New Delhi: The suspected patient of monkeypox, admitted to the LNJP Hospital here, had travelled abroad about a month ago, sources said on Wednesday.
A resident of Ghaziabad, the man had fever and lesions for the last one week while his reports from the National Institute of Virology, Pune are awaited, they said.
He was admitted to the state-run hospital on Tuesday afternoon and is in the isolation ward.
India has reported four cases of monkeypox, including three in Kerala, so far.
Meanwhile, the west Delhi man, who was the first reported monkeypox case in the capital, is currently recovering in the isolation ward of the Lok Nayak Jai Prakash (LNJP) Hospital.
His condition is stable and will be discharged once his lesions are completely healed, sources said.
According to the patient isolation guidelines issued by the Centre, those infected must stay in a separate room with "separate ventilation".
They must wear a triple-ply mask while the skin lesions should be covered to the best extent possible to minimise the risk of contact with others.
The patients should will remain in isolation until all lesions have healed and the scabs completely fallen off.
The special CBI court, in an 80-page order rejecting the bail pleas of all five accused in the case earlier this week, said: "The questions involved are with larger ramifications to the welfare of the common public and the credit/reputation of the institution of which the applicant/public servants involved are associated." | https://health.economictimes.indiatimes.com/news/industry/monkeypox-suspect-admitted-to-delhi-hospital-had-travelled-abroad-sources/93160006 | 2022-07-27T12:13:49Z | https://health.economictimes.indiatimes.com/news/industry/monkeypox-suspect-admitted-to-delhi-hospital-had-travelled-abroad-sources/93160006 | false |
Acquisition expands AHF footprint and sets the company & its customers up for profitability and growth
MOUNTVILLE, Pa., July 27, 2022 /PRNewswire/ -- AHF Products announced that it has closed the purchase of certain assets of Armstrong Flooring, Inc., including the rights to license the Armstrong Flooring® brand name as well as the purchase of three U.S. manufacturing facilities, in Lancaster and Beech Creek, PA and in Kankakee, IL.
Headquartered in Mountville, Pennsylvania, AHF Products is the largest hardwood flooring manufacturer in North America and has experienced rapid growth across a range of additional flooring categories, including vinyl plank, laminate, and commercial flooring products. With this purchase, AHF now operates 11 manufacturing facilities, ten in the U.S. and one in Cambodia, and four domestic distribution facilities to serve customers through a multi-channel strategy that includes dealers, home centers, and distributors around the world.
Brian Carson, CEO and President, AHF Products said: "AHF is primed to benefit from a strong long-term outlook in both residential repair and remodel spend and new residential housing construction, and the benefits afforded by our strong domestic manufacturing capabilities. This purchase also significantly increases our position in the commercial flooring segment, which is expected to grow. We have seen incredible growth since our inception in 2019, and we are thrilled to be adding the venerable Armstrong Flooring brand to our powerful portfolio."
"Today AHF offers 14 brands, including Armstrong Flooring, which allow us to expand our customer base and grow these manufacturing facilities," added Carson. "Purchasing these assets is important and transformative to AHF and to the people that work in the plant locations and in those communities. With 11 plants and some of best trade names in the flooring industry, we are going to continue to grow from here."
AHF Products previously acquired LM Flooring in 2019, followed by Parterre Flooring and American OEM in 2021. The Armstrong Flooring assets and brand license is the latest for AHF Products as it continues to grow both organically and through acquisition, continuing a strategy of serving its customers through sought-after products, outstanding service, and innovation.
AHF Products is a leading hardwood flooring manufacturer in the USA with a family of trusted brands serving the residential and commercial hardwood and vinyl flooring markets. With decades of experience in award-winning wood flooring design, product development, manufacturing, and service, we create quality flooring to last for generations through inspiring designs, product innovation and a deep commitment to outstanding customer service. Our residential flooring brands include Bruce®, Hartco®, Robbins®, LM Flooring ®, Capella®, HomerWood®, Hearthwood®, Raintree®, Autograph™, Emily Morrow Home™ and tmbr®. Our commercial brands include Bruce Contract™, Hartco Contract™, AHF Contract™ and Parterre®. Headquartered in Mountville, Pennsylvania, with manufacturing operations across the United States and in Cambodia, AHF Products employs over 2,600 dedicated team members. www.AHFProducts.com
Armstrong® is a trademark of Armstrong World Industries, Inc. All other marks are owned by AHF, LLC, its affiliates, or subsidiaries. All rights reserved.
View original content:
SOURCE AHF Products | https://www.kbtx.com/prnewswire/2022/07/27/ahf-products-completes-purchase-certain-assets-armstrong-flooring/ | 2022-07-27T12:14:48Z | https://www.kbtx.com/prnewswire/2022/07/27/ahf-products-completes-purchase-certain-assets-armstrong-flooring/ | false |
Round led by Nufarm will advance company's digital discovery platform and pipeline of leading crop health molecules
MYSTIC, Conn., July 27, 2022 /PRNewswire/ -- Enko, the crop health company, today announced $70 million in Series C funding, bringing the company's overall capital raised to date to $140 million. Global agrochemical company Nufarm led the round as part of an expanded partnership to bring innovative products to their core markets.
Enko will use the new funds to advance its product pipeline of crop protection chemistries that target critical pests and weeds through novel pathways. The funds will also expand Enko's ENKOMPASSTM technology platform, which combines DNA-encoded library screening with machine learning and structure-based design to quickly find new, better performing and more targeted chemistries. Since its start in 2017, Enko has generated hundreds of leading molecules across all categories of crop protection. Enko's product pipeline is currently led by a range of herbicides that are demonstrating breakthrough performance compared to industry standards like glyphosate.
"Reliance on outdated chemistries has led to rampant resistance that is threatening farmer livelihoods and our food supply," said Enko CEO and founder Jacqueline Heard. "Enko's digital platform massively increases the scale and discovery rate for new solutions, screening out off-target organisms from the get-go. The result is bringing safe and effective products to growers better, faster and cheaper. The need for this innovation has never been more urgent."
To move the industry forward amidst stalled R&D, Enko is collaborating with Syngenta and Bayer on promising new chemistries. Enko's target-based approach has generated its industry-leading discoveries in roughly half the time and with fewer resources than conventional R&D methods.
On expanding their partnership, Nufarm Managing Director and CEO Greg Hunt said, "We were early investors in Enko and have followed the performance of their pipeline in the lab and field over the last two years with increased interest. As an agricultural innovator, Nufarm's strategy is to partner with like-minded companies who recognize that innovation and technology are the future for sustainable agriculture practices. We were delighted to invest in this Series C financing round."
In addition to Nufarm, its investors include Anterra Capital, Taher Gozal, the Bill & Melinda Gates Foundation, Eight Roads Ventures, Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, Endeavor8, Alumni Ventures Group and Rabo Food & Agri Innovation Fund.
About Enko
Enko designs safe and sustainable solutions to farmers' biggest crop threats today, from pest resistance to new diseases by applying the latest drug discovery and development approaches from pharma to agriculture. Enko is headquartered in Mystic, Connecticut. For more information, visit enkochem.com.
About Nufarm
Nufarm is a global crop protection and seed technology company established over 100 years ago. It is listed on the Australian Securities Exchange (ASX:NUF) with its head office in Melbourne, Australia. As an agricultural innovator, Nufarm is focused on innovative crop protection and seed technology solutions. It has introduced to the market Omega-3 canola and has an expanding portfolio of unique GHG biofuel solutions. Nufarm has manufacturing and marketing operations in Australia, New Zealand, Asia, Europe and North America.
Media Contacts
Mission North for Enko
enko@missionnorth.com
View original content to download multimedia:
SOURCE Enko | https://www.mysuncoast.com/prnewswire/2022/07/27/enko-raises-70m-series-c-commercialize-safe-crop-protection-through-machine-learning-based-discovery-technology/ | 2022-07-27T12:17:29Z | https://www.mysuncoast.com/prnewswire/2022/07/27/enko-raises-70m-series-c-commercialize-safe-crop-protection-through-machine-learning-based-discovery-technology/ | false |
To better serve our Milwaukee community, we must continue hiring diverse, talented journalists
For the Milwaukee Journal Sentinel to succeed, we must have an inclusive and diverse workplace where employees are valued and feel empowered.
We are committed to building and sustaining a workforce that is reflective of the diversity in the communities we serve.
"It's important to have journalists and newsroom leaders with life experiences and backgrounds that help us understand the needs of the people we serve. But it is the job of each of us to listen and learn how we can best find answers to your most pressing and important questions," said editor George Stanley.
As part of our commitment to an inclusive culture, we are annually publishing the makeup of our newsroom staff. That same commitment is being carried out across the USA TODAY Network, which is made up of more than 200 local publications and USA TODAY.
More:Gannett newsrooms making steady progress in overall diversity
This information, a snapshot as of July 1, includes the gender and racial makeup of our news workforce and our coverage area, as well as for managers within our newsroom.
This year, the Journal Sentinel's newsroom staff is 75% white, 11.1% Black, 2.8% Asian, 6.5% Hispanic/Latino and 4.6% two or more races. Among managers, the staff is 76.5% white, 17.6% Black and 5.9% Hispanic/Latino. According to the American Community Survey by the U.S. Census Bureau, the Milwaukee area is 69.8% white, 13.5% Black, 3.9% Asian, 9.4% Hispanic/Latino, 0.3% Native American and 2.6% two or more races.
On gender, the newsroom is 42.6% women, and 29.4% of managers are women.
We've pledged that our newsroom will be reflective of the community we serve by 2025.
This means that we need to hire more Black journalists, more Latino journalists and more Asian journalists. We need more women journalists in our newsroom and its leadership, too.
A diverse and inclusive workforce helps us better connect and serve you, our readers and our community partners.
About the data
The American Community Survey by the U.S. Census Bureau asks two separate questions, one about Hispanic origin and one about race, allowing individuals to self-select from multiple options. However, to compare with internal Gannett employee information that asks individuals to mark only one option, we used the following categories: Hispanic or Latino (for ACS, regardless of any other race selected), White (not Hispanic or Latino), Black or African American (not Hispanic or Latino), Asian (not Hispanic or Latino), American Indian or Alaska Native (not Hispanic or Latino), Native Hawaiian or other Pacific Islander (not Hispanic or Latino), or two or more races (not Hispanic or Latino). All information on racial identity is provided voluntarily by employees. Gannett also allows an individual to not disclose their race or ethnicity. | https://www.jsonline.com/story/news/2022/07/27/milwaukee-journal-sentinel-hiring-must-continue-diverse/10029056002/ | 2022-07-27T12:19:13Z | https://www.jsonline.com/story/news/2022/07/27/milwaukee-journal-sentinel-hiring-must-continue-diverse/10029056002/ | false |
NEW YORK, July 27, 2022 /PRNewswire/ -- Corporate Property Associates 18 – Global Incorporated (CPA®:18 – Global) announced today that the proposed merger with W. P. Carey Inc. (NYSE: WPC), its advisor, was approved by its stockholders. The transaction is expected to close on August 1, 2022.
CPA®:18 – Global is a publicly registered non-traded real estate investment trust (REIT) with a diversified portfolio of commercial real estate properties leased to companies domestically and internationally in addition to self-storage and student housing assets.
Certain of the matters discussed in this press release constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995. The forward-looking statements include, among other things, statements regarding the anticipated timing of the closing of the merger. These statements are based on the current expectations of our management and are subject to change. There are a number of risks and uncertainties that could cause actual results to differ materially from these forward-looking statements. Other unknown or unpredictable factors could also have material adverse effects on future results, performance or achievements of CPA®:18 – Global. Discussions of some of these other important factors and assumptions are contained in CPA®:18 – Global 's filings with the Securities and Exchange Commission (the "SEC") and are available at the SEC's website at http://www.sec.gov, including Part I, Item 1A. Risk Factors in CPA®:18 – Global 's Annual Report on Form 10-K for the year ended December 31, 2021 and in Part II, Item 1A. Risk Factors in CPA®:18 – Global 's Quarterly Report on Form 10-Q for the quarter ended March 31, 2022. In light of these risks, uncertainties, assumptions and factors, the forward-looking events discussed in this communication may not occur. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release, unless noted otherwise. Except as required under the federal securities laws and the rules and regulations of the SEC, CPA®:18 – Global does not undertake any obligation to release publicly any revisions to the forward-looking statements to reflect events or circumstances after the date of this communication or to reflect the occurrence of unanticipated events.
Press Contact:
Anna McGrath
W. P. Carey Inc.
212-492-1166
amcgrath@wpcarey.com
Individual Investors:
W. P. Carey Inc.
(212) 492-8920
ir@wpcarey.com
View original content to download multimedia:
SOURCE CPA 18 - GLOBAL | https://www.kmvt.com/prnewswire/2022/07/27/cpa18-global-announces-stockholder-approval-merger-with-w-p-carey-inc/ | 2022-07-27T12:20:16Z | https://www.kmvt.com/prnewswire/2022/07/27/cpa18-global-announces-stockholder-approval-merger-with-w-p-carey-inc/ | false |
PENSKE AUTOMOTIVE GROUP REPORTS ALL-TIME RECORD QUARTERLY EARNINGS
Published: Jul. 27, 2022 at 6:58 AM EDT|Updated: 1 hour ago
Earnings Before Taxes Increased 8% to $500 Million
Income From Continuing Operations Increased 10% to $374 Million
Earnings Per Share Increased 17% to $4.93
Repurchased 3.5 Million Shares of Common Stock for $362.7 Million Year-To-Date Through July 26, 2022
Board of Directors Increases Securities Repurchase Authorization by $250 Million
BLOOMFIELD HILLS, Mich., July 27, 2022 /PRNewswire/ -- Penske Automotive Group, Inc. (NYSE: PAG), a diversified international transportation services company and one of the world's premier automotive and commercial truck retailers, today announced all-time record quarterly earnings for the second quarter of 2022. For the quarter, revenue decreased 1% to $6.9 billion. Foreign currency exchange negatively impacted revenue by $245.2 million. Excluding the impact from foreign currency exchange, revenue would have increased by 2%. Income from continuing operations attributable to common stockholders increased 10% to $374.0 million, and related earnings per share increased 17% to $4.93. Foreign currency exchange negatively impacted earnings per share by $0.11. For the three months ended June 30, 2021, income from continuing operations attributable to common stockholders was $338.8 million and related earnings per share was $4.20, and as shown in the attached non-GAAP reconciliation schedules, adjusted income from continuing operations was $360.2 million and related adjusted earnings per share was $4.47, reflecting increases of 4% and 10%, respectively.
Second Quarter 2022 Operating Highlights Compared to Second Quarter 2021
(Percentage Change Excluding Foreign Currency Exchange Shown in Parenthesis)
Commenting on the Company's results, Chair and CEO Roger Penske said, "I am pleased to report that our diversified business delivered all-time record quarterly earnings for the second quarter of 2022, including a sequential improvement in earnings before taxes, income from continuing operations, and earnings per share when compared to the first quarter of 2022. Despite the supply constraints that continue to impact inventory availability, demand remains strong, and we continue to benefit from the diversification of our operations."
For the six months ended June 30, 2022, the Company reported a 9% increase in revenue to $13.9 billion. Income from continuing operations attributable to common stockholders increased 42% to $741.9 million, and related earnings per share increased 50% to $9.70. Foreign currency exchange negatively impacted revenue by $279.8 million and earnings per share by $0.16. For the six months ended June 30, 2021, income from continuing operations attributable to common stockholders was $521.3 million and related earnings per share was $6.46, and as shown in the attached non-GAAP reconciliation schedules, adjusted income from continuing operations was $542.7 million and related adjusted earnings per share was $6.73, reflecting increases of 37% and 44%, respectively.
Retail Automotive Dealerships
For the three months ended June 30, 2022, total retail automotive revenue decreased 3% to $6.0 billion, including an 8% decrease on a same-store basis when compared to the same period last year. Total retail automotive gross profit increased 2% to $1.1 billion, including a 3% decrease on a same-store basis. Gross margin increased 90 basis points to 17.7% as variable gross profit per unit retailed increased 16%, or $809, to $5,964 and return on sales was 5.0%. Excluding foreign currency exchange impacts, total retail automotive revenue remained flat and total retail automotive gross profit increased 5%.
CarShop Used Vehicle Centers
As of June 30, 2022, we operated 21 CarShop used vehicle locations. For the three months ended June 30, 2022, retail unit sales increased by 7% to 20,124 while total revenue increased by 15% to $468.0 million, including an increase of 6% on a same-store basis. For the six months ended June 30, 2022, retail unit sales increased by 32% to 39,647 while total revenue increased by 51% to $983.9 million, including an increase of 37% on a same-store basis. For the three and six months ended June 30, 2022, losses before taxes were of $1.5 million and $2.7 million, respectively, due to the increased cost of acquiring used vehicles resulting from the lower supply of new vehicles available for sale and higher reconditioning costs.
Retail Commercial Truck Dealerships
As of June 30, 2022, we operated 39 North American commercial truck locations under the Premier Truck Group name which offer new and used trucks for sale, a full range of parts, maintenance and repair services, collision centers, and finance and insurance options. For the three months ended June 30, 2022, earnings before taxes increased 32% to $52.3 million compared to $39.7 million in the same period last year, and return on sales was 6.8%. For the six months ended June 30, 2022, earnings before taxes increased 65% to $110.8 million compared to $67.2 million in the same period last year, and return on sales was 7.1%.
Penske Australia
Penske Australia is the exclusive importer and distributor of certain heavy- and medium-duty trucks and buses and refuse collection vehicles, together with associated parts, across Australia, New Zealand, and portions of the Pacific and is a leading distributor of diesel and gas engines and power systems. For the three months ended June 30, 2022, revenue decreased 14% to $140.9 million compared to $164.6 million in the same period last year. However, earnings before taxes increased 5% to $8.8 million compared to $8.4 million in the same period last year, and return on sales was 6.2%. For the six months ended June 30, 2022, revenue decreased 1% to $294.8 million compared to $296.8 million in the same period last year. However, earnings before taxes increased 34% to $19.3 million compared to $14.4 million in the same period last year, and return on sales was 6.5%. Excluding foreign currency exchange impacts for the three and six months ended June 30, 2022, revenue decreased 7% and increased 7%, respectively.
Penske Transportation Solutions Investment
Penske Transportation Solutions ("PTS") is a leading provider of full-service truck leasing, truck rental, contract maintenance, and logistics services. Penske Automotive Group has a 28.9% ownership interest in PTS and accounts for its ownership interest using the equity method of accounting. For the three and six months ended June 30, 2022, the Company recorded $136.6 million and $255.1 million in earnings compared to $102.5 million and $156.2 million for the same periods last year, representing increases of 33% and 63%, respectively. The increase was principally driven by increased demand for PTS's full-service leasing, rental, logistics services, and remarketing of used trucks, which resulted in a 14% return on sales for PTS during the second quarter 2022.
Corporate Development and Capital Allocation
Year-to-date, the Company has added approximately $745 million in annualized revenue through acquisitions and open points. The acquisitions consist of four commercial truck dealerships located in Ontario, Canada and ten retail automotive franchises, consisting of six in the U.K. and four in the U.S. We also opened two retail automotive franchises that we were awarded in the U.S. Additionally, the Company has signed an agreement to acquire five Mercedes-Benz dealerships and three aftersales locations in North London, United Kingdom, from Mercedes-Benz Retail Group U.K. The dealerships and aftersales locations subject to the acquisition are expected to generate revenue of approximately $550 million for the full year of 2022. Closing of the transaction is expected to occur during the third quarter of 2022, subject to the satisfaction or waiver of customary conditions.
Based on the Company's strong earnings and cash flow, the Board of Directors has increased the quarterly dividend three times in 2022 from $0.46 per share to $0.53 per share. During the six months ended June 30, 2022, we also repurchased 2.7 million shares of common stock for approximately $275.4 million under our securities repurchase program and acquired 148,440 shares of our common stock for $17.2 million from employees in connection with a net share settlement feature of employee equity awards. From July 1, 2022, through July 26, 2022, we repurchased an additional 0.8 million shares for an aggregate purchase price of $87.3 million under our securities repurchase program. In July 2022, our Board of Directors increased the authority delegated to management to repurchase our outstanding securities by $250 million. As of July 26, 2022, the Company's total available repurchase authority is $330.6 million.
Conference Call
Penske Automotive Group will host a conference call discussing financial results relating to the second quarter of 2022 on Wednesday, July 27, 2022, at 2:00 p.m.Eastern Time. To listen to the conference call, participants must register in advance using this link: https://conferencingportals.com/event/dbtxjpcq. Upon registering, participants will receive a confirmation which includes dial-in numbers and a unique conference call access code and PIN for entry. We suggest registering at least 10 minutes prior to the start of the call. The call will also be simultaneously broadcast over the Internet. To access the live audio webcast, please use the following link https://events.q4inc.com/attendee/328850966, or through the Investors section of the Penske Automotive Group website. Additionally, an investor presentation relating to the second quarter 2022 financial results has been posted to the Company's website. To access the presentation or to listen to the Company's webcast, please refer to www.penskeautomotive.com.
About Penske Automotive
Penske Automotive Group, Inc., (NYSE: PAG) headquartered in Bloomfield Hills, Michigan, is a diversified international transportation services company and one of the world's premier automotive and commercial truck retailers. PAG operates dealerships principally in the United States, the United Kingdom, Canada, Germany, Italy, and Japan and is one of the largest retailers of commercial trucks in North America for Freightliner. PAG also distributes and retails commercial vehicles, diesel and gas engines, power systems, and related parts and services principally in Australia and New Zealand. Additionally, PAG owns 28.9% of Penske Transportation Solutions, a business that manages a fleet of over 386,000 vehicles providing innovative transportation, supply chain, and technology solutions to North American fleets. PAG is a member of the Fortune 500, Russell 1000, and Russell 3000 indexes and is ranked among the World's Most Admired Companies by Fortune Magazine. For additional information, visit the Company's website at www.penskeautomotive.com.
Non-GAAP Financial Measures
This release contains certain non-GAAP financial measures as defined under SEC rules, such as adjusted income from continuing operations, adjusted earnings per share, earnings before interest, taxes, depreciation, and amortization ("EBITDA"), adjusted EBITDA, and leverage ratio. The Company has reconciled these measures to the most directly comparable GAAP measures in the release. The Company believes that these widely accepted measures of operating profitability improve the transparency of the Company's disclosures and provide a meaningful presentation of the Company's results from its core business operations excluding the impact of items not related to the Company's ongoing core business operations and improve the period-to-period comparability of the Company's results from its core business operations. These non-GAAP financial measures are not substitutes for GAAP financial results and should only be considered in conjunction with the Company's financial information that is presented in accordance with GAAP.
Caution Concerning Forward Looking Statements
Statements in this press release may involve forward-looking statements, including forward-looking statements regarding Penske Automotive Group, Inc.'s financial performance, acquisitions, and growth plans. Actual results may vary materially because of risks and uncertainties that are difficult to predict. These risks and uncertainties include, among others, the Company's ability to successfully complete the acquisition of the Mercedes-Benz dealerships described in this press release, including the satisfaction or waiver of closing conditions with respect to such acquisition, the duration, severity, and resolution of the COVID-19 pandemic, government mandated restrictions on our business in light of COVID-19 or otherwise, macro-economic and geo-political conditions generally, conditions in the credit markets, inflation, changes in interest rates and foreign currency exchange rates, changes in tariff rates, changes in the distribution model in our international operations via agency or other means, new or enhanced regulations that may impact the sale of certain vehicles through our dealerships, adverse conditions affecting a particular manufacturer, including the adverse impact to the vehicle and parts supply chain due to limited vehicle availability as a result of the COVID-19 pandemic, the war in Ukraine, the shortage of automotive semiconductor chips or other components, natural disasters, recall initiatives or other disruptions that interrupt the supply of vehicles or parts to us, changes in consumer credit availability, the outcome of legal and administrative matters, and other factors over which management has limited control. These forward-looking statements should be evaluated together with additional information about Penske Automotive Group's business, markets, conditions, and other uncertainties, which could affect Penske Automotive Group's future performance. These risks and uncertainties are addressed in Penske Automotive Group's Form 10-K for the year ended December 31, 2021, Form 10-Q for the quarterly period ended March 31, 2022, and its other filings with the Securities and Exchange Commission ("SEC"). This press release speaks only as of its date, and Penske Automotive Group disclaims any duty to update the information herein.
The above press release was provided courtesy of PRNewswire. The views, opinions and statements in the press release are not endorsed by Gray Media Group nor do they necessarily state or reflect those of Gray Media Group, Inc. | https://www.mysuncoast.com/prnewswire/2022/07/27/penske-automotive-group-reports-all-time-record-quarterly-earnings/ | 2022-07-27T12:20:52Z | https://www.mysuncoast.com/prnewswire/2022/07/27/penske-automotive-group-reports-all-time-record-quarterly-earnings/ | true |
New E-commerce Platform and Website Offers Technology to Help People of All Ages Live Independently
LOUISVILLE, Ky., July 27, 2022 /PRNewswire/ -- LogicMark, Inc., (Nasdaq: LGMK) (the "Company" or "LogicMark") (formerly Nxt-ID, Inc.), a provider of personal emergency response systems (PERS), health communications devices and remote care and activity monitoring technologies to create a connected care platform, today announces its new direct-to-consumer sales channel to broadly deliver its solutions to more people, including families and caregivers. The company is unveiling a new website and e-commerce platform which will facilitate its new direct-to-consumer distribution channel.
"For more than 10 years [LogicMark formed 12/6/2011], our company and technology have earned the trust of our customers by helping them live worry-free knowing we are there to help when they need it most," said Chia-Lin Simmons, CEO of LogicMark. "Technology has made life easier and more convenient in many ways, and now we are building solutions that can support freedom for the whole family -- from caregivers to those needing care. We are excited to finally make our products available directly to consumers who need them."
Today LogicMark is working to disrupt the care economy and help people of all ages live with greater peace of mind. The new company website offers a user-friendly experience with the opportunity for consumers to purchase products directly from the online store. The website includes a fresh look and feel as well as the company's updated branding, messaging, and mission.
Consumers can directly purchase the company's best-selling products via the new website, including the GuardianAlert911+, GuardianAlert911 and FreedomAlert. The simple, easy-to-use solutions provide safety and security for people both at home and on-the-go.
LogicMark's new website and e-commerce platform comes on the heels of the company's recent name change (from Nxt-ID to LogicMark) to reflect the company's enhanced focus on the care economy and technology.
"It's time for innovation in the care economy, allowing caregivers to confidently care for those they love, while helping their loved ones to continue to live independently," continued Simmons. "Peace of mind is priceless. Our new direct-to-consumer e-commerce platform is just the beginning of LogicMark's evolution."
To date, LogicMark has supplied more than 500,000 PERS devices to seniors, veterans and loved ones, providing them with the confidence to live independently at home for as long as possible. Through distribution via the Veterans Health Administration medical centers and outpatient clinics, LogicMark provides these devices to U.S. veterans at no charge. The U.S. government awarded LogicMark a GSA contract in July 2021, enabling the company to partner with federal, state and local governments to widen the distribution of its products.
To learn more about LogicMark, their products and services, visit www.logicmark.com.
LogicMark, Inc. (formerly Nxt-ID, Inc.) provides personal emergency response systems (PERS), health communications devices and remote care and activity monitoring technologies to create a connected care platform. The Company's devices give people the ability to receive care at home and confidence to age in place. LogicMark revolutionized the PERS industry by incorporating two-way voice communication technology directly into its medical alert pendant and providing this life-saving technology at a price point that everyday consumers could afford. LogicMark's PERS solutions are sold through the United States Veterans Health Administration and dealers/distributors. The Company was awarded a contract by the U.S. General Services Administration that enables the Company to distribute its products to federal, state and local governments. For more information on projects and services, visit LogicMark.com.
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements reflect LogicMark's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding LogicMark's successful execution of its business strategy. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target," "intend" and "expect" and similar expressions, as they relate to LogicMark or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to LogicMark and are subject to a number of risks, uncertainties, and other factors that could cause LogicMark's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Media Contact:
Erica Zeidenberg
Hot Tomato Marketing
erica@hottomato.net
925-518-8159 mobile
View original content to download multimedia:
SOURCE LogicMark Inc. | https://www.kmvt.com/prnewswire/2022/07/27/logicmark-launches-direct-to-consumer-sales-channel/ | 2022-07-27T12:22:57Z | https://www.kmvt.com/prnewswire/2022/07/27/logicmark-launches-direct-to-consumer-sales-channel/ | false |
Pantera Capital leads Unstoppable Domains' Series A funding round
LAS VEGAS, July 27, 2022 /PRNewswire/ -- Unstoppable Domains, the leading platform for Web3 digital identity with more than 2.5 million registered NFT domains, today announced it has closed $65 million in Series A funding at a $1 billion valuation. The round was led by new investor Pantera Capital with participation from Mayfield, Gaingels, Alchemy Ventures, Redbeard Ventures, Spartan Group, OKG Investments, Polygon, CoinDCX, CoinGecko, We3 syndicate, Rainfall Capital, Broadhaven, EI Ventures, Hardyaka, and Alt Tab Capital, along with previous investors Boost VC and Draper Associates. Unstoppable Domains will use the funding to fuel product innovation and grow our partnerships in the web3 space as we continue to build a platform for user-owned and portable digital identity.
"Unstoppable Domains is rapidly defining a new category of decentralized identity that will change the internet as we know it," said Paul Veradittakit, Partner at Pantera Capital. "We're proud to back Matt and the rest of the team who are making this vision a reality."
Founded in 2018, Unstoppable Domains offers NFT domains that give people full ownership and control of their digital identity. The company has registered 2.5 million domains, which people can use to log into more than 150 Web3 applications, replace lengthy crypto wallet addresses on more than 80 wallets and exchanges, create decentralized websites, and build their web3 identity. Unstoppable Domains has built more than 300 partnerships with leading web3 companies like Polygon, Blockchain.com, MoonPay and more. Unstoppable Domains has generated more than $80 million in sales since launching in 2019.
"For too long, companies have controlled people's digital identities, and Unstoppable Domains is putting that power back into the hands of people," said Matthew Gould, Founder and CEO of Unstoppable Domains. "As the digital economy becomes a larger part of our lives, it's time for people to own their identity on the internet. We're thrilled to partner with Pantera and other investors who share our vision of onboarding billions of people onto Web3 through NFT domains that unlock user-owned, private, and portable identities."
Unstoppable Domains is a fully remote company and was recently named one of America's Best Startup Employers by Forbes.
Founded in 2018, Unstoppable Domains is an NFT domain name provider and digital identity platform working to onboard the world onto Web3. Unstoppable Domains offers NFT domains minted on the blockchain that give people full ownership and control of their digital identity, with no renewal fees. With Unstoppable Domains, people can replace lengthy alphanumeric crypto wallet addresses with a human-readable name and log into and transact with apps, wallets, exchanges and marketplaces. The company was named by Forbes as one of America's Best Startup Employers in 2022.
MEDIA CONTACT: press@unstoppabledomains.com
Pantera Capital is the first institutional investment firm focused exclusively on bitcoin, other digital currencies, and companies in the blockchain tech ecosystem. Pantera launched the first cryptocurrency fund in the United States when bitcoin was at $65/BTC in 2013. The firm subsequently launched the first exclusively-blockchain venture fund. In 2017, Pantera was the first firm to offer an early-stage token fund. Pantera Bitcoin Fund has returned over 32,000% in nine years and has returned billions to its investors. Pantera manages $4.7bn across three strategies – passive, hedge, and venture.
View original content to download multimedia:
SOURCE Unstoppable Domains | https://www.kbtx.com/prnewswire/2022/07/27/unstoppable-domains-raises-65-million-1-billion-valuation-turn-nfts-into-your-web3-digital-identity/ | 2022-07-27T12:23:46Z | https://www.kbtx.com/prnewswire/2022/07/27/unstoppable-domains-raises-65-million-1-billion-valuation-turn-nfts-into-your-web3-digital-identity/ | true |
PHILADELPHIA (WPVI) -- Ryan Reynolds is now the spokesperson for A&W Restaurants.
No, not that Ryan Reynolds.
The video in the player above is from a previous report about National Root Beer Float Day.
"I'm advertising's fresh faced golden boy," Ryan Reynolds, not that one, says in A&W's National Root Beer Float Day promotional video.
This Ryan Reynolds is a newspaper editor from Evansville, Indiana.
"I'll say anything you want for a fraction of the price of the old Ryan Reynolds," Ryan Reynolds, not that one, says.
This Ryan Reynolds was hired by A&W Restaurants to promote their root beer giveaway.
From now until August 6 (National Root Beer Float Day) you can get a free A&W Root Beer Float by signing up for the restaurant's Mug Club. You can find locations here.
No purchase is necessary, but A&W encourages donations to the Disable American Veterans nonprofit charity.
"This is our signature promotion," Liz Bazner, Senior Director of Marketing at A&W, said in a press release. "We think having Ryan Reynolds attached to it this year is going to make it our biggest and best yet."
She was talking about the newspaper editor Ryan Reynolds, of course.
Ryan Reynolds, not that one, describes his well-known counterpart as "Ryan Reynolds: actor, producer, creative director, gin slinger, soccer team owner, mobile network mogul, cellphone company tycoon and 2010 People Magazine's Sexiest Man Alive."
"Whatever. Save some headlines for the rest of us, Deadpool," Ryan Reynolds, not that one, says.
A&W says their Ryan Reynolds has previously only lent his creative abilities to personal projects and a full-time career in the media industry.
"To be honest we were kind of shocked when he agreed to do it," A&W's Bazner said. "It really is true that you miss 100% of the shots you don't take."
Again, A&W was talking about Ryan Reynolds, not that one. | https://6abc.com/ryan-reynolds-aw-restaurants-national-root-beer-float-day-spokesperson/12076190/ | 2022-07-27T12:26:28Z | https://6abc.com/ryan-reynolds-aw-restaurants-national-root-beer-float-day-spokesperson/12076190/ | false |
Extends Maturities to 2027 and 2028, Increases Term Loan Borrowing Capacity, and Results in a Fully Undrawn Revolving Credit Facility
IRVINE, Calif., July 27, 2022 /PRNewswire/ -- Sunstone Hotel Investors, Inc. (the "Company" or "Sunstone") (NYSE: SHO), the owner of Long-Term Relevant Real Estate® in the lodging industry, announced today that it has entered into a Second Amended and Restated Credit Agreement (the "Amended Credit Agreement") which expands the Company's unsecured borrowing capacity and extends the maturity of the in-place loans. The Amended Credit Agreement continues to provide for a $500 million revolving credit facility and increases the aggregate amount of the Company's two term loan facilities from $108 million to $350 million. The facilities will bear interest pursuant to a leverage-based pricing grid ranging from 1.35% to 2.25% over the applicable adjusted term SOFR. The $500 million revolving credit facility has two six-month extension options, which would result in an extended maturity of July 2027. The two term loan facilities each have a balance of $175 million and mature in July 2027 and January 2028. The Company utilized proceeds received from the incremental borrowing on the term loans to fully repay the $230 million that was outstanding on its revolving credit facility.
"We are pleased to announce this amendment to our credit agreement that further enhances our balance sheet flexibility, extends our maturities, and more prudently utilizes our debt capacity," commented Aaron Reyes, Chief Financial Officer. "We appreciate the support and partnership from our existing and new banking relationships, as their lending commitments to our expanded credit facilities demonstrate their confidence in our balance sheet and corporate strategy."
The Company's $850 million unsecured credit facilities are led jointly by Wells Fargo Securities, LLC, BofA Securities, Inc., JPMorgan Chase Bank, N.A., PNC Capital Markets LLC, U.S. Bank National Association, Truist Securities, Inc., and The Huntington National Bank. Wells Fargo Bank, National Association serves as the Administrative Agent. Bank of America, N.A. and JPMorgan Chase Bank, N.A. serve as the Syndication Agents, PNC Bank, National Association, U.S. Bank National Association, Truist Bank, and The Huntington National Bank are the Documentation Agents, and J.P. Morgan Securities LLC serves as the Sustainability Agent.
Sunstone Hotel Investors, Inc. is a lodging real estate investment trust ("REIT"). Sunstone's strategy is to create long-term stakeholder value through the acquisition, active ownership, and disposition of hotels considered to be Long-Term Relevant Real Estate®. For further information, please visit Sunstone's website at www.sunstonehotels.com.
For Additional Information:
Aaron Reyes
Sunstone Hotel Investors, Inc.
(949) 382-3018
View original content:
SOURCE Sunstone Hotel Investors, Inc. | https://www.kmvt.com/prnewswire/2022/07/27/sunstone-hotel-investors-completes-850-million-amended-restated-credit-agreement/ | 2022-07-27T12:26:31Z | https://www.kmvt.com/prnewswire/2022/07/27/sunstone-hotel-investors-completes-850-million-amended-restated-credit-agreement/ | false |
FIRST 20 STOPS OF TOUR ANNOUNCED TODAY INCLUDING BALTIMORE,
FT. LAUDERDALE, ATLANTA, MEMPHIS, AUSTIN, SAN DIEGO, LOS ANGELES AND LAS VEGAS, WITH MORE CITIES TO BE ANNOUNCED IN THE COMING WEEKS
TICKETS ON SALE FRIDAY, JULY 29 AT COCOMELONLIVE.COM
See a sneak peek HERE
NEW YORK, July 27, 2022 /PRNewswire/ -- CoComelon Live! JJ's Journey is ready to hit the road! Today Michael Cohl's powerhouse production company EMC Presents and Moonbug Entertainment announced the next leg of a massive 65+ city, North American tour kicking off in Baltimore, MD on September 16. The first set of dates will include Ft. Lauderdale (9/20), Atlanta (9/24), Memphis (9/26), Austin (10/2), San Diego (10/8), Los Angeles (10/9) and Las Vegas (10/10) with more dates to be announced (current schedule below). Tickets and VIP packages go on sale Friday, July 29. For complete tour, ticket, and official VIP package information please go to CoComelonLive.com.
Inspired by CoComelon, the #1 most watched entertainment brand on YouTube, fans and press have been raving about the first leg of the tour, saying "The visuals and choreography were nothing short of amazing!" and "So much fun for the kids and even the adults!" The Macaroni Kid blog writer added, "My kids were so excited to dance and sing along to some of their favorite songs along the way but also learn some new ones that had them equally excited to join in."
CoComelon LIVE! JJ's Journey is a Broadway-style musical production and an unforgettable adventure, encouraging parents and kids alike to get out of their seats and sing and dance along. Each stop will be a fun-filled, interactive musical romp with magical special effects. JJ and his family are putting on a show where JJ is writing his own song and he needs a little help. In the end, JJ learns that by using his imagination, he can create, solve problems and can have wonderful adventures, proving that with a little help from your family and friends, you can make your dreams come true. With all the favorite characters and over 20 songs, including new original music, the show is a terrific journey through the world of CoComelon.
"We're so glad JJ and his family are back and can share their exciting journey with other families around the country," said Michael Cohl. "The response we received from the first leg of the tour was extraordinary and I have heard from parents that this is a perfect live event to bond with their child."
"If you know kids who are obsessed with CoComelon and parents or family members who catch themselves singing along, this show is the perfect combination of a high-quality production for adults and consistent audience engagement to keep the kids entertained, "said producer Glenn Osher.
CoComelon has become a perennial leader on major streaming platforms like Amazon, Spotify, Apple Music, Roku and Netflix, where it set the record for consecutive days in the Top 10 'Most Watched TV Show.' As the #1 most-watched entertainment brand on YouTube, CoComelon generates billions of monthly views and has over 139 million subscribers.
CoComelon Live is produced and promoted globally by EMC Presents. The North American tour is presented in association with Premier Productions and S2BN Entertainment.
CoComelon Live! JJ Journey's Tour Schedule
Fri, Sept 16 Baltimore, MD - Lyric Theatre
Sat, Sept 17 Raleigh, NC - Memorial Auditorium
Sun, Sept. 18 Charlotte, NC - Ovens Auditorium
Tue, Sept. 20 Ft. Lauderdale, FL - Broward Center
Wed. Sept. 21 Tampa, FL - Straz Center
Thu. Sept. 22 Jacksonville, FL - Moran Theater
Sat. Sept. 24 Atlanta, GA - Fox Theatre
Sun. Sept. 25 Montgomery, AL - Montgomery Performing Arts Centre
Mon. Sept. 26 Memphis, TN - Orpheum Theatre
Wed. Sept 28 Grand Prairie, TX - Texas Trust CU Theatre at Grand Prairie
Thu., Sept. 29 Sugar Land, TX – Smart Financial Centre at Sugar Land
Sat. Oct. 1 San Antonio, TX - Tobin Center
Sun. Oct. 2 Austin, TX - Bass Hall
Tue. Oct. 4 Lubbock, TX - Buddy Holly Hall
Wed. Oct. 5 Midland, TX - Wagner Noel Performing Arts Center
Thu. Oct. 6 El Paso, TX - Abraham Chavez Theatre
Sat. Oct. 8 San Diego, CA - Civic Theatre
Sun. Oct. 9 Los Angeles, CA - Microsoft Theater
Mon. Oct. 10 Las Vegas, NV - Orleans Arena
Sat. Oct. 15 Long Beach, CA – Terrace Theater
EMC Presents is a partnership between CTS Eventim, one of the leading international providers of ticketing services and live entertainment, and award-winning tour promoter and producer Michael Cohl, creating one of the strongest global networks of promoters and venues. The partnership provides a comprehensive worldwide live entertainment platform, creating extraordinary shows and experiences, from concept creation to production and promotion."
Moonbug Entertainment is an award-winning global entertainment company behind some of the most popular kids' titles in the world. Moonbug's line-up includes global sensations CoComelon, Blippi, Little Baby Bum, Little Angel, My Magic Pet Morphle, Supa Strikas, Go Buster, Playtime with Twinkle, Gecko's Garage, ARPO and many more.
Moonbug's shows are on more than 150 platforms globally, including YouTube, Netflix, Amazon Prime Video, Sky, Super RTL, BBC iPlayer, HBO Max, Tencent, Youku and Roku. The company's portfolio currently stands at 29 IPs and 100+ brand partners. Moonbug content is currently available in 32 languages.
Moonbug is part of Candle Media, an independent, creator-friendly home for cutting-edge, high-quality, category-defining brands and franchises. By bringing together elite talent operating at the intersection of content, community, and commerce, it helps to position leading entertainment businesses for accelerated, sustainable growth in the current market and beyond. Candle is run by its Co-Chairmen and Co-CEOs, leading entertainment executives Kevin Mayer and Tom Staggs, and backed by investment capital from funds managed by Blackstone's flagship private equity business.
Contacts:
UK media contacts:
Monika Fried: monika.fried@moonbug.com
Louise Webster: louise.webster@moonbug.com
US Contacts:
Sunshine Sachs Morgan & Lylis
CoComelonlive@sunshinesachs.com
View original content:
SOURCE CoComelon | https://www.wbay.com/prnewswire/2022/07/27/cocomelon-live-jjs-journey-hits-road-massive-65-city-north-american-tour-inspired-by-cocomelon-1-most-watched-entertainment-brand-youtube/ | 2022-07-27T12:30:36Z | https://www.wbay.com/prnewswire/2022/07/27/cocomelon-live-jjs-journey-hits-road-massive-65-city-north-american-tour-inspired-by-cocomelon-1-most-watched-entertainment-brand-youtube/ | false |
America's IRA Experts honored for their thought leadership, education and impact in driving the wealth, investment and retirement industry forward
NEW YORK, July 27, 2022 /PRNewswire/ -- Ed Slott and Company, LLC, the nation's leading provider of technical IRA education for financial advisors, CPAs, insurance agents and attorneys, has been named to ThinkAdvisor's LUMINARIES Class of 2022 for the "Thought Leadership and Education" category. The award is designed to recognize firms making outstanding efforts to better understand and train new and existing industry participants. The recognition for Ed Slott and Company comes after it launched its on-demand, CE-approved, 12-course program, IRA Success, in partnership with The American College of Financial Services in the spring of 2021.
"I consider it a great honor for our team to receive this recognition for the second year in a row and I believe this year's nod is a testament to all of the hard work that was put in to create IRA Success," said Ed Slott, CPA, America's IRA Expert, founder of Ed Slott and Company, LLC and creator of irahelp.com. "Through our partnership with The American College of Financial Services, we have been able to take our timely, informative and entertaining tax-planning advice and make it easier than ever before to access, digest and implement. Thanks to the successful launch of this program, more advisors are better equipped to help families save more, keep more and make their retirement savings last."
IRA Success is the first of its kind, being an e-learning program on IRA distribution planning from two financial-education leaders. The goal in creating IRA Success was to make this education more accessible in a convenient, on-demand e-learning platform. The program delivers the applied knowledge advisors need to navigate retirement distribution complexities, manage for the end of the stretch IRA, help simplify the tax code and grow IRA rollover business. With an emphasis on the SECURE Act and all its game-changing provisions, this 12-course program covers everything from recognizing new backdoor Roth opportunities to identifying key beneficiary categories still eligible for stretch IRA provisions.
In addition to this new initiative, Ed Slott and Company has continued to provide a robust series of educational and training resources. Most recently, it hosted another sold-out 2-Day IRA Workshop in Nashville, TN where professionals learned how to answer the top questions from clients, prospects and centers of influence. Attendees also participated in Q&A segments, networking opportunities, received CE credits and a 400+ page course manual. Financial professionals interested in attending one of Ed Slott and Company's next 2-day IRA workshops, should visit irahelp.com/2-day.
ABOUT ED SLOTT AND COMPANY, LLC: Ed Slott and Company, LLC is the nation's leading provider of technical IRA education for financial advisors, CPAs and attorneys. Ed Slott's Elite IRA Advisor GroupSM is comprised of more than 500 of the nation's top financial professionals who are dedicated to the mastery of advanced retirement account and tax planning laws and strategies. Slott is a nationally recognized IRA distribution expert, best-selling author and professional speaker. His latest books include The New Retirement Savings Time Bomb (Penguin Random House, 2021), Ed Slott's Retirement Decisions Guide: 2022 Edition (IRAHelp, 2022), and Fund Your Future: A Tax-Smart Savings Plan in Your 20s and 30s (IRAHelp, 2021). He has also hosted several public television programs, including his latest, Ed Slott's Retirement Freedom!, and is a Professor of Practice at The American College of Financial Services. Visit irahelp.com for more information.
CONTACT
AdvisorPR®
(702) 685-7450
View original content to download multimedia:
SOURCE Ed Slott and Company | https://www.wibw.com/prnewswire/2022/07/27/ed-slott-company-named-thinkadvisors-luminaries-class-2022/ | 2022-07-27T12:32:42Z | https://www.wibw.com/prnewswire/2022/07/27/ed-slott-company-named-thinkadvisors-luminaries-class-2022/ | true |
$220 Million Fund continues to focus on digitization of Financial Technology
NASHVILLE, Tenn., July 27, 2022 /PRNewswire/ -- FINTOP Capital, a venture capital firm led by industry veterans focused on B2B SaaS (software as a service) companies in the Financial Technology (FinTech) space, announced today the successful close of FINTOP Fund III totaling $220 million, surpassing the firm's goal of $200 million. FINTOP Fund III is already active with five investments including Plinqit, Freight Science, Compliance.ai, Amaryllis and Xelix.
"We remain committed to capital-efficient entrepreneurs that are building great businesses in FinTech, and this new Fund will allow us to make bigger investments in more companies," said Joe Maxwell, managing partner at FINTOP Capital. "As operators, we understand the unique challenges entrepreneurs are facing in light of the economic downturn, as we've been through this cycle ourselves multiple times. However, we know that the modernization of finance continues to be a strong tailwind of the economy, and we are well-positioned to use these changing times as an opportunity to source strong deals and support budding companies with capital, a solid network and a strategic playbook so they can thrive."
FINTOP Fund III is built on the success of the previous 2016 and 2020 Funds, with most of the limited partners (LPs) from the previous Funds joining Fund III. FINTOP Capital relies on the management expertise of its partners, all of whom have experience operating FinTech companies of their own. As operators themselves, they excel at helping portfolio companies grow, which has led to many of the portfolio companies seeking out investments directly from FINTOP Capital for access to this knowledge base and network.
There are two recent new additions to the experienced partner stack, including Jared Winegrad and Chris Haley. Winegrad, a founding member of FINTOP who has now been promoted to partner, was the director of finance and operations at a small venture studio in Nashville prior to FINTOP. In addition to managing operations at FINTOP, Winegrad has played a key role in a number of FINTOP's investments, including Beanworks (acquired by Quadient), Kindful (acquired by Bloomerang), and Quavo. Haley is a FinTech operator with executive experience at companies like Black Diamond (CFO & General Counsel), Knowledge Infusion (COO), Harbor View Advisors (Partner), LegacyShield (CEO), and BridgeFT (Executive Chairman).
Co-founder and managing partner Rick Kushel added, "It's such an exciting time to be investing in FinTech, and we believe that Jared and Chris will be instrumental in the next phase of FINTOP's growth. Between the three flagship FINTOP Funds and our two JAM FINTOP Network Funds, JAM FINTOP Banktech and JAM FINTOP Blockchain, we've raised over $700 million aimed at this industry, and we will continue to leverage that capital and our expertise to push FinTech forward."
To learn more, visit www.fintopcapital.com or follow @fintopcap on Instagram and LinkedIn.
FINTOP Capital is a venture capital firm focused on Financial Technology (FinTech) companies with offices in Nashville, Tenn., St. Louis, Mo., New York City, Jacksonville, Florida, and New Jersey. Run by financial leaders and operators who have built successful startups themselves, the firm understands the ups and downs of the startup world. They bring strong networks, experience and capital to entrepreneurs building B2B service-enabled SaaS and software companies in the FinTech space.
View original content to download multimedia:
SOURCE FINTOP Capital | https://www.wbtv.com/prnewswire/2022/07/27/fintop-capitals-third-fund-oversubscribed-by-20-million/ | 2022-07-27T12:33:50Z | https://www.wbtv.com/prnewswire/2022/07/27/fintop-capitals-third-fund-oversubscribed-by-20-million/ | true |
NEW YORK, July 27, 2022 /PRNewswire/ -- Cantor Fitzgerald Income Trust, Inc. ("CF Income Trust"), a non-traded real estate investment trust and affiliate of Cantor Fitzgerald, L.P., announced today the completion of more than $118 million in real estate-related transactions since the beginning of 2022. As of June 30, 2022, the portfolio exceeds 6.9 million square feet1 with total assets controlled of $1.05 billion.2 Chris Milner, President of CF Income Trust, stated, "We have been active, thus far in 2022, and continue to execute on our high conviction themes of acquiring well-located multifamily properties and net lease assets with strong tenants."
Recent acquisitions include:
On April 22, 2022, CF Income Trust, through a joint venture with a subsidiary of Cantor Fitzgerald Investors, LLC, indirectly acquired 10% of the interests in a Delaware Statutory Trust that purchased a 15-story, 332,000 square foot Class-A office tower located in Nutley, New Jersey. The property is leased to Eisai Inc. and serves as the North American headquarters for Eisai Co., Ltd. ("Eisai"), a Japan-based global pharmaceutical company.
The property was most recently renovated in 2021 and is designed to nurture the company's hybrid flexible working model, which allows for collaboration and interaction among colleagues. Additional features include a 405-seat auditorium, private outdoor garden, and amenity area. "The property is located within the master planned ON3 life sciences campus, an area that will ultimately include 1.4 million square feet of office/R&D/medical space, multifamily residential, retail amenities, a full-service hotel, and significant green space," said Roger Shreero, Managing Director, Cantor Fitzgerald. "This newly renovated, high-quality asset is a great addition to the portfolio and is a centerpiece within the growing life sciences landscapes of the Nutley and Clifton townships."
On April 14, 2022, CF Income Trust, through a joint venture with an affiliate of CAF Management, LLC, acquired a 200-unit multifamily property located in Conroe, Texas.
Built in 2005, the property features one-, two-, and three-bedroom apartment home floor plans with amenities including a clubhouse, 24-hour fitness center, swimming pool, picnic and grilling area, sport court, dog park, and gated access.
"The area has seen significant growth in recent years due to corporate expansions by ExxonMobil, HPE, HP Inc., and ABS in neighboring The Woodlands and Springwoods Village," said Matt Keefer, Managing Director, Cantor Fitzgerald. "Housing demand continues to rise and the property is in a position to benefit from that demand."
On March 11, 2022, CF Income Trust, Inc., through a wholly owned subsidiary of its operating partnership, acquired a 465,256 square foot cross-dock dry/cold storage facility in Columbus, Ohio. The property is 100% leased to Mars Petcare, U.S. Inc., the domestic segment of Mars' global pet care business. Located adjacent to Mars Petcare's primary production facility, the property features 168,245 square feet of freezer space, LED lighting, 30' clear heights, 27 dock doors, two drive-in doors, 212 car spaces, and 100 trailer spaces on a 21.6-acre site.
"We are pleased with the performance and growth of CF Income Trust, said Jay Frank, President, Cantor Fitzgerald Asset Management. "We remain focused on adding well-located properties with predictable income streams to our defensively positioned portfolio. Our ability to be selective in today's market is key to our success."
Cantor Fitzgerald Income Trust, Inc. is a publicly registered, non-traded, monthly-valued perpetual NAV real estate investment trust (REIT) that owns and manages a diversified portfolio of institutional quality, income-producing commercial real estate including apartments, industrial, office, and necessity retail properties located in the United States. For more information, please visit: cfincometrust.com.
Cantor Fitzgerald, with over 12,000 employees, is a leading global financial services group at the forefront of financial and technological innovation and has been a proven and resilient leader for over 77 years. Cantor Fitzgerald & Co. is a preeminent investment bank serving more than 5,000 institutional clients around the world, recognized for its strengths in fixed income and equity capital markets, investment banking, SPAC underwriting and PIPE placements, prime brokerage, and commercial real estate, and for its global distribution platform. Cantor Fitzgerald & Co. is one of the 24 primary dealers authorized to transact business with the Federal Reserve Bank of New York. Cantor Fitzgerald is a leading SPAC sponsor, having completed multiple initial public offerings and announced multiple business combinations through its CF Acquisition platform. For more information, please visit: cantor.com
Cantor Fitzgerald's real estate investment management portfolio currently includes 7,721 multifamily units in addition to over 8.1 million square feet of office, industrial, and retail space across 146 properties. Cantor Fitzgerald and its affiliates participated in more than $296 billion of total real estate transactions since 2019.
Founded in 2010, CAF is a Dallas/Fort Worth based real estate firm specializing in the acquisition, redevelopment and management of institutional quality multifamily properties, primarily in the state of Texas. CAF currently manages 54 multifamily assets totaling over 17,000 units. For more information, please visit: cafmanagement.com.
1 Total square footage is not adjusted for CF Income Trust's current ownership percentage.
2 Represents gross assets controlled by CF income Trust as reported in Post-Effective Amendment No. 2 dated July 13, 2022 and not adjusted for CF Income Trust's current ownership percentage of any asset.
This press release contains forward-looking statements based on the currently held beliefs, opinions and assumptions of CFIT's manager. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance, or achievements of CFIT, to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements. Given these risks, uncertainties and other factors, recipients of this press release are cautioned not to place undue reliance on these forward-looking statements. CFIT's manager disclaims any obligation to update these forward-looking statements to reflect future events or developments or the impact of events which cannot currently be ascertained. In addition to statements, which are forward looking by reason of context, the words 'may', 'will', 'should', 'expects', 'plans', 'intends', 'anticipates', 'believes', 'estimates', 'predicts', 'potential' or 'continue' and similar expressions identify forward-looking statements.
View original content to download multimedia:
SOURCE Cantor Fitzgerald, L.P. | https://www.wsaz.com/prnewswire/2022/07/27/cantor-fitzgerald-income-trust-inc-closes-118-million-dollars-real-estate-related-acquisitions/ | 2022-07-27T12:36:27Z | https://www.wsaz.com/prnewswire/2022/07/27/cantor-fitzgerald-income-trust-inc-closes-118-million-dollars-real-estate-related-acquisitions/ | true |
Project to donate funds to assist in the protection and conservation of Critically Endangered orangutans
NEW YORK, July 27, 2022 /PRNewswire/ -- Cheeky Rangas, a collection of 9,700 unique, utility-enabled non-fungible tokens (NFTs) themed around the plight of orangutans and the destruction of their rainforest habitat, announced that they will donate proceeds to The Orangutan Project with the aim of protecting over 100,000 acres of rainforest.
By linking Web3, art and crypto with real-world issues, this project turns NFTs into media and Cheeky Ranga avatars into powerful virtual activists. Through a pure donation policy, the Cheeky Rangas project will provide significant funding for wildlife and wilderness projects to combat the extinction of Critically Endangered species and rainforest deforestation before it's too late.
"We want to make a positive impact and create a better environment not just for orangutans but for all endangered species," said Mahesh Silva, co-founder and director of Studio Crypto, creators of the Cheeky Rangas NFT collection. "We chose orangutans as they are our closest relatives in the animal kingdom. They are the most vulnerable of all the Great Apes, and their plight is dominated by a single issue – the destruction of their rainforest habitat.
"We selected The Orangutan Project because of its philosophy of getting the job done for orangutan conservation and protecting the whole ecosystem."
The Cheeky Rangas project will donate 25% of the mint proceeds exclusively to The Orangutan Project and 75% of ongoing royalty to relevant wildlife projects, including The Orangutan Project. All donations will be directly transferred to charities to ensure full transparency and accountability.
Funds directed to The Orangutan Project will support the protection and conservation of Critically Endangered orangutans in Sumatra and Borneo.
"Realistically, we only have 10 years to save orangutans," said Leif Cocks, founder of The Orangutan Project. "The ongoing rapid loss of rainforest habitat and the devastating impact of the illegal wildlife trade has created an extinction crisis that is unlike anything we've seen before. Unless we take drastic action within the next 10 years to secure and protect intact lowland rainforest ecosystems which can support sustainable populations of orangutans, then all orangutan species will face inevitable extinction.
"NFT projects like Cheeky Rangas have the potential to provide us with significant additional funds that will enable us to fight for the protection of orangutans and other Critically Endangered species. We are grateful to Cheeky Rangas and Studio Crypto for their support."
The sale of each Cheeky Ranga NFT approximately equates to protecting five acres of rainforest habitat in Sumatra and Borneo for two years. With 9,700 uniquely minted Cheeky Rangas up for grabs, that equates to 100,000 acres.
"Currently with our partners, we help protect over 100,000 acres of rainforest," Cocks said. "Through our Wildlife Protection Units, we are actively protecting these concessions to deter illegal activities such as logging and poaching to provide a safe haven where orangutans can thrive and recover in number."
"The Cheeky Rangas NFT collection will be carbon neutral with all blockchain transactions offset through sustainability platform, Aerial. In fact, the project will be carbon negative and climate positive when we quantify the impact of rainforest protection. Being carbon neutral - or better - is important to us as it determines the ongoing viability of the species and the ecosystems," said Silva.
Learn more about the Cheeky Rangas NFT Collection at https://cheekyrangas.com.
Studio Crypto was established with a primary mission of linking Web3 with real-world issues. We believe blockchain technology represents a new form of economic value that will fundamentally alter market structures. We invest in projects and companies forging new ground and building transformative infrastructure and applications that will shape the future of Web3 technology. Find out more at www.studiocrypto.io.
The Orangutan Project was established in 1998 with a critical mission; to ensure that Critically Endangered orangutan species are protected against Extinction and will continue to live in viable wild populations for generations to come. Today, The Orangutan Project is a dynamic, fast-growing and successful non-profit organisation that has raised over $25 million to support a wide range of critical projects that address the holistic problem facing fragmented orangutan populations - including fighting deforestation and habitat loss at the highest level. Find out more at www.theorangutanproject.org.
Media Contact
Mahesh Silva
Director
Studio Crypto
nft@studiocrypto.io
Media Contact
Heather Ripley
Orange Orchard
(865) 977-1973
hripley@orangeorchardpr.com
View original content to download multimedia:
SOURCE The Orangutan Project | https://www.wbtv.com/prnewswire/2022/07/27/nft-good-cheeky-rangas-support-orangutan-project/ | 2022-07-27T12:36:54Z | https://www.wbtv.com/prnewswire/2022/07/27/nft-good-cheeky-rangas-support-orangutan-project/ | true |
The leading Enterprise MLOps platform provider teams with leading data science consultancy to accelerate time-to-value for customers' model-driven business in highly regulated industries across Germany, Austria, and Switzerland
SAN FRANCISCO and MUNICH , July 27, 2022 /PRNewswire/ -- Domino Data Lab, provider of the leading Enterprise MLOps platform trusted by over 20% of the Fortune 100, and Alexander Thamm GmbH [at], a leader in strategic development and implementation of data-driven innovations and business models in German-speaking countries, announced a strategic partnership and a new joint service offering aimed at scaling data science in today's era of complex and constantly changing data regulations.
A new Data Science Journey Accelerator (DSJA) offering from the two companies will help customers in Germany, Austria and Switzerland realize a model-driven competitive advantage faster by pairing Domino's platform with [at]'s data engineering and data science consulting services. DSJA delivers the foundation for data science at enterprise scale —open and flexible Enterprise MLOps tooling to support the needs of both the data science and IT teams— validated by data experts [at] to meet privacy and IT architecture requirements.
While most companies understand the promise of data science, knowing where to start is challenging. Balancing corporate objectives, organizational design, existing processes, current and future technology investments, all in the context of region-specific trends and stringent data regulations means "best practices" to do so are difficult to identify and follow. A recent study by leading European market analyst firm BARC found that 55 percent of companies have not deployed an ML model yet and only 10 percent consider themselves advanced in this area.[1]
"Siloed data and infrastructure represent some of the biggest reasons why high-performing ML applications are not yet the norm," said Dr. Carsten Bange, CEO at BARC. "With an overarching data strategy and change management regarding infrastructure and processes, plus flexible data and MLOps tooling that adapts to dynamic infrastructure needs, enterprises can more easily deliver high-performing ML solutions regularly and effectively."
Domino's Enterprise MLOps platform helps companies become model-driven by allowing large data science and IT teams distributed across the globe to work better together developing and deploying more models faster. [at] has completed over 1,500 projects for over 100 clients across 5,000+ use cases, using tried and tested consulting methodologies: benchmarking current data capabilities, developing roadmaps, designing data operating models, and executing data science projects. Together, Domino and [at] aim to use Domino's Enterprise MLOps platform to quickly tailor data science solutions for customers with operations in German-speaking markets and key highly regulated verticals: automotive and engineering, financial services, insurance and life sciences.
"By adopting MLOps and working with MLOps-platforms like Domino Data Lab's, enterprises can build more models, innovate faster, and address more use cases," said Andreas Gillhuber, Co-CEO and Head of Engineering for Alexander Thamm. "We are very much looking forward to working with Domino Data Lab, especially because we share the mindset: It is always about creating real added value from data for the customer."
"Alexander Thamm has built an impressive consulting practice of navigating cross-border data strategies and fine tuning the art of scaling data science for some of the world's largest companies," said Thomas Robinson, Vice President of Strategic Partnerships and Corporate Development at Domino Data Lab. "Combining data science consulting with Domino's leading Enterprise MLOps platform presents a huge opportunity to help customers transform and scale data science across their operations in Germany, Switzerland and Austria."
The new Domino and AT joint service offering pairs the power of Domino's Enterprise MLOps platform with Alexander Thamm's data science consulting expertise, tailored to meet some of the world's most stringent privacy regulations. Together, Domino and [at]'s DSJA offers customers the key building blocks of a foundation for data science success:
- Data Strategy Assessment - A workshop using Alexander Thamm's design-thinking methods to assess and develop a data operating model, covering organizational structure, processes, roles, data governance, and IT systems landscape.
- Data Science Lifecycle Assessment - Using Domino's methodology, this workshop helps to discover customers' existing data science lifecycle and processes - from data to ideation to model development to model deployment and monitoring - to ensure alignment on current processes and challenges.
- Business Value Assessment - A process to determine the financial benefits of Domino's platform and [at]'s services, developing a business case calculating ROI, net present value, and payback period with benefits communicated across stakeholder groups (line-of-business, data science, IT, operations).
- Proof-of-Concept - A program that puts specific customer requirements into action to clearly demonstrate value by successfully implementing a use case.
The partnership comes at an opportune point in time for customers, both those based in German-speaking countries as well as global organizations with operations in highly regulated regions such as Germany. Domino's recently announced Nexus Hybrid MLOps architecture will provide companies the flexibility to rapidly scale, control and orchestrate data science workloads across different compute clusters, breaking down silos between environments across cloud and on-premises and preventing vendor lock-in. [at]'s expertise covers both data operations and the data science lifecycle, giving customers confidence that data science projects will balance German data locality and sovereignty requirements with future infrastructure investments.
Domino Data Lab powers model-driven businesses with its leading Enterprise MLOps platform trusted by over 20% of the Fortune 100. Domino accelerates the development and deployment of data science work while increasing collaboration and governance. With Domino, enterprises worldwide can develop better medicines, grow more productive crops, and build better cars, and much more. Founded in 2013, Domino is backed by Coatue Management, Great Hill Partners, Highland Capital, NVIDIA, Sequoia Capital and other leading investors. For more information, visit www.dominodatalab.com
Alexander Thamm GmbH is a leader in the development and implementation of data-driven innovations and business models in German-speaking countries. The service portfolio covers the entire data journey - from the data strategy to the development of algorithms and the construction of IT architectures to maintenance and operation. The company's Data Academy offers training courses on data science, big data and artificial intelligence. Alexander Thamm GmbH was founded in 2012 by Alexander Thamm and currently employs over 300 people. The head office is in Munich. Other locations are Berlin, Frankfurt, Leipzig, Stuttgart and Cologne. Customers include more than half of the DAX 30 companies. Visit www.alexanderthamm.com for more information. Connect with us on LinkedIn: https://www.linkedin.com/company/alexander-thamm-gmbh/
[1] BARC, "Driving Innovation With AI: Getting Ahead With Dataops And MLOps," July 2022
View original content:
SOURCE Domino Data Lab | https://www.wsaz.com/prnewswire/2022/07/27/domino-data-lab-alexander-thamm-partner-rapidly-scale-data-science-across-dach-region/ | 2022-07-27T12:37:15Z | https://www.wsaz.com/prnewswire/2022/07/27/domino-data-lab-alexander-thamm-partner-rapidly-scale-data-science-across-dach-region/ | false |
KIFFB to form a global consultancy
The private limited firm is named KIFFCON
The State Cabinet on Wednesday approved a KIFFB proposal to form a new global consultancy under its aegis.
The private limited firm is named KIFFCON.
It will advise, for a fee, Indian and foreign entities involved in infrastructure development schemes.
KIFFCON’s sphere would encompass transportation, construction, architecture, social impact surveys for mega projects, energy, detailed project report preparation, urban planning, and coastal and harbour engineering.
KIFFCON will bring an array of consultancies under one umbrella. It will have an initial business capital of ₹1 crore. KIFFB will hold 100% shares of KIFFCON. It will later divest 51% of the shares to reputed companies. The State government will appoint KIFFCON’s functional directors for five years.
- Comments will be moderated by The Hindu editorial team.
- Comments that are abusive, personal, incendiary or irrelevant cannot be published.
- Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
- We may remove hyperlinks within comments.
- Please use a genuine email ID and provide your name, to avoid rejection. | https://www.thehindu.com/news/national/kerala/kiffb-to-form-a-global-consultancy/article65689401.ece | 2022-07-27T12:38:11Z | https://www.thehindu.com/news/national/kerala/kiffb-to-form-a-global-consultancy/article65689401.ece | false |
Komainu is set to bring Digital Asset Custody Services to Institutional Clients in the Region
SAINT HELIER, JERSEY , July 27, 2022 /PRNewswire/ -- Komainu ["the Custodian"], a regulated digital asset custody provider built by institutions for institutions, today announced provisional regulatory approval from the Government of Dubai's Virtual Assets Regulatory Authority [VARA] to commence operational readiness even as the application goes through the warranted due diligence in accordance with VARA requirements, to enable Komainu to be amongst the first fully regulated digital asset custody services to institutional clients in the region.
Komainu acts as key gatekeeper to institutions gaining exposure to the digital asset industry with the provision of secure and regulated digital asset custody services for blockchain and beyond. Over the years, Komainu has established itself as one of the leading digital asset custody providers for institutional clients, providing the same safeguards and protections investors are accustomed to in traditional finance. The Custodian's industry-leading services have been designed by security, financial services and cryptocurrency experts and have been approved by external auditors.
Dubai and VARA are paving the way forward with their efforts to create a sophisticated and progressive regulatory framework, which will allow the region to become one of the world's most favourable jurisdictions for digital asset initiatives. Komainu has elected to base its regional HQ in Dubai and participate in this fast-evolving global virtual asset valley - in order to establish its leadership in the provision of institutional-grade digital asset services across the wider region.
H.E. Helal Saeed Almarri, Chairman of VARA, said, "Komainu's entry into VARA's regime is symbolic of the confidence and credibility that the Virtual Assets industry is gaining when backed by such strong endorsement from traditional finance leaders like Nomura. Such acceptance and active participation of tier 1 global institutional finance firms is not only an affirmation of Virtual Assets being integral to the future of finance, but also indicative of the potential that this industry can offer for economic empowerment. Dubai is pleased to welcome credible players like Komainu into VARA's virtual assets ecosystem."
The regulatory license once received, will establish Komainu as one of Dubai's first regulated crypto custody providers, bringing a much-needed service to the proliferating regional ecosystem. The endorsement from the Dubai Government strengthens the Custodian's fast-paced growth projections, in line with their core underpinning of doing so in a secure, robust and regulated manner. With the continued support of the Dubai regulators, Komainu is set to be a first mover in the MENA region.
Sebastian Widmann, Head of Strategy at Komainu, said, "Dubai and VARA are establishing a new hub for digital asset businesses and bringing like-minded companies into the country to help establish its growing crypto ecosystem and we look forward to contributing to these exciting developments. Komainu actively works with regulators, partners and our clients to make sure that our platform is held to the highest of standards and this latest endorsement by the Dubai Government is a further testament to that fact. By expanding into the MENA region, we are bringing a much-needed service to institutions operating within a regulated crypto marketplace. We are excited to bring Komainu Yield as well as the other new services set to launch in the near future to this marketplace and thereby serve a new demographic of institutions."
Komainu is the first hybrid custodian for institutional digital asset investors created by the Japanese investment bank Nomura, digital asset manager CoinShares and digital asset security company Ledger. Komainu is providing decentralized and secure digital asset custody services through a single application-based solution for institutions, offering multi-asset support and regulatory compliance. Headquartered in Jersey, Channel Islands, Komainu merges institutional financial services with leading security standards for the next generation of institutional custody.
Dubai Virtual Assets Regulatory Authority [VARA] is the world's first specialised regulator for the Virtual Assets sector. Established in March 2022, following the effect of Law No.4 of 2022, VARA is responsible by decree for licensing and regulating the Virtual Asset sector in the Emirate of Dubai and its free zone territories [excluding DIFC], and oversees all licensing requirements and applications for authorisation of Virtual Asset activities under UAE law. VARA plays a central role in creating Dubai's advanced legal framework to protect investors and establish international standards for Virtual Asset industry governance, while supporting the vision for a borderless economy.
Media Contact
Peter Padovano
M Group Strategic Communications [For Komainu]
646-859-5953
komainu@mgroupsc.com
View original content to download multimedia:
SOURCE Komainu | https://www.wsaz.com/prnewswire/2022/07/27/komainu-nomura-backed-crypto-custodian-granted-initial-provisional-regulatory-approval-operate-dubai/ | 2022-07-27T12:38:56Z | https://www.wsaz.com/prnewswire/2022/07/27/komainu-nomura-backed-crypto-custodian-granted-initial-provisional-regulatory-approval-operate-dubai/ | true |
Study Designed to Evaluate the Safety and Efficacy of the AMDS Hybrid Prosthesis to Treat Acute DeBakey Type I Aortic Dissections & Support U.S. FDA PMA Submission
ATLANTA, July 27, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has initiated enrollment in the PERSEVERE clinical trial to determine if patients with an acute DeBakey Type I aortic dissection can be treated safely and effectively using the AMDS Hybrid Prosthesis. The trial is designed to support the company's forthcoming application to the U.S. Food and Drug Administration (FDA) for premarket approval of the AMDS.
The PERSEVERE trial is a prospective, multicenter, non-randomized clinical trial consisting of approximately 100 participants in the U.S., who have experienced an acute DeBakey Type I aortic dissection. Each participant will be followed for up to 5 years. The combined primary efficacy and safety endpoints will determine the impact of the AMDS Hybrid Prosthesis on reducing mortality, new disabling stroke, myocardial infarction, and new onset renal failure requiring dialysis, and also re-expansion of the true lumen of the aorta.
"We are pleased to announce that the first patient in our PERSEVERE clinical trial has been enrolled at Hartford Hospital," said Pat Mackin, Chairman, President, and Chief Executive Officer of Artivion. "Through the PERSEVERE trial, we will study the safety and efficacy of the AMDS to treat patients suffering from acute DeBakey Type I aortic dissections, a life-threatening condition characterized by extremely high mortality rates."
Mr. Mackin added, "If the trial proceeds as planned and meets its endpoints, we believe we can achieve FDA approval for patient access to the AMDS in late 2024 or early 2025."
Dr. Wilson Szeto, the PERSEVERE National Principal Investigator, Chair of the Steering Committee and Chief of Cardiovascular Surgery at Penn Presbyterian Medical Center, said, "Acute aortic dissection is a devastating disease with high morbidity and mortality. The surgical treatment is technically demanding. With the PERSEVERE trial, we intend to show the benefits that AMDS brings to patient outcomes and expand the therapy to more surgeons."
Dr. Mohiuddin Cheema, the Principal Investigator and Cardiovascular Surgeon at Hartford Health, who implanted the first AMDS in the trial, said, "I'm thrilled to be participating in the PERSEVERE study and to have treated the 1st patient with the AMDS in the United States. Implantation of the device was simple and added minimal time to the surgery. On the post-op CT scan we saw expansion of the true lumen and resolved malperfusion. Additionally, there was no presence of distal anastomotic new entry (DANE), which gives confidence that the aorta will continue to remodel positively over time and decrease the risk of future re-operation."
The AMDS is the world's first aortic arch remodeling device for use in the treatment of acute Type I aortic dissections. It is used as a complement to, and in conjunction with, hemi-arch replacement without adding technical complexity. The design of the AMDS allows for rapid deployment of the graft in the aortic arch during a standard replacement of the ascending aorta, adding less than five minutes to the procedure time. The deployment of the AMDS preserves the native arch, potentially allowing for minimally invasive re-interventions, including the repair of additional entry tears, rather than an invasive arch repair. AMDS is available in the markets of European CE Mark countries and Canada. In the clinical trial supporting the CE Mark and Health Canada approvals, the AMDS was shown to reduce mortality, complications and reoperations in comparison to published rates with the standard of care, thereby improving the care of patients and offering potentially significant cost savings for the health care system.
Globally, approximately 48,000 patients suffer from acute Stanford Type A aortic dissections annually, an estimated $540 million market opportunity pending regulatory approvals. Aortic dissection occurs when the innermost layer of the aorta tears and blood surges through the tear separating the layers of the aorta. In acute DeBakey Type I aortic dissections, a subset of Type A dissections, the dissection flap originates in the ascending aorta and continues down into the descending thoracic aorta. Left untreated, aortic dissections can lead to death. The current standard of care for repairing acute DeBakey Type I aortic dissections with a primary entry tear in the ascending is a hemiarch repair which involves open chest surgery during which the ascending thoracic aorta is replaced. Though this typically addresses the most critical and pressing issues resulting from acute DeBakey Type I dissections, it is often not enough. Hemiarch repair alone does not address downstream true lumen expansion or treating the false lumen beyond the ascending aorta, which could lead to costly and often fatal complications such as continued blood flow in the false lumen, an aneurysmal aorta, and malperfusion with subsequent end-organ ischemia resulting from a lack of blood-flow.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.
Statements made in this press release that look forward in time or that express management's beliefs, expectations, or hopes are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements reflect the views of management at the time such statements are made. These statements include our beliefs that, if the trial meets its endpoints, we can still achieve FDA approval for the use of the AMDS by early 2025; and that approximately 48,000 patients suffer from acute Stanford Type A aortic dissections annually, representing an estimated $540 million market opportunity for Artivion upon various regulatory approvals. These forward-looking statements are subject to a number of risks, uncertainties, estimates, and assumptions that may cause actual results to differ materially from current expectations including that the Company may discontinue the PERSEVERE trial at any time; the PERSEVERE clinical trial may be delayed, may not prove its endpoints or may fail; and that, even if successful, the FDA or other regulatory bodies may not grant approval for the AMDS or may grant an indication narrower than that sought by Artivion, reducing the market opportunity for the AMDS. These risks and uncertainties include the risk factors detailed in our Securities and Exchange Commission filings, including our Form 10-K for year ended December 31, 2021. Artivion does not undertake to update its forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
View original content to download multimedia:
SOURCE Artivion, Inc. | https://www.wagmtv.com/prnewswire/2022/07/27/artivion-initiates-enrollment-persevere-clinical-trial/ | 2022-07-27T12:39:12Z | https://www.wagmtv.com/prnewswire/2022/07/27/artivion-initiates-enrollment-persevere-clinical-trial/ | false |
Arrow Reports $12.0 million in Q2 Net Income, Loan Growth of $108 Million
Published: Jul. 27, 2022 at 6:56 AM CDT|Updated: 44 minutes ago
GLENS FALLS, N.Y., July 27, 2022 /PRNewswire/ -- Arrow Financial Corporation (NasdaqGS® – AROW) announced financial results for the three-month period ended June 30, 2022. Net income for the second quarter of 2022 was $12.0 million and diluted earnings per share was $0.75.
Loan growth was strong in the second quarter of 2022, with gross loans increasing by $108 million. Excluding Paycheck Protection Program (PPP) loans, which decreased by $17 million, loans grew by $125 million in the quarter.
"Arrow had a strong second quarter with total loan balances at June 30, 2022 reaching a record high," said Arrow President and CEO Thomas J. Murphy. "I commend the Arrow Team for their outstanding efforts and strong work ethic. While economic challenges are expected this year, I am confident in our direction as a Company and our ability to deliver strong results for our shareholders, our customers and our communities."
For the second quarter of 2022, net income was $12.0 million compared to $13.3 million for the second quarter of 2021. The year-over-year decline in second quarter net income was primarily due to:
- An increase in the provision expense for credit losses to $905 thousand for the second quarter of 2022, as compared to $263 thousand in the second quarter of 2021.
- Net gain on sale of loans was lower by $615 thousand when comparing year-over-year quarters.
- A decrease of $2.6 million in income earned on PPP loans included as part of net interest income in the second quarter of 2022 compared to the second quarter of 2021.
Second Quarter Highlights
Earnings:
- Net income was $12.0 million.
- Net interest margin was 3.02%.
- Return on average assets (ROA) was 1.20%.
- Return on average equity (ROE) was 13.44%.
- Diluted earnings per share (EPS) was $0.75 for the second quarter.
- Second-quarter revenue was consistent to the prior-year comparative quarter.
- Net charge-offs for the second quarter of 2022 were $476 thousand as compared to $93 thousand for the comparable 2021 quarter.
Balance Sheet:
- Total assets were $4.0 billion as of June 30, 2022.
- Total loans were $2.8 billion as of June 30, 2022, a record high for Arrow.
- Total deposits were $3.5 billion as of June 30, 2022.
- Loans to deposits ratio as of June 30, 2022 was 80.2%
Additional Items:
- $17 million of PPP loans were forgiven in the second quarter of 2022.
- $1.5 million of PPP loans remained outstanding as of June 30, 2022.
- Book value per share was $22.25, up by 1.1% over the prior-year level.
- Nonperforming assets of $10.0 million at June 30, 2022 represented 0.25% of period-end assets, up from 0.20% at June 30, 2021.
- A core system upgrade is scheduled for the third quarter of 2022, with the first customer communications expected in early August.
Income Statement
- Net Interest Income: Net interest income for the second quarter was $29.0 million, up 2.4% from $28.4 million in the comparable quarter of 2021. Interest and fees on loans were $26.9 million for the second quarter of 2022, a decrease of 0.4% from $27.0 million for the quarter ending June 30, 2021. Interest and fees related to PPP loans, included in the $26.9 million total, were $439 thousand in the second quarter of 2022, a decrease from $3.1 million for the second quarter of 2021. Interest expense for the second quarter of 2022 was $1.6 million, an increase of $0.2 million, or 16.5%, from $1.3 million in expense for the comparable quarter ending June 30, 2021.
- Net Interest Margin: Net interest margin was 3.02% for the quarter, compared to 3.08% for the second quarter of 2021. The decrease in net interest margin from the prior year was primarily due to the decrease in the amount of PPP loan interest and related fees recognized in the second quarter of 2022 as compared to the comparable quarter of 2021. Net interest margin, excluding PPP income, increased from the comparable prior year quarter from 2.86% to 2.98% The cost of interest-bearing liabilities increased slightly primarily due to the repricing of municipal deposits.
- Provision for Credit Losses: For the second quarter of 2022, the provision for credit losses was $905 thousand compared to $263 thousand in provision expense in the second quarter of 2021. The key drivers for the increase were strong loan growth and a slight deterioration in forecasted economic conditions in the second quarter of 2022.
- Noninterest Income: Noninterest income for the three months ended June 30, 2022 was $7.7 million, compared to $8.5 million in the comparable 2021 quarter. Income from fiduciary activities for the three months ended June 30, 2022, decreased by $72 thousand over the comparable quarter of 2021. Fees and other services to customers increased $131 thousand over the comparable quarter of 2021. Gain on sales of loans decreased $615 thousand from the second quarter of 2021 as a result of a strategic decision to retain more newly originated real estate loans. Other operating income decreased $132 thousand from the comparable quarter of 2021 due to a variety of factors, including, among others, a $99 thousand loss on the disposal of a building.
- Noninterest Expense: Noninterest expense for the second quarter of 2022 was $20.3 million, an increase from $19.1 million for the second quarter of 2021. The largest component of noninterest expense was salaries and benefits paid to our employees, which totaled $11.7 million for the second quarter of 2022. The expense for estimated credit losses on off-balance sheet credit exposures included in other expenses was $110 thousand.
- Provision for Income Taxes: The provision for income taxes was $3.6 million for the second quarter of 2022, compared to $4.2 million for the same quarter of 2021.
Balance Sheet
- Total Assets: Total assets were $4.0 billion at June 30, 2022 an increase of $95.0 million, or 2.4%, compared to June 30, 2021 and a decrease of $165.2 million, or 4.0%, compared to March 31, 2022.
- Investments: Total investments were $766.9 million as of June 30, 2022 an increase of $122.5 million, or 19.0%, compared to June 30, 2021 and a decrease of $14.1 million, or 1.8%, compared to March 31, 2022.
- Loans: Total loans were $2.8 billion as of June 30, 2022. Loan growth for the second quarter of 2022 was $107.5 million and increased $200.7 million, or 7.6%, from June 30, 2021. In the second quarter, total outstanding commercial loans increased $8.0 million, or 1.0%. PPP loans, which are included in the commercial portfolio, decreased $17.2 million in the second quarter as a result of the continued loan forgiveness processed by the Small Business Administration. The consumer loan portfolio grew by $54.5 million, or 5.6% in the second quarter, primarily within the indirect automobile lending program. Total outstanding residential real estate loans increased $45.1 million, or 4.7%, for the second quarter of 2022.
- Allowance for Credit Losses: The allowance for credit losses was $28.1 million on June 30, 2022, which represented 0.99% of loans outstanding, as compared to 1.02% at June 30, 2021. Asset quality remained solid at June 30, 2022. Net loan losses, expressed as an annualized percentage of average loans outstanding, were 0.07% for the three-month period ended June 30, 2022, as compared to 0.01% for the three-month period ended June 30, 2021. Nonperforming assets of $10.0 million at June 30, 2022 represented 0.25% of period-end assets, compared to 0.20% at June 30, 2021.
- Deposits: At June 30, 2022, deposit balances were $3.5 billion. Deposits decreased in the second quarter of 2022 by $169.7 million and increased by $107.6 million, or 3.1%, from the prior-year level. Municipal deposits decreased $112.1 million in the second quarter and increased $4.8 million, or 0.6% from June 30, 2021. Non-municipal deposits decreased $57.6 million for the quarter and increased $102.8 million, or 4.0%, from June 30, 2021. Noninterest-bearing deposits represented 23.3% of total deposits at June 30, 2022, compared to 22.2% of total deposits at June 30, 2021. At June 30, 2022, total time deposits were $169.5 million, a decrease of $57.0 million, or 25.2%, compared to the prior year.
- Capital: Total stockholders' equity was $356.5 million on June 30, 2022, up $3.5 million, or 1.0%, from June 30, 2021. Arrow's regulatory capital ratios remained strong in the second quarter of 2022. As of June 30, 2022, Arrow's Common Equity Tier 1 Capital Ratio was 13.14% and Total Risk-Based Capital Ratio was 14.93%. The capital ratios of Arrow and both its subsidiary banks, Glens Falls National Bank and Trust Company and Saratoga National Bank and Trust Company, continued to exceed the "well capitalized" regulatory standards.
Additional Commentary
- Cash and Stock Dividends: On June 15, 2022, Arrow distributed a cash dividend of $0.27 per share. The cash dividend was 7% higher than the cash dividend paid by Arrow in the second quarter of 2021 due to a one cent increase in the cash dividend rate and after adjusting for the 3% stock dividend distributed on September 24, 2021.
- Industry Recognition: In the second quarter of 2022, both of Arrow's banking subsidiaries once again earned BauerFinancial, Inc. 5-Star Exceptional Performance Bank ratings.
About Arrow
Arrow Financial Corporation is a multi-bank holding company headquartered in Glens Falls, New York, serving the financial needs of northeastern New York. Arrow is the parent of Glens Falls National Bank and Trust Company and Saratoga National Bank and Trust Company. Other subsidiaries include Upstate Agency, LLC and North Country Investment Advisers, Inc.
Non-GAAP Financial Measures Reconciliation
In addition to presenting information in conformity with accounting principles generally accepted in the United States of America (GAAP), this news release contains financial information determined by methods other than GAAP (non-GAAP). Some measures used in this release, which are commonly utilized by financial institutions, have not been specifically exempted by the Securities and Exchange Commission (SEC) and may constitute "non-GAAP financial measures" within the meaning of the SEC's rules. These non-GAAP financial measures include: tangible equity, return on tangible equity, tax-equivalent adjustment and related net interest income, tax-equivalent, and the efficiency ratio. Management believes that the non-GAAP financial measures disclosed by Arrow are useful in evaluating Arrow's performance and that such information should be considered as supplemental in nature and not as a substitute for, or superior to, the related financial information prepared in accordance with GAAP. Non-GAAP financial measures may differ from similar measures presented by other companies. See the reconciliation of GAAP to non-GAAP measures in the section "Selected Quarterly Information."
Safe Harbor Statement
The information in this document may contain statements based on management's beliefs, assumptions, expectations, estimates and projections about the future. Such "forward-looking statements," as defined in Section 21E of the Securities Exchange Act of 1934, as amended, involve a degree of uncertainty and attendant risk. Actual outcomes and results may differ, explicitly or by implication. We are not obliged to revise or update these statements to reflect unanticipated events. This document should be read in conjunction with Arrow's Annual Report on Form 10-K for the year ended December 31, 2021 and other filings with the SEC.
View original content:
SOURCE Arrow Financial Corporation
The above press release was provided courtesy of PRNewswire. The views, opinions and statements in the press release are not endorsed by Gray Media Group nor do they necessarily state or reflect those of Gray Media Group, Inc. | https://www.kait8.com/prnewswire/2022/07/27/arrow-reports-120-million-q2-net-income-loan-growth-108-million/ | 2022-07-27T12:40:00Z | https://www.kait8.com/prnewswire/2022/07/27/arrow-reports-120-million-q2-net-income-loan-growth-108-million/ | true |
THOMASVILLE, N.C. (AP) _ Old Dominion Freight Line Inc. (ODFL) on Wednesday reported second-quarter net income of $376.1 million.
The Thomasville, North Carolina-based company said it had profit of $3.30 per share.
The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $3.10 per share.
The trucking company posted revenue of $1.67 billion in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $1.64 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ODFL at https://www.zacks.com/ap/ODFL | https://www.sfchronicle.com/business/article/Old-Dominion-Q2-Earnings-Snapshot-17331786.php | 2022-07-27T12:40:07Z | https://www.sfchronicle.com/business/article/Old-Dominion-Q2-Earnings-Snapshot-17331786.php | false |
ARLINGTON, Va., July 27, 2022 /PRNewswire/ --
Second Quarter 2022
- Operating cash flow of $0.1 billion; continue to expect positive free cash flow for 2022
- Increased 737 production to 31 per month; working with FAA on final actions to resume 787 deliveries
- Successfully completed CST-100 Starliner uncrewed Orbital Flight Test-2 (OFT-2)
- Revenue of $16.7 billion; GAAP earnings per share of $0.32 and core (non-GAAP)* loss per share of ($0.37)
- Total backlog of $372 billion; including over 4,200 commercial airplanes
The Boeing Company (NYSE: BA) reported second-quarter revenue of $16.7 billion, GAAP earnings per share of $0.32 and core loss per share (non-GAAP)* of ($0.37), driven by lower defense volume and unfavorable performance, partially offset by higher commercial volume (Table 1). Boeing recorded positive operating cash flow of $0.1 billion.
"We made important progress across key programs in the second quarter and are building momentum in our turnaround," said Dave Calhoun, Boeing President and Chief Executive Officer. "As we begin to hit key milestones, we were able to generate positive operating cash flow this quarter and remain on track to achieve positive free cash flow for 2022. While we are making meaningful progress, we have more work ahead. We will stay focused on safety, quality and transparency, as we drive stability, improve performance, and continue to invest in our future."
Operating cash flow improved to $0.1 billion in the quarter, reflecting higher commercial deliveries and timing of receipts and expenditures (Table 2).
Cash and investments in marketable securities decreased to $11.4 billion, compared to $12.3 billion at the beginning of the quarter, primarily driven by debt repayment (Table 3). The company has access to credit facilities of $14.7 billion which remain undrawn.
Total company backlog at quarter-end was $372 billion.
Segment Results
Commercial Airplanes
Commercial Airplanes second-quarter revenue increased to $6.2 billion, driven by higher 737 deliveries, partially offset by lower 787 deliveries (Table 4). Operating margin of (3.9)% also reflects abnormal costs and period expenses, including higher R&D expense.
Boeing has nearly completed the global safe return to service of the 737 MAX and the fleet has flown more than 1.5 million total flight hours since late 2020. The 737 production rate increased to 31 airplanes per month during the quarter.
On the 787 program, the company continues to work with the FAA to finalize actions to resume deliveries and is readying airplanes for delivery. The program is producing at a very low rate and will continue to do so until deliveries resume, with an expected gradual return to five per month over time. The company still anticipates 787 abnormal costs of approximately $2 billion, with most being incurred by the end of 2023, including $283 million recorded in the quarter.
Commercial Airplanes secured orders for 169 737 MAX airplanes and 13 freighters, including seven 777-8 Freighters from Lufthansa Group. Commercial Airplanes delivered 121 airplanes during the quarter and backlog included over 4,200 airplanes valued at $297 billion.
Defense, Space & Security
Defense, Space & Security second-quarter revenue decreased to $6.2 billion and second-quarter operating margin decreased to 1.1 percent, primarily driven by charges on fixed-price development programs, including MQ-25 and Commercial Crew, as well as unfavorable performance on other programs and lower volume on derivative aircraft programs. The MQ-25 program recorded a $147 million charge primarily due to higher costs to meet certain technical requirements. The Commercial Crew program also recorded a $93 million charge, primarily driven by launch manifest updates and additional costs associated with OFT-2.
During the quarter, the CH-47F Chinook Block II was selected as the German government's future heavy-lift helicopter. Defense, Space & Security also successfully completed the CST-100 Starliner uncrewed OFT-2.
Backlog at Defense, Space & Security was $55 billion, of which 33% percent represents orders from customers outside the U.S.
Global Services
Global Services second-quarter revenue increased to $4.3 billion and second-quarter operating margin increased to 16.9 percent primarily driven by higher commercial services volume and favorable mix.
During the quarter, Global Services received a contract for airlift flight dispatch services from the U.S. Air Force and was awarded a contract for avionics upgrades and cybersecurity support for the U.S. Navy. Global Services also delivered the first A-10 wing set to the U.S. Air Force.
Additional Financial Information
At quarter-end, Boeing Capital's net portfolio balance was $1.6 billion. The change in loss from other unallocated items and eliminations was primarily due to the recognition of deferred compensation income as compared to expense recorded in the second quarter 2021. The second quarter effective tax rate primarily reflects tax expense on pretax earnings and an increase to the valuation allowance.
Non-GAAP Measures Disclosures
We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America (GAAP) with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure. The following definitions are provided:
Core Operating Earnings, Core Operating Margin and Core Earnings Per Share
Core operating earnings is defined as GAAP earnings from operations excluding the FAS/CAS service cost adjustment. The FAS/CAS service cost adjustment represents the difference between the Financial Accounting Standards (FAS) pension and postretirement service costs calculated under GAAP and costs allocated to the business segments. Core operating margin is defined as core operating earnings expressed as a percentage of revenue. Core earnings per share is defined as GAAP diluted earnings per share excluding the net earnings per share impact of the FAS/CAS service cost adjustment and Non-operating pension and postretirement expenses. Non-operating pension and postretirement expenses represent the components of net periodic benefit costs other than service cost. Pension costs, comprising service and prior service costs computed in accordance with GAAP are allocated to Commercial Airplanes and BGS businesses supporting commercial customers. Pension costs allocated to BDS and BGS businesses supporting government customers are computed in accordance with U.S. Government Cost Accounting Standards (CAS), which employ different actuarial assumptions and accounting conventions than GAAP. CAS costs are allocable to government contracts. Other postretirement benefit costs are allocated to all business segments based on CAS, which is generally based on benefits paid. Management uses core operating earnings, core operating margin and core earnings per share for purposes of evaluating and forecasting underlying business performance. Management believes these core earnings measures provide investors additional insights into operational performance as they exclude non-service pension and post-retirement costs, which primarily represent costs driven by market factors and costs not allocable to government contracts. A reconciliation between the GAAP and non-GAAP measures is provided on pages 13.
Free Cash Flow
Free cash flow is GAAP operating cash flow reduced by capital expenditures for property, plant and equipment. Management believes free cash flow provides investors with an important perspective on the cash available for shareholders, debt repayment, and acquisitions after making the capital investments required to support ongoing business operations and long term value creation. Free cash flow does not represent the residual cash flow available for discretionary expenditures as it excludes certain mandatory expenditures such as repayment of maturing debt. Management uses free cash flow as a measure to assess both business performance and overall liquidity. Table 2 provides a reconciliation of free cash flow to GAAP operating cash flow.
Caution Concerning Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "should," "expects," "intends," "projects," "plans," "believes," "estimates," "targets," "anticipates," and similar expressions generally identify these forward-looking statements. Examples of forward-looking statements include statements relating to our future financial condition and operating results, as well as any other statement that does not directly relate to any historical or current fact. Forward-looking statements are based on expectations and assumptions that we believe to be reasonable when made, but that may not prove to be accurate. These statements are not guarantees and are subject to risks, uncertainties, and changes in circumstances that are difficult to predict. Many factors could cause actual results to differ materially and adversely from these forward-looking statements. Among these factors are risks related to: (1) the COVID-19 pandemic and related industry impacts, including with respect to our operations, our liquidity, the health of our customers and suppliers, and future demand for our products and services; (2) the 737 MAX, including the timing and conditions of remaining 737 MAX regulatory approvals, lower than planned production rates and/or delivery rates, and additional considerations to customers and suppliers; (3) general conditions in the economy and our industry, including those due to regulatory changes; (4) our reliance on our commercial airline customers; (5) the overall health of our aircraft production system, planned commercial aircraft production rate changes, our commercial development and derivative aircraft programs, and our aircraft being subject to stringent performance and reliability standards; (6) changing budget and appropriation levels and acquisition priorities of the U.S. government; (7) our dependence on U.S. government contracts; (8) our reliance on fixed-price contracts; (9) our reliance on cost-type contracts; (10) uncertainties concerning contracts that include in-orbit incentive payments; (11) our dependence on our subcontractors and suppliers, as well as the availability of raw materials; (12) changes in accounting estimates; (13) changes in the competitive landscape in our markets; (14) our non-U.S. operations, including sales to non-U.S. customers; (15) threats to the security of our, our customers' and/or our suppliers' information; (16) potential adverse developments in new or pending litigation and/or government investigations; (17) customer and aircraft concentration in our customer financing portfolio; (18) changes in our ability to obtain debt financing on commercially reasonable terms and at competitive rates; (19) realizing the anticipated benefits of mergers, acquisitions, joint ventures/strategic alliances or divestitures; (20) the adequacy of our insurance coverage to cover significant risk exposures; (21) potential business disruptions, including those related to physical security threats, information technology or cyber-attacks, epidemics, sanctions or natural disasters; (22) work stoppages or other labor disruptions; (23) substantial pension and other postretirement benefit obligations; (24) potential environmental liabilities; and (25) effects of climate change and legal, regulatory or market responses to such change.
Additional information concerning these and other factors can be found in our filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Any forward-looking statement speaks only as of the date on which it is made, and we assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.
The Boeing Company and Subsidiaries
Reconciliation of Non-GAAP Measures
(Unaudited)
The tables provided below reconcile the non-GAAP financial measures core operating earnings, core operating margin, and core (loss)/earnings per share with the most directly comparable GAAP financial measures, earnings from operations, operating margin, and diluted earnings per share. See page 6 of this release for additional information on the use of these non-GAAP financial measures.
The Boeing Company and Subsidiaries
Reconciliation of Non-GAAP Measures
(Unaudited)
The tables provided below reconcile the non-GAAP financial measures core operating (loss)/earnings, core operating margin, and core loss per share with the most directly comparable GAAP financial measures, (loss)/earnings from operations, operating margin, and diluted (loss)/earnings per share. See page 6 of this release for additional information on the use of these non-GAAP financial measures.
View original content:
SOURCE Boeing | https://www.kait8.com/prnewswire/2022/07/27/boeing-reports-second-quarter-results/ | 2022-07-27T12:40:54Z | https://www.kait8.com/prnewswire/2022/07/27/boeing-reports-second-quarter-results/ | false |
The last time the Milwaukee Brewers failed to score, the National League Central leaders responded with a seven-run inning and a 10-run showing against another division leader.
Coming off their first shutout defeat in more than a month, the Brewers seek a similar rebound performance Tuesday night when they host the Minnesota Twins in the opener of a two-game interleague series.
Milwaukee was blanked for the ninth time this season on Monday in a 2-0 loss to the visiting Colorado Rockies. The Brewers mustered just five hits and had all three of their at-bats with runners in scoring position during the ninth inning.
The Brewers scored 25 runs while winning the first three games of the four-game series and are averaging 4.9 runs per game this month. However, they are coming off their first shutout loss since a 4-0 defeat to the New York Mets on June 14.
“Our guys when we got into some good counts, nothing happened,” Milwaukee manager Craig Counsell said.
Since their last shutout loss, the Brewers are 19-15. Four of their nine games with double-digit runs have come since June 14, including a 10-9 victory over Colorado on Sunday.
Minnesota heads to Milwaukee coming off consecutive blowout wins in Detroit and then an off day on Monday. The Twins were held to three runs or fewer in four of their final six games before the All-Star break. They opened the second half by producing 8-4 and 9-1 victories over the Tigers.
In the Sunday win, Jose Miranda, Gio Urshela and Gary Sanchez combined for six hits, five RBIs and four runs from the bottom third of the batting order.
“We’ve been talking about that all season,” Twins manager Rocco Baldelli said. “If you wait for your 1-2-3 hitters to get you going every game, you are going to have a lot of bad days. The bottom of our order has gotten us going a lot this year.”
Minnesota’s Luis Arraez, the major league batting leader, went 4-for-9 with three RBIs in the series and heads to Milwaukee with a .341 average.
The Twins will get Miguel Sano back on Tuesday after a lengthy injured-list stint caused by a torn meniscus in his left knee. Sano, whose last major league appearance was on April 30, batted .333 with five homers in 11 RBIs in 12 rehab games.
Sano was 5-for-54 (.093) on the season before undergoing knee surgery. He batted .223 with 30 homers and 75 RBIs in 135 games last season.
“He’s the kind of guy that you want on your team,” Baldelli said. “I would always say that, from the first day I met him until now.”
If Sano starts, his first at-bat will come against Ethan Small (0-0, 6.75 ERA), who will be making his second career appearance and start. Small made his debut in Chicago on May 30, when he allowed two runs in 2 2/3 innings against the Cubs.
The 2019 first-round draft pick is 6-4 with a 3.34 ERA in 15 starts for Triple-A Nashville this year.
“Been here and done it before,” Small said of pitching in the majors. “Still very inexperienced as far as that goes, but I’m excited to be back and I feel like I’m ready.”
Minnesota will counter with Dylan Bundy (6-4, 4.71 ERA), who is 2-0 with a 4.43 ERA over his past four outings. He will be pitching for the first time since July 16, when he allowed three runs in 5 1/3 innings during a 6-3 win over the Chicago White Sox.
Bundy will be facing Milwaukee for the first time in his career.
–Field Level Media | https://www.fox16.com/mlb/twins-miguel-sano-ready-to-return-vs-brewers/ | 2022-07-27T12:41:05Z | https://www.fox16.com/mlb/twins-miguel-sano-ready-to-return-vs-brewers/ | false |
LONG ISLAND CITY, N.Y. (AP) _ Steven Madden Ltd. (SHOO) on Wednesday reported second-quarter profit of $48.5 million.
The Long Island City, New York-based company said it had net income of 62 cents per share. Earnings, adjusted for non-recurring costs, were 63 cents per share.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 59 cents per share.
The footwear and accessories retailer posted revenue of $535 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $493.4 million.
Steven Madden expects full-year earnings in the range of $2.90 to $3 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SHOO at https://www.zacks.com/ap/SHOO | https://www.sfchronicle.com/business/article/Steven-Madden-Q2-Earnings-Snapshot-17331764.php | 2022-07-27T12:41:33Z | https://www.sfchronicle.com/business/article/Steven-Madden-Q2-Earnings-Snapshot-17331764.php | true |
HANGZHOU, China, July 27, 2022 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN; the "Company"), a leading new energy vehicle (NEV) dealership group under the brand name "Jiuzi" in China, today announced that its operating entity, Hangzhou Zhitongche Technology Limited ("Zhitongche"), has added five new franchisees in Guangxi Zhuang Autonomous Region ("Guangxi"), China since the execution of the regional exclusive agency agreement (the "Agreement" with Shanghai Aiways Yiwei Automobiles Sales Co., Ltd. ("Aiways Yiwei"), the subsidiary of Aiways Automobiles Company Ltd. ("Aiways Auto").
Pursuant to the Agreement, in the first two months of the one-year term, or starting on July 1st, 2022, Zhitongche will establish 12 Aiways experience centers in major cities in Guangxi. Since the signing of the agreement, Zhitongche has made fruitful progress by recruiting five franchisees in Nanning, Liuzhou, Beihai, Guilin, and Yulin, among which three franchisees have paid the franchise fees in full. In the meantime, Zhitongche is also negotiating with 12 potential franchisees who have expressed interest in joining.
"I'm extremely proud of the great achievement that our brilliant Guangxi team has made in such a short period. Our success in gaining new franchisees is due to the synergy effect created by the brand awareness of Jiuzi and Aiways", said Mr. Shuibo Zhang, CEO of Jiuzi Holdings, Inc., "Our Jiuzi brand is well recognized in Guangxi through our existing 13 franchise stores. By leveraging the additional prestige of Aiways brand, we believe the collaboration with Aiways would accelerate our business expansion in Guangxi. Due to our fast expansion as a result of the collaboration Aiways, we expect to add 13 new franchise stores in Guangxi by the end of this year in addition to the 12 existing ones, adding to a total of 25 new franchise stores in Guangxi in 2022."
About Jiuzi Holdings, Inc.
Jiuzi Holdings, Inc., headquartered in Hangzhou, China, and established in 2017, franchises and operates retail stores under the brand name "Jiuzi" to sell New Energy Vehicles ("NEVs") in third and fourth-tier cities in China. The Company mainly sells battery-operated electric vehicles and sources NEVs through more than twenty NEV manufacturers. It has 51 operating franchise stores and one company-owned store. For more information, visit the Company's website at http://www.zjjzxny.cn/.
Forward-Looking Statements
All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. They are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs, including the expectation that the Offering will be completed. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent events, circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and its other filings with the SEC.
For more information, please contact:
Stephen Tong
Email: jiuzi@mana-ir.com
View original content:
SOURCE Jiuzi Holdings, Inc. | https://www.weau.com/prnewswire/2022/07/27/jiuzi-holdings-inc-recruits-five-new-franchisees-guangxi/ | 2022-07-27T12:42:18Z | https://www.weau.com/prnewswire/2022/07/27/jiuzi-holdings-inc-recruits-five-new-franchisees-guangxi/ | false |
CRS nod for operation of trains in Nagapattinam - Velankanni BG section
Services to resume from July 29 on this stretch
The Commissioner of Railway Safety (CRS), Southern Circle, Bengaluru, has authorised operation of passenger trains in the 10-km Nagapattinam - Velankanni broad gauge section which has set the stage for resumption of train services on this stretch from this month-end.
The authorisation from the CRS came on Monday after he inspected the stretch which is situated in the coastal belt last week following completion of track improvement works that was executed by the Southern Railway Construction Organisation.
The CRS has given authorisation for operation of passenger trains at 80 kilometre per hour speed, senior railway officers said. As part of his day-long inspection on July 20, the CRS, accompanied by top Southern Railway officers, also conducted a speed trial by travelling on board a special train from Velankanni to Nagapattinam during which maximum speed of 105 kilometre per hour was attained.
Based on the recommendations of the Research Design and Standards Organisation, which comes under the Ministry of Railways, the Southern Railway had carried out protection / stabilisation works in the Nagapattinam - Velankanni BG stretch which included construction of reinforced cement concrete retaining walls at various locations along the section as it was situated in the coastal area and widening of formation ahead of requesting the CRS to inspect the broad gauge section following completion of works. The works were carried out to increase the speed of the trains.
Although trains were being operated in this section earlier, they were, however, run with restricted speed. Another senior official said the Principal Chief Electrical Engineer, Southern Railway had carried out OHE (overhead electrical equipment) inspection in this section on Monday and gave his authorisation for electric traction. The Central Organisation for Railway Electrification had executed overhead electrification works in the Nagapattinam - Velankanni section that falls under the Tiruchi Railway Division. Railway officials thereafter conducted a trial run by an electric locomotive in April.
RESTORATION OF TRAIN SERVICES
With the CRS giving his clearance for operation of passenger trains, the Tiruchi Railway Division on Wednesday announced the resumption of Karaikal - Velankanni - Karaikal and Nagapattinam- Velankanni - Nagapattinam daily trains from July 29. Both trains will be operated as unreserved express specials. The Tiruchi - Velankanni - Tiruchi daily unreserved express special which is presently running to and from Nagapattinam will be extended to Velankanni with effect from July 29, a press release from Tiruchi Division said.
- Comments will be moderated by The Hindu editorial team.
- Comments that are abusive, personal, incendiary or irrelevant cannot be published.
- Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
- We may remove hyperlinks within comments.
- Please use a genuine email ID and provide your name, to avoid rejection. | https://www.thehindu.com/news/cities/Tiruchirapalli/crs-nod-for-operation-of-trains-in-nagapattinam-velankanni-bg-section/article65689530.ece | 2022-07-27T12:42:39Z | https://www.thehindu.com/news/cities/Tiruchirapalli/crs-nod-for-operation-of-trains-in-nagapattinam-velankanni-bg-section/article65689530.ece | false |
Webcast scheduled for Tuesday, August 9 at 11:30 a.m. Eastern Time
CARLSBAD, Calif., July 27, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Tuesday, August 9th at 11:30 a.m. Eastern Time to discuss its second quarter financial results and report on pipeline and business progress.
The webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.
View original content to download multimedia:
SOURCE Ionis Pharmaceuticals, Inc. | https://www.kait8.com/prnewswire/2022/07/27/ionis-hold-second-quarter-2022-financial-results-webcast/ | 2022-07-27T12:44:23Z | https://www.kait8.com/prnewswire/2022/07/27/ionis-hold-second-quarter-2022-financial-results-webcast/ | false |
PORTLAND, Ore. (AP) — Free transportation to cooling centers and garbage pickup well before sunrise were among the steps being taken in the Pacific Northwest as the region hit the peak of a multiday heatwave.
Temperatures soared to 102 degrees Fahrenheit (38.9 Celsius) in Oregon’s largest city on Tuesday, which is expected to be the hottest day of a scorching spell that will be unusually long for this part of the United States. It was also a new daily record for the city for July 26, besting the previous mark set in 2020.
Seattle also reported a new all-time daily high of 94 F (34.4 C), breaking the previous record of 92 F (33.3 C) from 2018, according to the National Weather Service.
Elsewhere in Washington state, record daily temperatures were also registered in Bellingham and the capital, Olympia, which experienced 90 F (32.2 C) and 97 F (36.1 C) respectively.
Oregon Gov. Kate Brown declared a state of emergency across much of the state, warning the extreme temperatures may cause utility outages and transportation disruptions. Temperatures aren’t expected to cool in western Oregon and Washington until the weekend.
Under the sweltering heat, Matthew Carr spent his lunch break in a fountain in downtown Portland, Oregon. The 57-year-old works outside picking up trash for the city and had to find a way to cool off.
“This is pretty hot,” Carr said. “I can just take my uniform off, jump in there with my shorts for my break, and hang out for a good 10 or 15 minutes.”
Oregon health officials say there has been an uptick in the number of people reporting heat-related illness in emergency departments, and the number of those calling emergency services numbers for similar symptoms.
“Heat-related illness daily visits are above expected levels statewide,” said Jonathan Modie, lead communications officer at the Oregon Health Authority’s Public Health Division. He said there were 32 such visits to emergency rooms on Monday compared to three to five per day before the heat wave began.
Portland officials have opened cooling centers in public buildings and installed misting stations in parks. TriMet, which operates public transportation in the Portland metropolitan area, will allow passengers who cannot afford fares to ride for free when heading to cooling centers.
Most of Portland’s garbage companies began earlier pick-ups on Tuesday morning, starting as early as 4 a.m. to reduce drivers’ exposure to heat and health risks. The early rounds will likely continue through Friday morning.
Multnomah County, which includes Portland, planned to open four overnight emergency cooling shelters starting Tuesday night so people who can’t get cool on their own could spend the night. The locations can accommodate a total of 245 guests, said Multnomah County spokesperson Kate Yeiser.
“We’re going to find space for anybody who needs it,” Yeiser said, adding that the sites have a “no-turn-away policy.” She said the county may open an additional overnight center on Wednesday if there’s high demand.
Many libraries are extending their hours, staying open until 8 or 9 p.m. to allow people more time to cool off.
Residents and officials in the Northwest have been trying to adjust to the likely reality of longer, hotter heat waves following last summer’s deadly “heat dome” weather phenomenon that prompted record temperatures and deaths.
In response, Oregon passed a law requiring all new housing built after April 2024 to have air conditioning installed in at least one room. The law already prohibits landlords in most cases from restricting tenants from installing cooling devices in their rental units.
About 800 people died in Oregon, Washington and British Columbia during a 2021 heat wave that hit in late June and early July. The temperature at the time soared to an all-time high of 116 F (46.7 C) in Portland and smashed heat records in cities and towns across the region. Many of those who died were elderly and lived alone.
While temperatures this week are not expected to get that high, the anticipated number of consecutive hot days has raised concerns among officials.
The National Weather Service has issued an extreme heat warning for large swaths of Oregon and Washington state.
Officials in Seattle and Portland have issued air quality advisories from Tuesday through Saturday, warning that smog may reach levels that could be unhealthy for sensitive groups.
Cooling sites are open throughout Seattle, greater King County and throughout western Washington
___
AP photographer Craig Mitchelldyer contributed.
___
Claire Rush is a corps member for the Associated Press/Report for America Statehouse News Initiative. Report for America is a nonprofit national service program that places journalists in local newsrooms to report on undercovered issues. Follow her on Twitter. | https://www.fox16.com/news/national/records-fall-as-northwest-swelters-under-multiday-heat-wave/ | 2022-07-27T12:44:29Z | https://www.fox16.com/news/national/records-fall-as-northwest-swelters-under-multiday-heat-wave/ | false |
CLEVELAND (AP) _ Sherwin-Williams Co. (SHW) on Wednesday reported second-quarter earnings of $577.9 million.
The Cleveland-based company said it had net income of $2.21 per share. Earnings, adjusted for non-recurring costs, came to $2.41 per share.
The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $2.81 per share.
The paint and coatings maker posted revenue of $5.87 billion in the period, also falling short of Street forecasts. Six analysts surveyed by Zacks expected $5.99 billion.
Sherwin-Williams expects full-year earnings in the range of $8.50 to $8.80 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SHW at https://www.zacks.com/ap/SHW | https://www.sfgate.com/business/article/Sherwin-Williams-Q2-Earnings-Snapshot-17331782.php | 2022-07-27T12:45:21Z | https://www.sfgate.com/business/article/Sherwin-Williams-Q2-Earnings-Snapshot-17331782.php | false |
IoT Leader Achieves Significant Revenue Growth in Industrial & Commercial and Home & Life Business Units
AUSTIN, Texas , July 27, 2022 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, reported robust financial results for the second quarter, which ended July 2, 2022. Revenue exceeded the top end of the guidance range at $263 million, up 13% sequentially and 55% year-on-year.
"We continue to gain momentum, building on strong design win performance, a growing opportunity funnel and market share expansion despite the challenging macro environment. We delivered record revenue in the quarter and operating results ahead of model, driving strong EPS growth," said Matt Johnson, President and Chief Executive Officer of Silicon Labs. "We just marked the one-year anniversary of becoming a pure-play IoT company, and we are more confident than ever in our ability to lead and scale in the large and growing IoT wireless market."
Second Quarter Financial Highlights
- Revenue increased to $263 million, up 13% sequentially and 55% year-on-year
- Industrial & Commercial revenue for the quarter was $144 million, up 61% year-on-year
- Home & Life revenue for the quarter was $119 million, up 49% year-on-year
- Gross margin of 62% was slightly favorable due to product mix in the quarter
Results on a GAAP basis:
- GAAP gross margin was 62%
- GAAP R&D expenses were $84 million
- GAAP SG&A expenses were $49 million
- GAAP operating income as a percentage of revenue was 12%
- GAAP diluted earnings per share were $0.60
Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables were as follows:
- Non-GAAP gross margin was 62%
- Non-GAAP R&D expenses were $68 million
- Non-GAAP SG&A expenses were $41 million
- Non-GAAP operating income as a percentage of revenue was 21%
- Non-GAAP diluted earnings per share were $1.17
Business Highlights
- Announced a new Bluetooth Location Services solution using accurate, low-power Bluetooth devices to simplify Angle of Arrival (AoA) and Angle of Departure (AoD) location services. This new platform combines the industry-leading energy efficiency of Silicon Labs' BG22 system-in-a package (SiP) modules and SoCs, which can operate for up to ten years on only a coin cell battery, with advanced software that can track assets, improve indoor navigation, and locate tags with sub-meter accuracy.
- Completed the buyback of $350 million of the company's shares through the most recent open market repurchase program, resulting in the retirement of 2.5 million shares and bringing the year-to-date total for share repurchases to $600 million, retiring a total of 4.3 million shares. Additionally, the company's board of directors has authorized a new $250 million open market repurchase program of the company's common stock, through the end of 2023.
- Announced the appointment of Robert ("Bob") Conrad to the company's board of directors. Conrad brings nearly 40 years of experience in the semiconductor industry, most recently with NXP Semiconductors (NASDAQ: NXPI) as SVP of the Automotive Microcontrollers and Processors Business until his retirement in 2019. In addition, Bob brings significant experience driving strategic focus and successfully scaling businesses.
- William ("Bill") Wood announced he will not stand for reelection and will be retiring from the Silicon Labs board after 25 years of service. Bill joined the board of directors in 1997 and served as lead director from 2005-2021. His board tenure concludes at the 2023 annual meeting of stockholders.
"Bill Wood has been instrumental to Silicon Labs' success since the very beginning of our journey," said Johnson. "We're grateful for his leadership throughout the years and wish him the very best."
Business Outlook
The company expects third-quarter revenue to be in the range of $265 to $275 million. The company also estimates the following results:
On a GAAP basis:
- GAAP gross margin of approximately 60%
- GAAP operating expenses of approximately $137 million
- GAAP effective tax rate of approximately 36%
- GAAP diluted earnings per share between $0.49 to $0.59
On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables:
- Non-GAAP gross margin of approximately 60.5%
- Non-GAAP operating expenses of approximately $113 million
- Non-GAAP effective tax rate of approximately 26%
- Non-GAAP diluted earnings per share between $1.08 to $1.18
Earnings Webcast and Conference Call
Silicon Labs will host an earnings conference call to discuss the quarterly results and answer questions at 7:30 am CDT today. An audio webcast will be available on Silicon 'Labs' website (www.silabs.com) under Investor Relations. In addition, the company will post an audio recording of the event at silabs.com/investors and make a replay available through August 3, 2022, online or by calling (877) 344-7529 (US) or (412) 317-0088 (international) and entering access code 2437694.
About Silicon Labs
Silicon Labs (NASDAQ: SLAB) is a leader in secure, intelligent wireless technology for a more connected world. Our integrated hardware and software platform, intuitive development tools, thriving ecosystem, and robust support make us an ideal long-term partner in building advanced industrial, commercial, home and life applications. We make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with innovative solutions that transform industries, grow economies, and improve lives. silabs.com
Forward-Looking Statements
This press release contains forward-looking statements based on Silicon Labs' current expectations. The words "believe", "estimate", "expect", "intend", "anticipate", "plan", "project", "will", and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: the timing and scope of share repurchases, and/or dividends; the impact of COVID-19 on the U.S. and global economy, including the restrictions on travel and transportation and other actions taken by governmental authorities and disruptions to the business of our customers or our global supply chain that have occurred or may occur in the future, the ongoing impact of COVID-19 on our employees and our ability to provide services to our customers and respond to their needs; risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs' distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs' business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest, including risks that demand and the supply chain may be adversely affected by military conflict (including between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally; debt-related risks; capital-raising risks; the competitive and cyclical nature of the semiconductor industry; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs' products and its networks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. The level of share repurchases and/or dividends depends on market conditions and the level of other uses of cash. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.
Note to editors: Silicon Laboratories, Silicon Labs, the "S" symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
Non-GAAP Financial Measurements
In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.
The non-GAAP financial measurements do not replace the presentation of Silicon Labs' GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs' financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.
View original content to download multimedia:
SOURCE Silicon Labs | https://www.wagmtv.com/prnewswire/2022/07/27/silicon-labs-grows-revenue-55-second-quarter-2022/ | 2022-07-27T12:46:53Z | https://www.wagmtv.com/prnewswire/2022/07/27/silicon-labs-grows-revenue-55-second-quarter-2022/ | true |
The group, who call themselves Hebden Bridge Disinfo Squat, are looking for tables, chairs, a sofa, bean bags, cushions, rugs and blankets.
They posted on social media: "In order to make this space the best we can, and so that we can host events for the community, there are some furniture items we are in need of.
"If you’ve got any old furniture hanging around and would like it to go to a good cause we will happily take it off your hands! If you’re available to drop anything off, that is fantastic but if not we can pick up."
As reported by the Courier, the squatters have taken over what used to be William Holt Greengrocers in Bridge Gate.
They have told us they have a host of events planned, and last night held an open mic night.
They said: "Hebden Disinfo Squat is an autonomous community space complete with a library, free zines, and vegan refreshments.
"We have a range of free events planned, from film screenings to live music and poetry.
"Hebden Bridge has a rich history of squatting, which has been a foundation of the community.
"We want to revive and continue this tradition, and we are committed to continuing this project beyond this building.
"This is a legal occupation and we are well within our rights, as anybody is, to occupy a disused commercial building and turn it into something useful.
"In a world where everything has a price and gentrification ravages our communities, we want to create a space that is as free and as accessible as possible, for as long as possible."
A spokesperson for West Yorkshire Police said: "Police received a report of a burglary at a commercial premises on Bridge Gate, Hebden Bridge. The report was received at 12.30pm on Monday.
"The matter is being treated as a civil issue."
According to the Government website: "Simply being on another person’s non-residential property without their permission is not usually a crime.
"The police can take action if squatters commit other crimes when entering or staying in a property." | https://www.halifaxcourier.co.uk/news/people/hebden-bridge-squatters-group-occupying-former-greengrocers-appeal-for-donated-furniture-3783220 | 2022-07-27T12:47:39Z | https://www.halifaxcourier.co.uk/news/people/hebden-bridge-squatters-group-occupying-former-greengrocers-appeal-for-donated-furniture-3783220 | false |
OTTAWA, Ontario (AP) _ Shopify Inc. (SHOP) on Wednesday reported a loss of $1.2 billion in its second quarter.
On a per-share basis, the Ottawa, Ontario-based company said it had a loss of 95 cents. Losses, adjusted for non-recurring costs and stock option expense, were 3 cents per share.
The results did not meet Wall Street expectations. The average estimate of 31 analysts surveyed by Zacks Investment Research was for earnings of 3 cents per share.
The cloud-based commerce company posted revenue of $1.3 billion in the period, which also did not meet Street forecasts. Thirty-two analysts surveyed by Zacks expected $1.33 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SHOP at https://www.zacks.com/ap/SHOP | https://www.seattlepi.com/business/article/Shopify-Q2-Earnings-Snapshot-17331809.php | 2022-07-27T12:50:53Z | https://www.seattlepi.com/business/article/Shopify-Q2-Earnings-Snapshot-17331809.php | false |
SEOUL, South Korea, July 27, 2022 /PRNewswire/ -- Automotive cybersecurity and mobility solutions provider AUTOCRYPT announced that its smart-billing EV charger "Q Charger" has received the Open Charge Point Protocol (OCPP) 1.6 certification issued by the Open Charge Alliance.
At a charging speed of 3.3 kW, AUTOCRYPT's Q Charger (model: ACO-100 BTW) is a Level 1 EV charger equipped with a 110-240 V standard charging cable compatible with all electric vehicles, and easily installable onto any wall outlet.
The Q Charger is a charger designed for shared usage, and users can scan the unique QR code located on each charger via AUTOCRYPT's charger information app, after which payment will be processed within the app using the registered payment card. The charger's built-in authentication module securely verifies the user's identity and payment status before approval for charging. All payments will then be received by the charge point operator (CPO) or the owner of the charger, who is responsible for the electricity bill.
"Our goal is twofold: Make chargers more available and make the charging experience more enjoyable for EV owners. For the millions of residents here in Korea who live in apartments, a lack of chargers has been a critical barrier to EV adoption. Deploying our smart-billing chargers in apartment and office buildings is a fast and efficient way to bring reliable EV charging to those who need it," said Daniel ES Kim, CEO of AUTOCRYPT. "Furthermore, the OCPP 1.6 certification validates the safety, security, and durability of our chargers. We look forward to enhancing charging availability in shared parking spaces across the globe."
AUTOCRYPT's Q Charger project is a sub-component of its comprehensive EV information and charging platform EVIQ, an integrated digital platform that connects EV owners and CPOs through big data, enhancing the experience of both EV charging and charging station management.
To find out more about AUTOCRYPT's Q Charger and EVIQ, contact global@autocrypt.io.
About AUTOCRYPT
AUTOCRYPT is the leading player in automotive and smart mobility security technologies, paving the way for Cooperative Intelligent Transport Systems (C-ITS) and autonomous driving through a multi-layered, holistic approach. Through security solutions for V2X, V2G (including PnC security), in-vehicle systems, and fleet management, AUTOCRYPT ensures that security is prioritized and optimized before vehicles hit the road.
View original content to download multimedia:
SOURCE AUTOCRYPT | https://www.kfyrtv.com/prnewswire/2022/07/27/autocrypts-smart-billing-ev-charger-q-charger-receives-ocpp-16-certification/ | 2022-07-27T12:51:05Z | https://www.kfyrtv.com/prnewswire/2022/07/27/autocrypts-smart-billing-ev-charger-q-charger-receives-ocpp-16-certification/ | true |
Get Saucy on July 29th at 7-Eleven, Speedway, and Stripes
IRVING, Texas, July 27, 2022 /PRNewswire/ -- There's a lot to celebrate in July—notably 7-Eleven's 95th birthday on July 11!—and that includes July 29, aka National Chicken Wing Day. This year, 7-Eleven, Inc. invites 7Rewards® and Speedy Rewards® members to get saucy with 10 classic wings for just $10 at participating 7-Eleven®, Speedway®, and Stripes® stores*.
No matter the customer's wing flavor preference—roasted, spicy, or buffalo—America's largest convenience retailer offers them hot and ready to eat. Don't miss out on the best-selling Buffalo Wings, double glazed with a classic, bold buffalo sauce for the perfect amount of flavor!
"Chicken wings remain one of the most popular and sauciest items at 7-Eleven, and not just during football season," said Robin Murphy, 7-Eleven Senior Director of Fresh Foods. "The chicken wing is a classic handheld favorite that makes the perfect snack or quick meal. And this deal is fire—both in flavor, spice, and price!"
But the fun doesn't stop there! For a limited time, members of the award-winning 7Rewards loyalty program—found in the 7-Eleven app offering customers exclusive deals and discounts on their favorite products—can enjoy Classic Wing Weekends with 5 wings for $5.99 Friday through Sunday**.
Trying to stay cool this summer? Customers can beat the heat and get this fire deal delivered via the 7NOW® delivery app! For a limited time, first-time users receive $5 off their first three orders with code SAVE3X***. Available with the 7NOW Gold Pass™ subscription delivery service, customers can get their delivery fee waived on more than 3,000 of their favorite 7-Eleven products for just $5.95 a month****.
The 7NOW delivery app can be downloaded from the App Store or Google Play, or by visiting 7Rewards.com.
*Valid from 7/29/22 - 7/30/22. Limited delivery area. A small basket fee may apply to any offer if minimum purchase requirement is not met. Delivery charges may apply. Limited delivery area. All offers limited - while supplies last. 7-Eleven, Inc. reserves the right to modify, change or cancel this offer at any time. Void where prohibited.
**Valid Through 8/2/22. MFR coupon. Available while supplies last. Offer good at participating U.S. 7-Eleven® stores, excludes Hawaii. Offer not valid with any other coupon or discount. No cash value. Consumer pays applicable fees & sales taxes. COPIES OR REPRODUCTION BY ANY MEANS IS PROHIBITED AND SHALL VOID THE COUPON.
***Valid 5/25/2022 - 9/6/2022. National offer. New customer offer only. Applicable with promo code only. One per customer, one per device. Delivery order only.
****By joining you will be signing up for a recurring monthly subscription to the 7NOW Gold Pass. After the 14-day free trial period ends, your payment method on file will be charged $5.95 plus applicable taxes and your subscription will automatically renew monthly until you cancel through your account page. Delivery fee will be waived on delivery orders.
About 7-Eleven, Inc.
7-Eleven, Inc. is the premier name in the convenience-retailing industry. Based in Irving, Texas, 7-Eleven operates, franchises and/or licenses more than 13,000 stores in the U.S. and Canada. In addition to 7-Eleven® stores, 7-Eleven, Inc. operates and franchises Speedway®, Stripes®, Laredo Taco Company® and Raise the Roost® Chicken and Biscuits locations. Known for its iconic brands such as Slurpee®, Big Bite® and Big Gulp®, 7-Eleven has expanded into high-quality sandwiches, salads, side dishes, cut fruit and protein boxes, as well as pizza, chicken wings and mini beef tacos. 7-Eleven offers customers industry-leading private brand products under the 7-Select™ brand including healthy options, decadent treats and everyday favorites at an outstanding value. Customers can earn and redeem points on various items in stores nationwide through its 7Rewards® loyalty program with more than 50 million members, place an order in the 7NOW® delivery app in over 2,000 cities, or rely on 7-Eleven for bill payment service, self-service lockers and other convenient services. Find out more online at www.7-Eleven.com.
View original content to download multimedia:
SOURCE 7-Eleven, Inc. | https://www.kalb.com/prnewswire/2022/07/27/7-eleven-celebrates-national-chicken-wing-day-with-10-10-deal-classic-wings/ | 2022-07-27T12:51:11Z | https://www.kalb.com/prnewswire/2022/07/27/7-eleven-celebrates-national-chicken-wing-day-with-10-10-deal-classic-wings/ | true |
The last two years have seen many of us welcome a new four-legged friend into our homes, as the Kennel Club saw dog ownership rise by nearly eight per cent during the global pandemic.
But with 221 different breeds of pedigree dog to choose from, there’s plenty of thinking to do before you select your perfect pup – whether you want a large dog, family-friendly dog, or crossbreed.
For all the latest dog news, pictures, advice and information, join our Scotsdog Facebook group here
One of the terrible truths of dog ownership is that we are likely to outlive our adored pet, with the average dog living just 10-13 years – but some breeds tend to have longer lives than others.
Here are the 10 record-breaking dogs that live the longest lives.
1. Chihuahua
Perhaps surprisingly, small dogs tend to live longer than large dogs - a point proven by the Chihuahua. The tiny breed lives for an average of an impressive 15-20 years.
Photo: Canva/Getty Images
2. Jack Russell
Another small dog with a long life, the Jack Russell can also live for up to 20 years, although tend to average a lifespan closer to 16 years.
Photo: Canva/Getty Images
3. Australian Cattle Dog
An Australian Cattle Dog called Bluey holds the record for the longest-lived dog - reaching an incredible 29 years of age. The breed normally lives for around 15 years.
Photo: Canva/Getty Images
4. Poodle
While Standard Poodles and Miniature Poodles both live relatively long lives, the Toy Poodle outdoes them both with a lifespan of up to 18 years.
Photo: Canva/Getty Images | https://www.falkirkherald.co.uk/lifestyle/family-and-parenting/dog-with-long-lives-here-are-the-10-breeds-of-adorable-dog-that-live-the-longest-including-the-loving-chihuahua-3318570 | 2022-07-27T12:51:46Z | https://www.falkirkherald.co.uk/lifestyle/family-and-parenting/dog-with-long-lives-here-are-the-10-breeds-of-adorable-dog-that-live-the-longest-including-the-loving-chihuahua-3318570 | true |
PROVIDENCE, R.I., July 27, 2022 /PRNewswire/ -- Bally's Corporation (NYSE: BALY) today announced the final results of its modified "Dutch Auction" tender offer, which expired at 12:00 midnight, New York City time, at the end of the day on July 22, 2022.
Based on the final count by American Stock Transfer & Trust Company, LLC, the depositary for the tender offer, 4,697,619 common shares were validly tendered at or below the final purchase price of $22.00 per share and not validly withdrawn, including shares that were tendered through notice of guaranteed delivery.
In accordance with the terms and conditions of the tender offer, Bally's has accepted for purchase a total of 4,697,619 common shares at the purchase price of $22.00 per share, for an aggregate purchase price of $103,347,618, excluding fees and expenses relating to the tender offer. These shares represent approximately 8.9% of Bally's outstanding common shares. As Bally's accepted for purchase all shares that were validly tendered at a purchase price at or below $22.00 per share and not validly withdrawn, there is no proration factor. The depositary will promptly pay for all shares accepted for purchase.
Bally's may, in the future, decide to make share repurchases from time to time on the open market or in private transactions, subject to applicable law. Any of these repurchases may be on the same terms or on terms that are more or less favorable to the selling shareholders in those transactions than the terms of the tender offer. Bally's currently has $334.6 million available for use under its previously announced capital return program.
Goldman Sachs & Co. LLC acted as the lead dealer manager for the tender offer and Capital One Securities, Inc., Truist Securities, Inc. and Wells Fargo Securities, LLC acted as the co-dealer managers. MacKenzie Partners, Inc. served as the information agent and American Stock Transfer & Trust Company, LLC acted as the depositary.
Bally's Corporation is a global casino-entertainment company with a growing omni-channel presence of Online Sports Betting and iGaming offerings. It currently owns and manages 14 casinos across 10 states, a horse racetrack in Colorado and has access to OSB licenses in 18 states. It also owns Gamesys Group, a leading, global, online gaming operator, Bally Interactive, a first-in-class sports betting platform, Monkey Knife Fight, the fastest growing daily fantasy sports site in North America, SportCaller, a leading, global B2B free-to-play game provider, and Telescope Inc., a leading provider of real-time fan engagement solutions.
With approximately 10,000 employees, Bally's Casino operations include more than 15,800 slot machines, 500 table games and 5,300 hotel rooms. Upon closing the previously announced Tropicana Las Vegas (NV) transaction, as well as completing the construction of a land-based casino near the Nittany Mall in State College, PA, Bally's will own and manage 16 casinos across 11 states. Its shares trade on the New York Stock Exchange under the ticker symbol "BALY."
This press release contains "forward-looking" statements within the meaning of the federal securities laws. Forward-looking statements are all statements other than those of historical fact, and generally may be identified by the use of words such as "anticipate," "believe," "estimate," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or implied by the forward-looking statements. Any forward-looking statement made by Bally's in this press release, its reports filed with the Securities and Exchange Commission (the "SEC") and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties arise from time to time, and it is impossible for Bally's to predict or identify all such events or how they may affect it. Factors that could cause these differences include, but are not limited to, risks and uncertainties related to the payment for shares accepted in the tender offer and the timing thereof, and those factors discussed in Bally's Annual Report on Form 10-K for the year ended December 31, 2021, subsequent Quarterly Report on Form 10-Q and other reports filed by Bally's with the SEC. Bally's undertakes no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
Investor Contact
Robert Lavan
Chief Financial Officer
401-475-8564
InvestorRelations@ballys.com
Media Contact
Richard Goldman
Kekst CNC
646-847-6102
BallysMediaInquiries@kekstcnc.com
BALY-INV
View original content to download multimedia:
SOURCE Bally's Corporation | https://www.wbrc.com/prnewswire/2022/07/27/ballys-announces-final-results-tender-offer/ | 2022-07-27T12:52:38Z | https://www.wbrc.com/prnewswire/2022/07/27/ballys-announces-final-results-tender-offer/ | true |
(The Hill) — Three in four Democrats surveyed in a new CNN poll said they don’t want President Joe Biden as their party’s presidential nominee in 2004.
The poll found that 75 percent said they want someone else as the Democratic presidential nominee in 2024, while 25 percent selected Biden.
By comparison, 51 percent of Democrats questioned in a similar poll earlier this year said they wanted a different candidate to be their presidential nominee in the next election, while 45 percent of respondents showed interest in Biden running again.
Fifty-five percent of Republican respondents in the new survey, meanwhile, said that they don’t want former President Donald Trump to be their party’s nominee in 2024, while 44 percent of respondents said the opposite.
This is a 6-point increase from a poll earlier this year when 49 percent of Republican respondents said they wanted a different candidate to be their presidential nominee, and 50 percent of respondents showed interest in Trump running for office again.
A majority of respondents in the new poll — 54 percent — also said they believe American democracy is under attack, while 40 percent of respondents said American democracy is being tested but not under attack. Six percent of respondents said that democracy isn’t under attack.
The CNN poll was conducted from July 22 to July 24 with a total of 1,002 respondents participating in the survey. The poll’s margin of error is 4 percentage points.
A survey of likely 2024 New Hampshire Democratic primary voters released on Tuesday found that Transportation Secretary Pete Buttigieg received slightly more support than Biden.
Buttigieg had 17 percent support in the University of New Hampshire (UNH) Survey Center Granite Poll compared to Biden’s 16 percent.
Vice President Kamala Harris was supported by 6 percent of respondents in that survey, which had a margin of error of 4.7 percentage points. | https://www.wfla.com/nextstar-news-wire/3-in-4-democrats-dont-want-biden-as-2024-nominee-poll/ | 2022-07-27T12:55:36Z | https://www.wfla.com/nextstar-news-wire/3-in-4-democrats-dont-want-biden-as-2024-nominee-poll/ | false |
Oracle Fusion Cloud ERP positioned as highest in "Ability to Execute" and furthest on "Completeness of Vision" in service-centric cloud ERP market analysis
AUSTIN, Texas, July 27, 2022 /PRNewswire/ -- Oracle has been named a Leader in the 2022 Gartner® Magic Quadrant for Cloud ERP for Service-Centric Enterprises for Oracle Fusion Cloud Enterprise Resource Planning (ERP). The Magic Quadrant, which evaluated 10 providers, recognized Oracle as a Leader for its "Ability to Execute" and "Completeness of Vision". A complimentary copy of the report is available here.
According to the Magic Quadrant for Cloud ERP for Service-Centric Enterprises report, "Leaders demonstrate a market-defining vision of how service-centric ERP systems and processes can be supported and improved by moving them to the cloud. They couple this with a clear Ability to Execute this vision through products, services, and go-to-market strategies."
"Oracle Cloud ERP is the only proven solution on the market that has the product depth and vertical breadth to meet the unique industry needs of our customers." said Rondy Ng, executive vice president of applications development, Oracle. "We believe the Gartner recognition highlights the trust placed in us by our service-centric customers for their digital back-office transformations and underscores their successes in overcoming unprecedented global challenges to thrive and prosper by leveraging continuous innovation from our SaaS."
Part of Oracle Fusion Cloud Applications Suite, a complete set of cloud applications designed and built for changing customer needs, Oracle Cloud ERP allows organizations to quickly optimize their business with touchless operations, predictive insights, and embedded collaboration features. With machine learning, artificial intelligence, and customer-driven innovations added every 90 days, Oracle Cloud ERP helps organizations increase efficiency, embrace new business models, respond to shifting market conditions and capitalize on new opportunities.
Over 11,000 organizations turn to Oracle Cloud ERP and Cloud HCM applications to run their businesses. Oracle Cloud ERP offers a comprehensive set of enterprise finance and operations capabilities, including financials, accounting hub, procurement, project management, enterprise performance management, risk management, subscription management, and supply chain management & manufacturing. Oracle Cloud HCM delivers market leading capabilities for human resources, talent management, workforce management, payroll, and the award winning employee experience platform, Oracle ME. These self-updating platforms provide customers with the industry's most advanced technologies every 90 days, giving organizations the ability to build, innovate, automate, adapt, and leverage new business opportunities on-demand.
Oracle has garnered consistent industry recognition for its finance applications. Oracle was named a Leader for the third successive time in the 2021 Gartner® Magic Quadrant™ for Cloud ERP for Product-Centric Enterprises and was ranked a Leader in the 2021 Gartner Magic Quadrant for Cloud Core Financial Management Suites for Midsize, Large and Global Enterprises" for the fifth straight year. Additionally, Oracle was named a Customers' Choice in the 2021 Gartner ® Peer Insights™ 'Voice of the Customer': Cloud Financial Planning and Analysis Solutions. Finally, Oracle was named a Leader for the sixth successive year in the Gartner Magic Quadrant for Cloud HCM Suites for 1,000+ Employee Enterprises.
To learn more about Oracle Cloud ERP customers, visit www.oracle.com/erp/customers/
Gartner Disclaimer
GARTNER and MAGIC QUADRANT are registered trademarks and service marks, and PEER INSIGHTS is a trademark and service mark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.
Trademarks
Oracle, Java, and MySQL are registered trademarks of Oracle Corporation.
View original content to download multimedia:
SOURCE Oracle | https://www.kfyrtv.com/prnewswire/2022/07/27/oracle-recognized-leader-2022-gartner-magic-quadrant-cloud-erp-service-centric-enterprises/ | 2022-07-27T12:56:53Z | https://www.kfyrtv.com/prnewswire/2022/07/27/oracle-recognized-leader-2022-gartner-magic-quadrant-cloud-erp-service-centric-enterprises/ | true |
Thomas D. Fagan Jr. Appointed Vice President, U.S. Alzheimer's Disease Commercial at Eisai Inc.
NUTLEY, N.J., July 27, 2022 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate appointment of Thomas D. Fagan Jr. as Vice President, U.S. Alzheimer's Disease Commercial. In this role, he will be responsible for leading the development and implementation of the commercial launch strategy for the company's Alzheimer's disease (AD) business in the United States, as well as accelerate the growth and expansion of the AD team. He will also serve as a member of the company's Executive Committee for the Americas. The appointment comes at an exciting time for the company as Eisai continues to advance a robust AD pipeline.
Mr. Fagan joins Eisai with an extensive leadership background and strong record in driving business results. In his new position, he will work closely with internal teams and Eisai's partners to prepare for the potential launch and growth of a late-stage investigational anti-amyloid protofibril antibody. To fulfill our company's mission to best serve patients and their families, key responsibilities will include continuing to build and sustain trust with stakeholders across the AD community, pursuing new innovations to simplify the patient journey, and ensuring broad access for appropriate patients to benefit from potential new therapies.
"For four decades, Eisai has been at the forefront of AD research and development. We are very pleased to welcome Tom, whose knowledge and experience in AD will be essential as we seek to bring leading therapies and solutions to people living with AD, their families, and the health care professionals who serve them as soon as possible," said Ivan Cheung, Chairman & CEO of Eisai Inc., Global Alzheimer's Disease Officer, and Senior Corporate Officer, Eisai Co., Ltd. "Tom is the latest strategic hire as Eisai continues to add to our strong U.S. executive team in an effort to advance our human health care mission and social good."
Mr. Fagan joins Eisai with more than 20 years of experience serving the pharmaceutical, medical device and diagnostics industries during which time he accumulated roles of increasing responsibility across product and brand development, commercialization, business development and alliance management including seven years in roles dedicated to AD. He has held the role of Global Commercial Leader, Alzheimer's Disease, where he designed, built and led commercial teams in the launch of a first-in-class PET radiopharmaceutical used in the diagnosis of AD. He also served as the Global Brand Development Leader for AD, in which he was the commercial lead for an alliance on a late-stage molecule for the treatment of early AD. Mr. Fagan earned his Master of Business Administration (MBA) degree in general management from Stanford University and holds a Bachelor of Arts degree in Economics from DePauw University, where he graduated summa cum laude and was a member of Phi Beta Kappa.
Eisai's comprehensive investigational dementia pipeline includes disease modification and prevention compounds spanning the continuum of dementia: Amyloid, Tau, Neurodegeneration and Neuroinflammation (ATN). To learn more about Eisai's exciting pipeline, please visit www.eisai.com.
About Eisai Inc.
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn.
About Eisai Co., Ltd.
The Eisai Corporate Philosophy is "to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides." Under this Philosophy (also known as human health care (hhc) philosophy), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.
Under the medium-term business plan "EWAY Future & Beyond," which began in April 2021, Eisai is expanding its main role in healthcare, that is, we should contribute not only to people in the medical domain but also to people in the daily living domain. We aim to evolve into an hhceco (hhc philosophy + eco-system) company that empowers people "to realize their fullest life" by creating solutions based on science and data through building an ecosystem in collaboration with other industries.
In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), with working on various activities together with global partners.
For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.), and connect with us on Twitter @Eisai_SDGs.
Media Inquiries
Patricia Councill
Eisai Inc.
551-262-2686
Patricia_Councill@eisai.com
View original content to download multimedia:
SOURCE Eisai Inc. | https://www.kwch.com/prnewswire/2022/07/27/eisai-announces-key-executive-appointment-alzheimers-disease-leadership/ | 2022-07-27T12:59:23Z | https://www.kwch.com/prnewswire/2022/07/27/eisai-announces-key-executive-appointment-alzheimers-disease-leadership/ | false |
PRINCETON, N.J., July 27, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received agreement from the US Food & Drug Administration (FDA) on an initial pediatric study plan (iPSP) for HyBryte™ (synthetic hypericin) for the treatment of cutaneous T-cell lymphoma (CTCL). The agreed iPSP stipulates that Soligenix intends on requesting a full waiver of pediatric studies upon submission of a new drug application (NDA). Agreement with FDA on an iPSP is one of the regulatory requirements that must be met prior to submitting a NDA.
"We are pleased to have FDA's agreement on our proposal to request a full waiver of pediatric studies at the time of our HyBryte™ NDA filing later this year," stated Christopher J. Schaber, PhD, President & Chief Executive Officer of Soligenix. "This is consistent with decisions by the European Medicines Agency (EMA) and Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom which have previously granted product-specific waivers from the requirement for pediatric studies in applications for marketing authorization of HyBryte™ in the UK and Europe."
HyBryte™ (research name SGX301) is a novel, first-in-class, photodynamic therapy utilizing safe, visible light for activation. The active ingredient in HyBryte™ is synthetic hypericin, a potent photosensitizer that is topically applied to skin lesions that is taken up by the malignant T-cells, and then activated by visible light 16 to 24 hours later. The use of visible light in the red-yellow spectrum has the advantage of penetrating more deeply into the skin (much more so than ultraviolet light) and therefore potentially treating deeper skin disease and thicker plaques and lesions. This treatment approach avoids the risk of secondary malignancies (including melanoma) inherent with the frequently employed DNA-damaging drugs and other phototherapy that are dependent on ultraviolet exposure. Combined with photoactivation, hypericin has demonstrated significant anti-proliferative effects on activated normal human lymphoid cells and inhibited growth of malignant T-cells isolated from CTCL patients. In a published Phase 2 clinical study in CTCL, patients experienced a statistically significant (p=0.04) improvement with topical hypericin treatment whereas the placebo was ineffective. HyBryte™ has received orphan drug and fast track designations from the FDA, as well as orphan designation from the European Medicines Agency (EMA).
The recently published Phase 3 FLASH trial trial enrolled a total of 169 patients (166 evaluable) with Stage IA, IB or IIA CTCL. The trial consisted of three treatment cycles. Treatments were administered twice weekly for the first 6 weeks and treatment response was determined at the end of the 8th week of each cycle. In the first double-blind treatment cycle, 116 patients received HyBryte™ treatment (0.25% synthetic hypericin) and 50 received placebo treatment of their index lesions. A total of 16% of the patients receiving HyBryte™ achieved at least a 50% reduction in their lesions (graded using a standard measurement of dermatologic lesions, the CAILS score) compared to only 4% of patients in the placebo group at 8 weeks (p=0.04) during the first treatment cycle (primary endpoint). HyBryte™ treatment in the first cycle was safe and well tolerated.
In the second open-label treatment cycle (Cycle 2), all patients received HyBryte™ treatment of their index lesions. Evaluation of 155 patients in this cycle (110 receiving 12 weeks of HyBryte™ treatment and 45 receiving 6 weeks of placebo treatment followed by 6 weeks of HyBryte™ treatment), demonstrated that the response rate among the 12-week treatment group was 40% (p<0.0001 vs the placebo treatment rate in Cycle 1). Comparison of the 12-week and 6-week treatment groups also revealed a statistically significant improvement (p<0.0001) between the two groups, indicating that continued treatment results in better outcomes. HyBryte™ continued to be safe and well tolerated. Additional analyses also indicated that HyBryte™ is equally effective in treating both plaque (response 42%, p<0.0001 relative to placebo treatment in Cycle 1) and patch (response 37%, p=0.0009 relative to placebo treatment in Cycle 1) lesions of CTCL, a particularly relevant finding given the historical difficulty in treating plaque lesions in particular.
The third (optional) treatment cycle (Cycle 3) was focused on safety and all patients could elect to receive HyBryte™ treatment of all their lesions. Of note, 66% of patients elected to continue with this optional compassionate use / safety cycle of the study. Of the subset of patients that received HyBryte™ throughout all 3 cycles of treatment, 49% of them demonstrated a positive treatment response (p<0.0001 vs patients receiving placebo in Cycle 1). Moreover, in a subset of patients evaluated in this cycle, it was demonstrated that HyBryte™ is not systemically available, consistent with the general safety of this topical product observed to date. At the end of Cycle 3, HyBryte™ continued to be well tolerated despite extended and increased use of the product to treat multiple lesions.
Overall safety of HyBryte™ is a critical attribute of this treatment and was monitored throughout the three treatment cycles (Cycles 1, 2 and 3) and the 6-month follow-up period. HyBryte's™ mechanism of action is not associated with DNA damage, making it a safer alternative than currently available therapies, all of which are associated with significant and sometimes fatal, side effects. Predominantly these include the risk of melanoma and other malignancies, as well as the risk of significant skin damage and premature skin aging. Currently available treatments are only approved in the context of previous treatment failure with other modalities and there is no approved front-line therapy available. Within this landscape, treatment of CTCL is strongly motivated by the safety risk of each product. HyBryte™ potentially represents the safest available efficacious treatment for CTCL. With no systemic absorption, a compound that is not mutagenic and a light source that is not carcinogenic, there is no evidence to date of any potential safety issues.
The Phase 3 CTCL clinical study was partially funded by the National Cancer Institute via a Phase II SBIR grant (#1R44CA210848-01A1) awarded to Soligenix, Inc.
CTCL is a class of non-Hodgkin's lymphoma (NHL), a type of cancer of the white blood cells that are an integral part of the immune system. Unlike most NHLs which generally involve B-cell lymphocytes (involved in producing antibodies), CTCL is caused by an expansion of malignant T-cell lymphocytes (involved in cell-mediated immunity) normally programmed to migrate to the skin. These malignant cells migrate to the skin where they form various lesions, typically beginning as patches and may progress to raised plaques and tumors. Mortality is related to the stage of CTCL, with median survival generally ranging from about 12 years in the early stages to only 2.5 years when the disease has advanced. There is currently no cure for CTCL. Typically, CTCL lesions are treated and regress but usually return either in the same part of the body or in new areas.
CTCL constitutes a rare group of NHLs, occurring in about 4% of the approximate 700,000 individuals living with the disease. It is estimated, based upon review of historic published studies and reports and an interpolation of data on the incidence of CTCL that it affects over 25,000 individuals in the U.S., with approximately 3,000 new cases seen annually.
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte™ (SGX301 or synthetic hypericin) as a novel photodynamic therapy utilizing safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). With a successful Phase 3 study completed, regulatory approval is being sought and commercialization activities for this product candidate are being advanced initially in the U.S. Development programs in this business segment also include our first-in-class innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and proprietary formulations of oral beclomethasone 17,21-dipropionate (BDP) for the prevention/treatment of gastrointestinal (GI) disorders characterized by severe inflammation including pediatric Crohn's disease (SGX203).
Our Public Health Solutions business segment includes active development programs for RiVax®, our ricin toxin vaccine candidate, and SGX943, our therapeutic candidate for antibiotic resistant and emerging infectious disease, and our vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax™, our vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2). The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known as ThermoVax®. To date, this business segment has been supported with government grant and contract funding from the National Institute of Allergy and Infectious Diseases (NIAID), the Defense Threat Reduction Agency (DTRA) and the Biomedical Advanced Research and Development Authority (BARDA).
For further information regarding Soligenix, Inc., please visit the Company's website at https://www.soligenix.com and follow us on LinkedIn and Twitter at @Soligenix_Inc.
This press release may contain forward-looking statements that reflect Soligenix, Inc.'s current expectations about its future results, performance, prospects and opportunities, including but not limited to, potential market sizes, patient populations and clinical trial enrollment. Statements that are not historical facts, such as "anticipates," "estimates," "believes," "hopes," "intends," "plans," "expects," "goal," "may," "suggest," "will," "potential," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements, such as experienced with the COVID-19 outbreak. Soligenix cannot assure you that it will be able to successfully develop, achieve regulatory approval for or commercialize products based on its technologies, particularly in light of the significant uncertainty inherent in developing therapeutics and vaccines against bioterror threats, conducting preclinical and clinical trials of therapeutics and vaccines, obtaining regulatory approvals and manufacturing therapeutics and vaccines, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development efforts, that it will be able to successfully obtain any further funding to support product development and commercialization efforts, including grants and awards, maintain its existing grants which are subject to performance requirements, enter into any biodefense procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will not negatively affect its business, or that the U.S. Congress may not pass any legislation that would provide additional funding for the Project BioShield program. In addition, there can be no assurance as to the timing or success of any of its clinical/preclinical trials. Despite the statistically significant result achieved in the HyBryte™ (SGX301) Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma, there can be no assurance that a marketing authorization from the FDA or EMA will be successful. Further, there can be no assurance that RiVax® will qualify for a biodefense Priority Review Voucher (PRV) or that the prior sales of PRVs will be indicative of any potential sales price for a PRV for RiVax®. Also, no assurance can be provided that the Company will receive or continue to receive non-dilutive government funding from grants and contracts that have been or may be awarded or for which the Company will apply in the future. These and other risk factors are described from time to time in filings with the Securities and Exchange Commission, including, but not limited to, Soligenix's reports on Forms 10-Q and 10-K. Unless required by law, Soligenix assumes no obligation to update or revise any forward-looking statements as a result of new information or future events.
View original content to download multimedia:
SOURCE Soligenix, Inc. | https://www.kalb.com/prnewswire/2022/07/27/soligenix-receives-agreement-fda-initial-pediatric-study-plan-hybryte-treatment-cutaneous-t-cell-lymphoma/ | 2022-07-27T12:59:43Z | https://www.kalb.com/prnewswire/2022/07/27/soligenix-receives-agreement-fda-initial-pediatric-study-plan-hybryte-treatment-cutaneous-t-cell-lymphoma/ | false |
WALLINGFORD, Conn. (AP) _ Amphenol Corp. (APH) on Wednesday reported second-quarter profit of $472.5 million.
The Wallingford, Connecticut-based company said it had net income of 76 cents per share. Earnings, adjusted for non-recurring gains, came to 75 cents per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 67 cents per share.
The maker of fiber-optic products posted revenue of $3.14 billion in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $2.93 billion.
For the current quarter ending in October, Amphenol expects its per-share earnings to range from 73 cents to 75 cents.
The company said it expects revenue in the range of $3.04 billion to $3.1 billion for the fiscal third quarter. Analysts surveyed by Zacks had expected revenue of $3.03 billion.
Amphenol shares have dropped 21% since the beginning of the year, while the S&P's 500 index has fallen 18%. The stock has decreased almost 2% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on APH at https://www.zacks.com/ap/APH | https://www.expressnews.com/business/article/Amphenol-Q2-Earnings-Snapshot-17331865.php | 2022-07-27T12:59:55Z | https://www.expressnews.com/business/article/Amphenol-Q2-Earnings-Snapshot-17331865.php | false |
The forecast is showing a hot day in Waterloo. The forecast calls for it to be a warm 84 degrees. We'll see a low temperature of 62 degrees today. Expect clear skies today. High UV indexes are expected. Be careful outside, especially during late morning through mid-afternoon. If your shadow is shorter than you, seek shade and wear protective clothing and generously apply sunscreen on exposed skin. The area will see gentle winds today, with forecast models showing only 10 mph wind conditions coming up from Northwest. This report is created automatically with weather data provided by TownNews.com. Stay in the know. Visit wcfcourier.com for local news and weather.
Here is today's weather outlook for Jul. 27, 2022 in Waterloo, IA
Related to this story
Most Popular
Very hot conditions across the state today, but then a cold front will arrive. Rain looks likely with severe storms expected in spots. Full details on the timing and threats in our updated forecast.
The severe weather threat will be limited to eastern Iowa this evening, but the chance for severe storms is coming back for everyone on Saturday with increasing temperatures. Get all the details here.
A few showers and storms during the morning and early afternoon Thursday, but rain looks more likely across the state beginning late tonight. Find out when the best chance of rain is in our area here.
Tonight's weather conditions in Waterloo: Variable clouds with scattered thunderstorms. Potential for severe thunderstorms. Low 69F. SSW winds…
This evening in Waterloo: Partly to mostly cloudy skies with scattered thunderstorms before midnight. Low 68F. Winds SSE at 5 to 10 mph. Chanc…
The forecast is showing a hot day in Waterloo. It looks like it will be a warm 83 degrees. Expect a drastic drop in temperatures though, with …
Summer sports camps and pre-season training often have kids running hard in high heat and humidity. The combination can be deadly.
The Waterloo area can expect a sizzling hot day. Temperatures are projected to be a quite blistering high of 96. Today has the makings of a pe…
Waterloo's evening forecast: Partly cloudy in the evening with more clouds for later at night. Low 57F. Winds N at 5 to 10 mph. Looking ahead,…
Waterloo folks should be prepared for high temperatures. It looks like it will be a balmy 89 degrees. We'll see a low temperature of 64 degree… | https://wcfcourier.com/weather/here-is-todays-weather-outlook-for-jul-27-2022-in-waterloo-ia/article_8bb40805-e31d-5ef4-998f-39c8aeb66786.html | 2022-07-27T12:59:55Z | https://wcfcourier.com/weather/here-is-todays-weather-outlook-for-jul-27-2022-in-waterloo-ia/article_8bb40805-e31d-5ef4-998f-39c8aeb66786.html | true |
Bain & Company's new study shows how innovative primary care models from nontraditional players will deliver more efficient care, improve patient outcomes and lower costs
BOSTON, July 27, 2022 /PRNewswire/ -- Bain & Company's study, Primary Care 2030: Innovative Models Transform the Landscape, shows that new primary care models from nontraditional players—such as retailers, payer-owned providers, advanced primary care disrupters and concierge providers —could capture as much as a third of the US primary care market by 2030. This would be a far cry from today's market, which remains dominated by traditional providers in fee-for-service arrangements.
"As the industry continues to shift toward value-based reimbursement, there has been an increase of nontraditional players and models in primary care," said Dr. Erin Ney, an expert associate partner at Bain & Company. "As we look ahead, rising costs, physician shortages, consumerism and digital disruption will continue putting pressure on traditional healthcare models, paving the way for additional growth of models that promote more efficient care, improved outcomes and reduced total cost."
The shift from fee-for-service to fee-for-value reimbursement models has been one of the most significant sources of innovation in primary care, a trend Bain expects will only accelerate. Both independent and payer-owned advanced primary care providers (APCs) will continue playing a major role here. Although APC disrupters make up just a fraction of the total market, they are following the profit pools and spearheading population-specific models that aim to operate in full capitation. What's more, they are already demonstrating better clinical outcomes, lower total cost of care and higher upside potential.
Looking ahead, Bain & Company expects new care models with a heightened focus on specific populations, broader adoption of multidisciplinary care teams, and growth of alternative sites and channels of care to redefine the primary care space. This includes the growth of population-specific scopes, which allow providers to invest in resources and capabilities tailored to a defined patient population for more coordinated and comprehensive care delivery.
Another major driving force for change in care models will be the pending physician shortage; the US is expected to be short 45,000 physicians by 2030. Today, more than 70% of physicians don't work alongside other specialists, and more than 45% don't work alongside advanced practice providers (APPs). That won't be sustainable by 2030, when Bain expects leading primary care providers to function in multidisciplinary care teams with an integrated approach to medical, behavioral and social determinants of health.
To effectively deliver care amid the physician shortage, organizations will have to rely more on APPs, especially in alternative sites and channels, such as retail health or virtual care. APPs will likely continue to focus on routine and urgent care while physicians take the lead on care for the most complex cases.
Sites of care are moving from clinics to homes, retailers and digital platforms. During the pandemic, 18% of primary care visits were virtual— soaring from a mere 1% in 2018. Although the share of virtual primary care settled around 12% at the end of 2021, it has earned patients' and physicians' trust, becoming a permanent fixture in the healthcare landscape. At the same time, patients still prefer to see their own doctor, and the need for physical examinations will always prevail. Given these considerations, Bain expects primary care providers with an omnichannel presence to excel over pure-play virtual providers. That bodes well for many retailers, as they look to build comprehensive, omnichannel primary care.
Bain expects payers to continue to grow their market share over the next decade. Entering primary care in 2011, payers and payer-owned services companies already hold around 5% of the market, care for approximately 13 million lives, and employ around 12,000 physicians. That trajectory is set to continue. Payers will increasingly acquire well-coordinated, high-functioning practices, as well as the technological and digital capabilities required to scale risk-bearing models. Private equity will also claim a larger share of the primary care space as investor interest holds steady. Bain anticipates increased consolidation of private equity– and venture capital–backed market disrupters throughout the next decade.
- Risk-bearing, population-specific models will scale. Fully capitated APCs, led by disrupters and payers, will grow nationally. They will add value by mitigating administrative complexity for clinicians and improving patient outcomes through tailored offerings and enhanced care coordination.
- Payers and payer-owned services companies will become one of the largest models. With expected continued vertical integration over the next decade, these models could capture up to 15% of primary care market.
- Retailers will grab market share with full-scope primary care. Retail behemoths could account for 5-10% of total primary care by 2030. They will likely outperform traditional primary care providers on the patient experience, attracting customers through increased access and convenience, particularly in geographically underserved areas.
- Alternative models will squeeze traditional models. Traditional fee-for-service will still be the largest model in 2030, but it stands to lose 15-20% of market share as alternative models often provide enhanced patient experiences, better physician experiences and more collaborative team-based care.
- Virtual channels will endure. The pandemic showed the success of virtual health channels, a model that will likely be embraced by young healthy patients. Virtual health could climb to 20% of market penetration by 2030.
Editor's Note: For more information or interview requests please contact, Katie Ware at katie.ware@bain.com or tel. +1 646 562 8102.
Bain & Company is a global consultancy that helps the world's most ambitious change makers define the future.
Across 65 cities in 40 countries, we work alongside our clients as one team with a shared ambition to achieve extraordinary results, outperform the competition, and redefine industries. We complement our tailored, integrated expertise with a vibrant ecosystem of digital innovators to deliver better, faster, and more enduring outcomes. Our 10-year commitment to invest more than $1 billion in pro bono services brings our talent, expertise, and insight to organizations tackling today's urgent challenges in education, racial equity, social justice, economic development, and the environment. We earned a gold rating from EcoVadis, the leading platform for environmental, social, and ethical performance ratings for global supply chains, putting us in the top 2% of all companies. Since our founding in 1973, we have measured our success by the success of our clients, and we proudly maintain the highest level of client advocacy in the industry.
View original content to download multimedia:
SOURCE Bain & Company | https://www.kwch.com/prnewswire/2022/07/27/new-models-primary-care-will-capture-30-us-market-by-2030-retailers-payer-owned-providers-advanced-primary-care-disruptors-gain-traction/ | 2022-07-27T13:02:09Z | https://www.kwch.com/prnewswire/2022/07/27/new-models-primary-care-will-capture-30-us-market-by-2030-retailers-payer-owned-providers-advanced-primary-care-disruptors-gain-traction/ | true |
ARLINGTON, Va., July 27, 2022 /PRNewswire/ --
Second Quarter 2022
- Operating cash flow of $0.1 billion; continue to expect positive free cash flow for 2022
- Increased 737 production to 31 per month; working with FAA on final actions to resume 787 deliveries
- Successfully completed CST-100 Starliner uncrewed Orbital Flight Test-2 (OFT-2)
- Revenue of $16.7 billion; GAAP earnings per share of $0.32 and core (non-GAAP)* loss per share of ($0.37)
- Total backlog of $372 billion; including over 4,200 commercial airplanes
The Boeing Company (NYSE: BA) reported second-quarter revenue of $16.7 billion, GAAP earnings per share of $0.32 and core loss per share (non-GAAP)* of ($0.37), driven by lower defense volume and unfavorable performance, partially offset by higher commercial volume (Table 1). Boeing recorded positive operating cash flow of $0.1 billion.
"We made important progress across key programs in the second quarter and are building momentum in our turnaround," said Dave Calhoun, Boeing President and Chief Executive Officer. "As we begin to hit key milestones, we were able to generate positive operating cash flow this quarter and remain on track to achieve positive free cash flow for 2022. While we are making meaningful progress, we have more work ahead. We will stay focused on safety, quality and transparency, as we drive stability, improve performance, and continue to invest in our future."
Operating cash flow improved to $0.1 billion in the quarter, reflecting higher commercial deliveries and timing of receipts and expenditures (Table 2).
Cash and investments in marketable securities decreased to $11.4 billion, compared to $12.3 billion at the beginning of the quarter, primarily driven by debt repayment (Table 3). The company has access to credit facilities of $14.7 billion which remain undrawn.
Total company backlog at quarter-end was $372 billion.
Segment Results
Commercial Airplanes
Commercial Airplanes second-quarter revenue increased to $6.2 billion, driven by higher 737 deliveries, partially offset by lower 787 deliveries (Table 4). Operating margin of (3.9)% also reflects abnormal costs and period expenses, including higher R&D expense.
Boeing has nearly completed the global safe return to service of the 737 MAX and the fleet has flown more than 1.5 million total flight hours since late 2020. The 737 production rate increased to 31 airplanes per month during the quarter.
On the 787 program, the company continues to work with the FAA to finalize actions to resume deliveries and is readying airplanes for delivery. The program is producing at a very low rate and will continue to do so until deliveries resume, with an expected gradual return to five per month over time. The company still anticipates 787 abnormal costs of approximately $2 billion, with most being incurred by the end of 2023, including $283 million recorded in the quarter.
Commercial Airplanes secured orders for 169 737 MAX airplanes and 13 freighters, including seven 777-8 Freighters from Lufthansa Group. Commercial Airplanes delivered 121 airplanes during the quarter and backlog included over 4,200 airplanes valued at $297 billion.
Defense, Space & Security
Defense, Space & Security second-quarter revenue decreased to $6.2 billion and second-quarter operating margin decreased to 1.1 percent, primarily driven by charges on fixed-price development programs, including MQ-25 and Commercial Crew, as well as unfavorable performance on other programs and lower volume on derivative aircraft programs. The MQ-25 program recorded a $147 million charge primarily due to higher costs to meet certain technical requirements. The Commercial Crew program also recorded a $93 million charge, primarily driven by launch manifest updates and additional costs associated with OFT-2.
During the quarter, the CH-47F Chinook Block II was selected as the German government's future heavy-lift helicopter. Defense, Space & Security also successfully completed the CST-100 Starliner uncrewed OFT-2.
Backlog at Defense, Space & Security was $55 billion, of which 33% percent represents orders from customers outside the U.S.
Global Services
Global Services second-quarter revenue increased to $4.3 billion and second-quarter operating margin increased to 16.9 percent primarily driven by higher commercial services volume and favorable mix.
During the quarter, Global Services received a contract for airlift flight dispatch services from the U.S. Air Force and was awarded a contract for avionics upgrades and cybersecurity support for the U.S. Navy. Global Services also delivered the first A-10 wing set to the U.S. Air Force.
Additional Financial Information
At quarter-end, Boeing Capital's net portfolio balance was $1.6 billion. The change in loss from other unallocated items and eliminations was primarily due to the recognition of deferred compensation income as compared to expense recorded in the second quarter 2021. The second quarter effective tax rate primarily reflects tax expense on pretax earnings and an increase to the valuation allowance.
Non-GAAP Measures Disclosures
We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America (GAAP) with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure. The following definitions are provided:
Core Operating Earnings, Core Operating Margin and Core Earnings Per Share
Core operating earnings is defined as GAAP earnings from operations excluding the FAS/CAS service cost adjustment. The FAS/CAS service cost adjustment represents the difference between the Financial Accounting Standards (FAS) pension and postretirement service costs calculated under GAAP and costs allocated to the business segments. Core operating margin is defined as core operating earnings expressed as a percentage of revenue. Core earnings per share is defined as GAAP diluted earnings per share excluding the net earnings per share impact of the FAS/CAS service cost adjustment and Non-operating pension and postretirement expenses. Non-operating pension and postretirement expenses represent the components of net periodic benefit costs other than service cost. Pension costs, comprising service and prior service costs computed in accordance with GAAP are allocated to Commercial Airplanes and BGS businesses supporting commercial customers. Pension costs allocated to BDS and BGS businesses supporting government customers are computed in accordance with U.S. Government Cost Accounting Standards (CAS), which employ different actuarial assumptions and accounting conventions than GAAP. CAS costs are allocable to government contracts. Other postretirement benefit costs are allocated to all business segments based on CAS, which is generally based on benefits paid. Management uses core operating earnings, core operating margin and core earnings per share for purposes of evaluating and forecasting underlying business performance. Management believes these core earnings measures provide investors additional insights into operational performance as they exclude non-service pension and post-retirement costs, which primarily represent costs driven by market factors and costs not allocable to government contracts. A reconciliation between the GAAP and non-GAAP measures is provided on pages 13.
Free Cash Flow
Free cash flow is GAAP operating cash flow reduced by capital expenditures for property, plant and equipment. Management believes free cash flow provides investors with an important perspective on the cash available for shareholders, debt repayment, and acquisitions after making the capital investments required to support ongoing business operations and long term value creation. Free cash flow does not represent the residual cash flow available for discretionary expenditures as it excludes certain mandatory expenditures such as repayment of maturing debt. Management uses free cash flow as a measure to assess both business performance and overall liquidity. Table 2 provides a reconciliation of free cash flow to GAAP operating cash flow.
Caution Concerning Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "should," "expects," "intends," "projects," "plans," "believes," "estimates," "targets," "anticipates," and similar expressions generally identify these forward-looking statements. Examples of forward-looking statements include statements relating to our future financial condition and operating results, as well as any other statement that does not directly relate to any historical or current fact. Forward-looking statements are based on expectations and assumptions that we believe to be reasonable when made, but that may not prove to be accurate. These statements are not guarantees and are subject to risks, uncertainties, and changes in circumstances that are difficult to predict. Many factors could cause actual results to differ materially and adversely from these forward-looking statements. Among these factors are risks related to: (1) the COVID-19 pandemic and related industry impacts, including with respect to our operations, our liquidity, the health of our customers and suppliers, and future demand for our products and services; (2) the 737 MAX, including the timing and conditions of remaining 737 MAX regulatory approvals, lower than planned production rates and/or delivery rates, and additional considerations to customers and suppliers; (3) general conditions in the economy and our industry, including those due to regulatory changes; (4) our reliance on our commercial airline customers; (5) the overall health of our aircraft production system, planned commercial aircraft production rate changes, our commercial development and derivative aircraft programs, and our aircraft being subject to stringent performance and reliability standards; (6) changing budget and appropriation levels and acquisition priorities of the U.S. government; (7) our dependence on U.S. government contracts; (8) our reliance on fixed-price contracts; (9) our reliance on cost-type contracts; (10) uncertainties concerning contracts that include in-orbit incentive payments; (11) our dependence on our subcontractors and suppliers, as well as the availability of raw materials; (12) changes in accounting estimates; (13) changes in the competitive landscape in our markets; (14) our non-U.S. operations, including sales to non-U.S. customers; (15) threats to the security of our, our customers' and/or our suppliers' information; (16) potential adverse developments in new or pending litigation and/or government investigations; (17) customer and aircraft concentration in our customer financing portfolio; (18) changes in our ability to obtain debt financing on commercially reasonable terms and at competitive rates; (19) realizing the anticipated benefits of mergers, acquisitions, joint ventures/strategic alliances or divestitures; (20) the adequacy of our insurance coverage to cover significant risk exposures; (21) potential business disruptions, including those related to physical security threats, information technology or cyber-attacks, epidemics, sanctions or natural disasters; (22) work stoppages or other labor disruptions; (23) substantial pension and other postretirement benefit obligations; (24) potential environmental liabilities; and (25) effects of climate change and legal, regulatory or market responses to such change.
Additional information concerning these and other factors can be found in our filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Any forward-looking statement speaks only as of the date on which it is made, and we assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.
The Boeing Company and Subsidiaries
Reconciliation of Non-GAAP Measures
(Unaudited)
The tables provided below reconcile the non-GAAP financial measures core operating earnings, core operating margin, and core (loss)/earnings per share with the most directly comparable GAAP financial measures, earnings from operations, operating margin, and diluted earnings per share. See page 6 of this release for additional information on the use of these non-GAAP financial measures.
The Boeing Company and Subsidiaries
Reconciliation of Non-GAAP Measures
(Unaudited)
The tables provided below reconcile the non-GAAP financial measures core operating (loss)/earnings, core operating margin, and core loss per share with the most directly comparable GAAP financial measures, (loss)/earnings from operations, operating margin, and diluted (loss)/earnings per share. See page 6 of this release for additional information on the use of these non-GAAP financial measures.
View original content:
SOURCE Boeing | https://www.wymt.com/prnewswire/2022/07/27/boeing-reports-second-quarter-results/ | 2022-07-27T13:02:59Z | https://www.wymt.com/prnewswire/2022/07/27/boeing-reports-second-quarter-results/ | true |
Equity Group Hoosier Investments Adds to Nationwide Staffing Portfolio to Meet Florida Business Needs
MIAMI, July 27, 2022 /PRNewswire/ -- Hoosier Investment LLC, an Indiana private equity firm specializing in staffing group Acquisition and growth, dba the national brand, JobSquad Staffing Solutions, has acquired Affinity Resources and Albion Staffing Solutions that now join formerly acquired Creative Staffing and Best Candidates. Together, these four entities will consolidate and become JobSquad Staffing Solutions. This consolidation creates the largest staffing firm in South Florida; as well as expands the JobSquad Staffing Solutions brand nationally – making it one of the fastest growing staffing groups and candidate networks in the United States. *
JobSquad CEO Jay Wilkinson comments, "Because Florida businesses continue to need more flexible and responsive staffing solutions, we have developed and now deliver a client and candidate experience that drives more value at a reasonable cost. We believe in the hybrid approach –a blend of effective and nimble technology at the fingertips of our specialized, expert teams that drives more value –including our team of fully bilingual recruiters across Florida and throughout the United States. WE strive to be as streamlined and flexible as possible compared to others in the staffing industry –then prove it with overall savings to every business we serve."
Affinity President Brad Mete, Best Candidate President Alfredo Cardenas, and Albion Staffing President Jorge Gonzalez agree that "Becoming part of the JobSquad Family gives us more powerful recruiting tools, candidate pools, and technologies that help us become a nimble extension of our client's HR and management teams." Creative Staffing (Hoosier's first South Florida acquisition in 2018) President John Bitterman agrees and comments, "There is no better time than now for us to come together, launch JobSquad, and deliver more value to the great state of Florida and beyond." *As of June 1, 2022
For more information, please contact: brad@thejobsquad.com, press@thejobsquad.com, press@hoosierinvestments.com, or call (574) 931-2989
View original content to download multimedia:
SOURCE JobSquad Staffing Solutions | https://www.wcjb.com/prnewswire/2022/07/27/four-major-staffing-groups-consolidate-become-south-floridas-largest-staffing-organization-under-new-name-jobsquad-staffing-solutions/ | 2022-07-27T13:03:33Z | https://www.wcjb.com/prnewswire/2022/07/27/four-major-staffing-groups-consolidate-become-south-floridas-largest-staffing-organization-under-new-name-jobsquad-staffing-solutions/ | true |
DES MOINES, Iowa (AP) — A giant Mega Millions lottery jackpot ballooned to $1.02 billion after no one matched all six numbers Tuesday night and won the top prize.
The new estimated jackpot will be the nation’s fourth-largest lottery prize.
The jackpot has grown so large because no one has matched the game’s six selected numbers since April 15. That’s 29 consecutive drawings without a big winner.
Tuesday’s numbers were: 07-29-60-63-66, Mega Ball: 15.
The $1.02 billion prize is for winners who choose the annuity option, paid annually over 30 years. Most winners opt for the cash option, which for the next drawing Friday night is an estimated $602.5 million.
The odds of winning the jackpot are 1 in 302.5 million.
Mega Millions is played in 45 states as well as Washington, D.C., and the U.S. Virgin Islands. The game is coordinated by state lotteries. | https://www.wivb.com/news/national/mega-millions-jackpot-now-over-1-billion-after-no-one-wins/ | 2022-07-27T13:05:33Z | https://www.wivb.com/news/national/mega-millions-jackpot-now-over-1-billion-after-no-one-wins/ | false |
Israeli startup heralded for its unique "correspondent-banking-in-a-box" service
TEL AVIV, Israel, July 27, 2022 /PRNewswire/ -- TenureX, the Israeli start-up that is fixing the broken correspondent banking industry, has been recognised as one of the world's leading fintechs by influential market intelligence firm Aite-Novarica Group.
TenureX is changing the face of correspondent banking with a new, platform-based approach that provides "correspondent banking in a box". The company's cloud-based digital platform comprises a set of innovative solutions that embed end-to-end payments data and compliance rules into every transaction. The TenureX platform makes it easy for any financial institution to grow their correspondent relationships, expand into new markets, roll out international settlements, and deploy new payment flows - quickly, cost-effectively, and compliantly.
Now, TenureX has been featured in Aite Group's latest Commercial Banking Fintech Spotlight: Q2 2022, which examines vendors who are revolutionizing the financial services industry through "as-a-Service" platforms. The report recognises the need for new commercial banking capabilities and examines five global fintechs that are harnessing automation to improve efficiency, FI-to-FI relationships, and the customer experience.
Responding to the report, TenureX Co-Founder & COO Or Kapelinsky, said, "For TenureX to be included in such an influential report is a fantastic reward for our team's hard work, but it's just as important for the correspondent banking industry itself. When we founded TenureX in 2020, we had a simple mission: to fix an industry in decline by sweeping away legacy technology which provided no transparency and visibility into cross-border payments, and preventing financial institutions from accessing the data they need to make intelligent, strategic and compliant decisions.
"We're delighted that Aite Group has identified our unique approach to these challenges through our Correspondent Banking as a Service ("Correspondent banking in a box"), while also recognising that our core product - the DTC(™) (Digital Transaction Certificate) - brings unique technological and innovation in this market. The report is required reading for any financial institution seeking to strengthen its relationships with other banks and FIs, revolutionize cross-border payments, and eliminate cost and complexity for compliance teams."
The full report is available for purchase here: https://aite-novarica.com/report/commercial-banking-fintech-spotlight-q2-2022
About TenureX
TenureX was founded in 2020 by four banking experts with a wide variety of industry experience. They know first-hand the frustrations and missed opportunities faced by non-bank financial institutions as they struggle to work together, and are passionate about making things simpler for everyone in correspondent banking.
The TenureX vision is to democratize correspondent banking by moving away from subjective, rigid, bilateral, relationship banking. Instead the company is building objective, streamlined, multilateral, transaction-based relationships.
About Aite Group Fintech Spotlight
The Aite-Novarica Fintech Spotlight is a quarterly series of reports looking at select emerging fintech vendors active in the financial services industry. With the vendor landscape increasingly crowded and banks and their clients facing a growing array of choice, the spotlight series aims to provide insight on interesting vendors that offer a strong unique selling point and innovative approach from a partnership or competitor perspective.
See https://aite-novarica.com/
Logo - https://mma.prnewswire.com/media/1838172/TenureX_Logo.jpg
For further information:
Izhar Arieli - CEO and Co-founder
Phone
+ 972 (0) - 73 – 326-0303 (ISR)
+1- 605 – 836-8739 (USA)
Email: izhar@tenurex.com
View original content:
SOURCE TenureX | https://www.wcjb.com/prnewswire/2022/07/27/tenurex-recognized-world-leading-fintech-latest-aite-group-spotlight-report/ | 2022-07-27T13:07:53Z | https://www.wcjb.com/prnewswire/2022/07/27/tenurex-recognized-world-leading-fintech-latest-aite-group-spotlight-report/ | false |
The stunning pictures from Josh Navidi’s spectacular wedding
Wales, Cardiff and Lions star Navidi and his partner Ellé held their wedding at a luxury venue in the Welsh countryside
Stunning pictures give a glimpse into the spectacular wedding of Wales star Josh Navidi and his gorgeous bride Ellé Holley Navidi.
The pair celebrated their nuptials at Sant Ffraed House in Abergavenny on Saturday, July 23, after getting engaged on holiday last summer.
The happy couple were joined by 150 family and friends to celebrate their special day, just a few days after Navidi returned from Wales duties in South Africa, with beautiful memories captured on the day by Lauren Amelia Photography.
Navidi had been hoping to complete his wedding speech away from the training field on tour and had joked he may rope in his brother and best man Sam, whose Bridgend-based business Navidi Hair Company was trusted with hairdressing duties on the big day.
Ellé, the new Mrs Navidi, wore a stunning strapless gown by Riki Dalal and from Eva Ashley Bridal, completed with a flowing veil and gorgeous bouquet by Hilary’s Floral Design, who provided the day's flowers.
Sant Ffraed House is part of the Oldwalls Collection which boasts luxury venues Oldwalls Gower and Fairyhill. It is set within 14 acres of grounds with views of the Sugar Loaf mountain, and is just a 10-minute drive from Abergavenny. | https://www.walesonline.co.uk/sport/rugby/rugby-news/gallery/josh-navidi-wedding-photos-abergavenny-24599020 | 2022-07-27T13:08:56Z | https://www.walesonline.co.uk/sport/rugby/rugby-news/gallery/josh-navidi-wedding-photos-abergavenny-24599020 | true |
PRINCETON, N.J., July 27, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received agreement from the US Food & Drug Administration (FDA) on an initial pediatric study plan (iPSP) for HyBryte™ (synthetic hypericin) for the treatment of cutaneous T-cell lymphoma (CTCL). The agreed iPSP stipulates that Soligenix intends on requesting a full waiver of pediatric studies upon submission of a new drug application (NDA). Agreement with FDA on an iPSP is one of the regulatory requirements that must be met prior to submitting a NDA.
"We are pleased to have FDA's agreement on our proposal to request a full waiver of pediatric studies at the time of our HyBryte™ NDA filing later this year," stated Christopher J. Schaber, PhD, President & Chief Executive Officer of Soligenix. "This is consistent with decisions by the European Medicines Agency (EMA) and Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom which have previously granted product-specific waivers from the requirement for pediatric studies in applications for marketing authorization of HyBryte™ in the UK and Europe."
HyBryte™ (research name SGX301) is a novel, first-in-class, photodynamic therapy utilizing safe, visible light for activation. The active ingredient in HyBryte™ is synthetic hypericin, a potent photosensitizer that is topically applied to skin lesions that is taken up by the malignant T-cells, and then activated by visible light 16 to 24 hours later. The use of visible light in the red-yellow spectrum has the advantage of penetrating more deeply into the skin (much more so than ultraviolet light) and therefore potentially treating deeper skin disease and thicker plaques and lesions. This treatment approach avoids the risk of secondary malignancies (including melanoma) inherent with the frequently employed DNA-damaging drugs and other phototherapy that are dependent on ultraviolet exposure. Combined with photoactivation, hypericin has demonstrated significant anti-proliferative effects on activated normal human lymphoid cells and inhibited growth of malignant T-cells isolated from CTCL patients. In a published Phase 2 clinical study in CTCL, patients experienced a statistically significant (p=0.04) improvement with topical hypericin treatment whereas the placebo was ineffective. HyBryte™ has received orphan drug and fast track designations from the FDA, as well as orphan designation from the European Medicines Agency (EMA).
The recently published Phase 3 FLASH trial trial enrolled a total of 169 patients (166 evaluable) with Stage IA, IB or IIA CTCL. The trial consisted of three treatment cycles. Treatments were administered twice weekly for the first 6 weeks and treatment response was determined at the end of the 8th week of each cycle. In the first double-blind treatment cycle, 116 patients received HyBryte™ treatment (0.25% synthetic hypericin) and 50 received placebo treatment of their index lesions. A total of 16% of the patients receiving HyBryte™ achieved at least a 50% reduction in their lesions (graded using a standard measurement of dermatologic lesions, the CAILS score) compared to only 4% of patients in the placebo group at 8 weeks (p=0.04) during the first treatment cycle (primary endpoint). HyBryte™ treatment in the first cycle was safe and well tolerated.
In the second open-label treatment cycle (Cycle 2), all patients received HyBryte™ treatment of their index lesions. Evaluation of 155 patients in this cycle (110 receiving 12 weeks of HyBryte™ treatment and 45 receiving 6 weeks of placebo treatment followed by 6 weeks of HyBryte™ treatment), demonstrated that the response rate among the 12-week treatment group was 40% (p<0.0001 vs the placebo treatment rate in Cycle 1). Comparison of the 12-week and 6-week treatment groups also revealed a statistically significant improvement (p<0.0001) between the two groups, indicating that continued treatment results in better outcomes. HyBryte™ continued to be safe and well tolerated. Additional analyses also indicated that HyBryte™ is equally effective in treating both plaque (response 42%, p<0.0001 relative to placebo treatment in Cycle 1) and patch (response 37%, p=0.0009 relative to placebo treatment in Cycle 1) lesions of CTCL, a particularly relevant finding given the historical difficulty in treating plaque lesions in particular.
The third (optional) treatment cycle (Cycle 3) was focused on safety and all patients could elect to receive HyBryte™ treatment of all their lesions. Of note, 66% of patients elected to continue with this optional compassionate use / safety cycle of the study. Of the subset of patients that received HyBryte™ throughout all 3 cycles of treatment, 49% of them demonstrated a positive treatment response (p<0.0001 vs patients receiving placebo in Cycle 1). Moreover, in a subset of patients evaluated in this cycle, it was demonstrated that HyBryte™ is not systemically available, consistent with the general safety of this topical product observed to date. At the end of Cycle 3, HyBryte™ continued to be well tolerated despite extended and increased use of the product to treat multiple lesions.
Overall safety of HyBryte™ is a critical attribute of this treatment and was monitored throughout the three treatment cycles (Cycles 1, 2 and 3) and the 6-month follow-up period. HyBryte's™ mechanism of action is not associated with DNA damage, making it a safer alternative than currently available therapies, all of which are associated with significant and sometimes fatal, side effects. Predominantly these include the risk of melanoma and other malignancies, as well as the risk of significant skin damage and premature skin aging. Currently available treatments are only approved in the context of previous treatment failure with other modalities and there is no approved front-line therapy available. Within this landscape, treatment of CTCL is strongly motivated by the safety risk of each product. HyBryte™ potentially represents the safest available efficacious treatment for CTCL. With no systemic absorption, a compound that is not mutagenic and a light source that is not carcinogenic, there is no evidence to date of any potential safety issues.
The Phase 3 CTCL clinical study was partially funded by the National Cancer Institute via a Phase II SBIR grant (#1R44CA210848-01A1) awarded to Soligenix, Inc.
CTCL is a class of non-Hodgkin's lymphoma (NHL), a type of cancer of the white blood cells that are an integral part of the immune system. Unlike most NHLs which generally involve B-cell lymphocytes (involved in producing antibodies), CTCL is caused by an expansion of malignant T-cell lymphocytes (involved in cell-mediated immunity) normally programmed to migrate to the skin. These malignant cells migrate to the skin where they form various lesions, typically beginning as patches and may progress to raised plaques and tumors. Mortality is related to the stage of CTCL, with median survival generally ranging from about 12 years in the early stages to only 2.5 years when the disease has advanced. There is currently no cure for CTCL. Typically, CTCL lesions are treated and regress but usually return either in the same part of the body or in new areas.
CTCL constitutes a rare group of NHLs, occurring in about 4% of the approximate 700,000 individuals living with the disease. It is estimated, based upon review of historic published studies and reports and an interpolation of data on the incidence of CTCL that it affects over 25,000 individuals in the U.S., with approximately 3,000 new cases seen annually.
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte™ (SGX301 or synthetic hypericin) as a novel photodynamic therapy utilizing safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). With a successful Phase 3 study completed, regulatory approval is being sought and commercialization activities for this product candidate are being advanced initially in the U.S. Development programs in this business segment also include our first-in-class innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and proprietary formulations of oral beclomethasone 17,21-dipropionate (BDP) for the prevention/treatment of gastrointestinal (GI) disorders characterized by severe inflammation including pediatric Crohn's disease (SGX203).
Our Public Health Solutions business segment includes active development programs for RiVax®, our ricin toxin vaccine candidate, and SGX943, our therapeutic candidate for antibiotic resistant and emerging infectious disease, and our vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax™, our vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2). The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known as ThermoVax®. To date, this business segment has been supported with government grant and contract funding from the National Institute of Allergy and Infectious Diseases (NIAID), the Defense Threat Reduction Agency (DTRA) and the Biomedical Advanced Research and Development Authority (BARDA).
For further information regarding Soligenix, Inc., please visit the Company's website at https://www.soligenix.com and follow us on LinkedIn and Twitter at @Soligenix_Inc.
This press release may contain forward-looking statements that reflect Soligenix, Inc.'s current expectations about its future results, performance, prospects and opportunities, including but not limited to, potential market sizes, patient populations and clinical trial enrollment. Statements that are not historical facts, such as "anticipates," "estimates," "believes," "hopes," "intends," "plans," "expects," "goal," "may," "suggest," "will," "potential," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements, such as experienced with the COVID-19 outbreak. Soligenix cannot assure you that it will be able to successfully develop, achieve regulatory approval for or commercialize products based on its technologies, particularly in light of the significant uncertainty inherent in developing therapeutics and vaccines against bioterror threats, conducting preclinical and clinical trials of therapeutics and vaccines, obtaining regulatory approvals and manufacturing therapeutics and vaccines, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development efforts, that it will be able to successfully obtain any further funding to support product development and commercialization efforts, including grants and awards, maintain its existing grants which are subject to performance requirements, enter into any biodefense procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will not negatively affect its business, or that the U.S. Congress may not pass any legislation that would provide additional funding for the Project BioShield program. In addition, there can be no assurance as to the timing or success of any of its clinical/preclinical trials. Despite the statistically significant result achieved in the HyBryte™ (SGX301) Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma, there can be no assurance that a marketing authorization from the FDA or EMA will be successful. Further, there can be no assurance that RiVax® will qualify for a biodefense Priority Review Voucher (PRV) or that the prior sales of PRVs will be indicative of any potential sales price for a PRV for RiVax®. Also, no assurance can be provided that the Company will receive or continue to receive non-dilutive government funding from grants and contracts that have been or may be awarded or for which the Company will apply in the future. These and other risk factors are described from time to time in filings with the Securities and Exchange Commission, including, but not limited to, Soligenix's reports on Forms 10-Q and 10-K. Unless required by law, Soligenix assumes no obligation to update or revise any forward-looking statements as a result of new information or future events.
View original content to download multimedia:
SOURCE Soligenix, Inc. | https://www.wymt.com/prnewswire/2022/07/27/soligenix-receives-agreement-fda-initial-pediatric-study-plan-hybryte-treatment-cutaneous-t-cell-lymphoma/ | 2022-07-27T13:08:58Z | https://www.wymt.com/prnewswire/2022/07/27/soligenix-receives-agreement-fda-initial-pediatric-study-plan-hybryte-treatment-cutaneous-t-cell-lymphoma/ | false |
The classic, cheerful sunflower can provide pops of sunny yellow all over any outdoor area.
Sunflowers have the scientific name Helianthus, which comes from the Greek “helios” (sun), and “anthos” (flower). Sunflowers don’t just get their name from commonly being yellow like the sun but also from being heliotropic, meaning they move their faces to follow the path of the sun in the sky.
Some sunflowers can grow quite tall — anywhere from 3 to 10 feet — while dwarf varieties will stay closer to the ground. While most sunflowers are annuals, meaning you can replant them each year from the seeds collected from the previous year’s flowers, there are some perennial sunflowers as well.
But did you know that besides the familiar, bright and sunny shade of yellow sunflowers there are also more rare hues, including pink sunflowers? We’re not talking about some artificially dyed, saturated pink blooms that you might find in a florist’s shop or grocery store but naturally beautiful pink sunflowers.
A few kinds of pink sunflowers that turn up online are called Midnight Oil and Iris Tectorum Rose. These names also pop up with iris flowers as well. Strawberry blonde and Ms. Mars are other varieties of pink sunflowers you can find online.
One consistent theme pops up with online reviews on pink sunflowers: You never know exactly what version of the shade you’ll get.
“The colors ranged from deep-purple hues to barely-there bubble gum pink,” said one reviewer on the page for Burpee’s strawberry blonde hybrids.
“Mine didn’t turn a pink but more of a brick red with a little touch of pink,” said another Burpee reviewer on the Ms. Mars sunflower. “A beautiful flower that I am going to grow every year now!”
When you do see pink sunflowers, they may not be the true flamingo pink you’re probably imagining, but people who’ve grown them say they’re still beautiful. Another thing that makes these blooms special is that pink sunflowers still seem to be a rare variety.
An anemone that looks like a pink sunflower is the Curtain Call Deep Rose variety, a Japanese anemone, with a vivid pink shade and smaller blooms than typical sunflowers.
If you spot a deep pink-purplish, sunflower-like bloom, it could also be a coneflower. Similar to sunflowers but of a different genus are coneflowers, and the Eastern Purple Coneflower comes in a deep shade of pink. Pictured below is an Eastern Purple Coneflower. You can see why these may be confused for pink sunflowers to the untrained eye!
Other pink flower varieties that resemble sunflowers that you might have seen are from the same shared Asteraceae family. These include anemones, asters, chrysanthemums, dahlias, daisies, dandelions, goldenrods, marigolds and false sunflowers or heliopsis. Pink shades of some of these flowers can be more common. Many of these are also perennials, meaning you don’t have to replant them each year as they will come back on their own.
You’ll also find many other unique colored sunflowers out there including deep red, orange, green and bronze.
Whatever kind of sunflower you plant, there is one key thing: make sure they can get a lot of sun! Make sure you water them regularly and don’t let them dry out. Once a sunflower’s blooms have faded, you can leave them to dry and then harvest the seeds out of the center of the sunflower to use for replanting or even snacking.
This story originally appeared on Simplemost. Checkout Simplemost for additional stories. | https://www.wmar2news.com/pink-sunflowers-unique-look-iconic-plant | 2022-07-27T13:10:05Z | https://www.wmar2news.com/pink-sunflowers-unique-look-iconic-plant | false |
ROCHESTER, N.Y. (AP) _ Monro Muffler Brake Inc. (MNRO) on Wednesday reported fiscal first-quarter profit of $12.5 million.
On a per-share basis, the Rochester, New York-based company said it had profit of 37 cents. Earnings, adjusted for non-recurring costs, came to 42 cents per share.
The automotive repair chain posted revenue of $349.5 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MNRO at https://www.zacks.com/ap/MNRO | https://www.stamfordadvocate.com/business/article/Monro-Fiscal-Q1-Earnings-Snapshot-17331835.php | 2022-07-27T13:10:41Z | https://www.stamfordadvocate.com/business/article/Monro-Fiscal-Q1-Earnings-Snapshot-17331835.php | false |
Oracle Fusion Cloud ERP positioned as highest in "Ability to Execute" and furthest on "Completeness of Vision" in service-centric cloud ERP market analysis
AUSTIN, Texas, July 27, 2022 /PRNewswire/ -- Oracle has been named a Leader in the 2022 Gartner® Magic Quadrant for Cloud ERP for Service-Centric Enterprises for Oracle Fusion Cloud Enterprise Resource Planning (ERP). The Magic Quadrant, which evaluated 10 providers, recognized Oracle as a Leader for its "Ability to Execute" and "Completeness of Vision". A complimentary copy of the report is available here.
According to the Magic Quadrant for Cloud ERP for Service-Centric Enterprises report, "Leaders demonstrate a market-defining vision of how service-centric ERP systems and processes can be supported and improved by moving them to the cloud. They couple this with a clear Ability to Execute this vision through products, services, and go-to-market strategies."
"Oracle Cloud ERP is the only proven solution on the market that has the product depth and vertical breadth to meet the unique industry needs of our customers." said Rondy Ng, executive vice president of applications development, Oracle. "We believe the Gartner recognition highlights the trust placed in us by our service-centric customers for their digital back-office transformations and underscores their successes in overcoming unprecedented global challenges to thrive and prosper by leveraging continuous innovation from our SaaS."
Part of Oracle Fusion Cloud Applications Suite, a complete set of cloud applications designed and built for changing customer needs, Oracle Cloud ERP allows organizations to quickly optimize their business with touchless operations, predictive insights, and embedded collaboration features. With machine learning, artificial intelligence, and customer-driven innovations added every 90 days, Oracle Cloud ERP helps organizations increase efficiency, embrace new business models, respond to shifting market conditions and capitalize on new opportunities.
Over 11,000 organizations turn to Oracle Cloud ERP and Cloud HCM applications to run their businesses. Oracle Cloud ERP offers a comprehensive set of enterprise finance and operations capabilities, including financials, accounting hub, procurement, project management, enterprise performance management, risk management, subscription management, and supply chain management & manufacturing. Oracle Cloud HCM delivers market leading capabilities for human resources, talent management, workforce management, payroll, and the award winning employee experience platform, Oracle ME. These self-updating platforms provide customers with the industry's most advanced technologies every 90 days, giving organizations the ability to build, innovate, automate, adapt, and leverage new business opportunities on-demand.
Oracle has garnered consistent industry recognition for its finance applications. Oracle was named a Leader for the third successive time in the 2021 Gartner® Magic Quadrant™ for Cloud ERP for Product-Centric Enterprises and was ranked a Leader in the 2021 Gartner Magic Quadrant for Cloud Core Financial Management Suites for Midsize, Large and Global Enterprises" for the fifth straight year. Additionally, Oracle was named a Customers' Choice in the 2021 Gartner ® Peer Insights™ 'Voice of the Customer': Cloud Financial Planning and Analysis Solutions. Finally, Oracle was named a Leader for the sixth successive year in the Gartner Magic Quadrant for Cloud HCM Suites for 1,000+ Employee Enterprises.
To learn more about Oracle Cloud ERP customers, visit www.oracle.com/erp/customers/
Gartner Disclaimer
GARTNER and MAGIC QUADRANT are registered trademarks and service marks, and PEER INSIGHTS is a trademark and service mark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.
Trademarks
Oracle, Java, and MySQL are registered trademarks of Oracle Corporation.
View original content to download multimedia:
SOURCE Oracle | https://www.wlbt.com/prnewswire/2022/07/27/oracle-recognized-leader-2022-gartner-magic-quadrant-cloud-erp-service-centric-enterprises/ | 2022-07-27T13:11:38Z | https://www.wlbt.com/prnewswire/2022/07/27/oracle-recognized-leader-2022-gartner-magic-quadrant-cloud-erp-service-centric-enterprises/ | true |
The relationship demonstrates Archer's continued momentum as it moves toward its goal of achieving Type Certification of its production aircraft in 2024
SANTA CLARA, Calif. and PHOENIX, July 27, 2022 /PRNewswire/ -- Archer Aviation Inc. ("Archer") (NYSE: ACHR) has entered into an agreement with Honeywell (NASDAQ: HON) covering the supply of flight control actuation and thermal management technologies. Honeywell's actuation technology is a key enabler of Archer's 12 tilt 6 configuration, and Honeywell's thermal management technology will help Archer provide a best-in-class in-cabin experience for its passengers.
Archer's production aircraft will operate in dense urban environments, making critical precision from the aircraft's flight controls and actuators a must. Honeywell's actuators can accept hundreds of micro adjustments and commands per second from fly-by-wire computers, enabling precise navigation. Archer works to incorporate the latest advancements in technology into its aircraft to draw on its safety benefits, and accommodate the unique elements of its electric vertical takeoff and landing (eVTOL) aircraft. As such, Archer has selected the MicroVCS, Honeywell's thermal management system that provides several advantages compared to conventional systems, including lower weight, higher efficiency, and higher reliability in its size and power class.
Honeywell has more than 60 years of experience delivering actuation and thermal management systems for space, aerospace and naval applications and is an established leader in the eVTOL segment, offering a full line of avionics, navigation, electric propulsion, radar and communications systems, in addition to flight controls and actuation technology.
"Honeywell's position as an established leader in delivering advanced aerospace technologies will be critical to our delivering on our goal of certifying our production aircraft in 2024," said Adam Goldstein, CEO, Archer. "It is evident to us that Honeywell shares our belief that the key to commercializing eVTOL aircraft is working with leading aerospace suppliers to ensure we can deliver as safe an aircraft as possible."
"Honeywell has a wide variety of ready-now solutions that will create a more sustainable future for the aviation sector, and the technology we're providing Archer is a great example of that," said Stéphane Fymat, vice president and general manager, Urban Air Mobility and Unmanned Aerial Systems, Honeywell Aerospace. "We're committed to making Urban Air Mobility an everyday form of travel, and Archer's aircraft will help bring that vision to life."
Honeywell Aerospace products and services are found on virtually every commercial, defense and space aircraft. The Aerospace business unit builds aircraft engines, cockpit and cabin electronics, wireless connectivity systems, mechanical components and more. Its hardware and software solutions create more fuel-efficient aircraft, more direct and on-time flights and safer skies and airports. For more information, visit www.honeywell.com or follow us at @Honeywell_Aero.
Honeywell (www.honeywell.com) is a Fortune 100 technology company that delivers industry-specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.
Archer's mission is to advance the benefits of sustainable air mobility. Archer's goal is to move people throughout the world's cities in a quick, safe, sustainable, and cost-effective manner. Archer is designing and developing electric vertical takeoff and landing aircraft for use in urban air mobility. Archer's team is based in Santa Clara, CA. To learn more, visit www.archer.com.
Contacts:
Media
Adam Kress
(602) 760-6252
adam.kress@honeywell.com
Louise Bristow
louise.bristow@archer.com
archer@launchsquad.com
investors@archer.com
View original content to download multimedia:
SOURCE Honeywell | https://www.wflx.com/prnewswire/2022/07/27/archer-selects-honeywell-supply-actuators-climate-system-technology-its-production-aircraft-adding-its-growing-supply-base-aerospace-industry-leaders/ | 2022-07-27T13:12:09Z | https://www.wflx.com/prnewswire/2022/07/27/archer-selects-honeywell-supply-actuators-climate-system-technology-its-production-aircraft-adding-its-growing-supply-base-aerospace-industry-leaders/ | false |
Israeli startup heralded for its unique "correspondent-banking-in-a-box" service
TEL AVIV, Israel, July 27, 2022 /PRNewswire/ -- TenureX, the Israeli start-up that is fixing the broken correspondent banking industry, has been recognised as one of the world's leading fintechs by influential market intelligence firm Aite-Novarica Group.
TenureX is changing the face of correspondent banking with a new, platform-based approach that provides "correspondent banking in a box". The company's cloud-based digital platform comprises a set of innovative solutions that embed end-to-end payments data and compliance rules into every transaction. The TenureX platform makes it easy for any financial institution to grow their correspondent relationships, expand into new markets, roll out international settlements, and deploy new payment flows - quickly, cost-effectively, and compliantly.
Now, TenureX has been featured in Aite Group's latest Commercial Banking Fintech Spotlight: Q2 2022, which examines vendors who are revolutionizing the financial services industry through "as-a-Service" platforms. The report recognises the need for new commercial banking capabilities and examines five global fintechs that are harnessing automation to improve efficiency, FI-to-FI relationships, and the customer experience.
Responding to the report, TenureX Co-Founder & COO Or Kapelinsky, said, "For TenureX to be included in such an influential report is a fantastic reward for our team's hard work, but it's just as important for the correspondent banking industry itself. When we founded TenureX in 2020, we had a simple mission: to fix an industry in decline by sweeping away legacy technology which provided no transparency and visibility into cross-border payments, and preventing financial institutions from accessing the data they need to make intelligent, strategic and compliant decisions.
"We're delighted that Aite Group has identified our unique approach to these challenges through our Correspondent Banking as a Service ("Correspondent banking in a box"), while also recognising that our core product - the DTC(™) (Digital Transaction Certificate) - brings unique technological and innovation in this market. The report is required reading for any financial institution seeking to strengthen its relationships with other banks and FIs, revolutionize cross-border payments, and eliminate cost and complexity for compliance teams."
The full report is available for purchase here: https://aite-novarica.com/report/commercial-banking-fintech-spotlight-q2-2022
About TenureX
TenureX was founded in 2020 by four banking experts with a wide variety of industry experience. They know first-hand the frustrations and missed opportunities faced by non-bank financial institutions as they struggle to work together, and are passionate about making things simpler for everyone in correspondent banking.
The TenureX vision is to democratize correspondent banking by moving away from subjective, rigid, bilateral, relationship banking. Instead the company is building objective, streamlined, multilateral, transaction-based relationships.
About Aite Group Fintech Spotlight
The Aite-Novarica Fintech Spotlight is a quarterly series of reports looking at select emerging fintech vendors active in the financial services industry. With the vendor landscape increasingly crowded and banks and their clients facing a growing array of choice, the spotlight series aims to provide insight on interesting vendors that offer a strong unique selling point and innovative approach from a partnership or competitor perspective.
See https://aite-novarica.com/
Logo - https://mma.prnewswire.com/media/1838172/TenureX_Logo.jpg
For further information:
Izhar Arieli - CEO and Co-founder
Phone
+ 972 (0) - 73 – 326-0303 (ISR)
+1- 605 – 836-8739 (USA)
Email: izhar@tenurex.com
View original content:
SOURCE TenureX | https://www.wlbt.com/prnewswire/2022/07/27/tenurex-recognized-world-leading-fintech-latest-aite-group-spotlight-report/ | 2022-07-27T13:13:44Z | https://www.wlbt.com/prnewswire/2022/07/27/tenurex-recognized-world-leading-fintech-latest-aite-group-spotlight-report/ | true |
HARRISBURG, Pa. (AP) — A Pennsylvania representative attended the same-sex wedding of his son three days after voting against legislation to protect the recognition of same-sex marriages.
Rep. Glenn Thompson, a Republican who represents a large swath of conservative northern Pennsylvania, voted against the bill brought by Democrats to the floor of the U.S. House.
The vote came amid concerns that the Supreme Court ruling overturning the landmark Roe v. Wade decision on abortion access could jeopardize other rights aside from access to abortion, including 2015’s Obergefell v. Hodges decision, which established the rights of same-sex couples to marry nationwide.
The bill protecting the recognition passed Tuesday, 267-157, with 47 Republicans — including three from Pennsylvania — joining every Democrat in backing it.
On Friday, Thompson attended the same-sex wedding of his son.
“Congressman and Mrs. Thompson were thrilled to attend and celebrate their son’s marriage on Friday night as he began this new chapter in his life,” Thompson’s office said in a statement. “The Thompsons are very happy to welcome their new son-in-law into their family.”
Thompson’s press secretary also called the bill “nothing more than an election-year messaging stunt for Democrats in Congress who have failed to address historic inflation and out of control prices at gas pumps and grocery stores.”
The House bill would require the federal and state governments to recognize same-sex marriages, but would not stop a state from banning such marriages in the future.
In 2014, a federal judge struck down Pennsylvania’s same-sex marriage ban, and then-Gov. Tom Corbett declined to appeal it. | https://www.ksn.com/news/national-world/ap-us-news/rep-says-no-to-gay-marriage-attends-sons-same-sex-wedding/ | 2022-07-27T13:14:02Z | https://www.ksn.com/news/national-world/ap-us-news/rep-says-no-to-gay-marriage-attends-sons-same-sex-wedding/ | false |
BOGO deal is good through Zaxby's app all day long on July 29
ATHENS, Ga., July 27, 2022 /PRNewswire/ -- Zaxby's, the premium quick-service restaurant known for its Chicken Fingerz™, wings and signature sauces, is celebrating National Chicken Wing Day with a special 'Buy One, Get One' Boneless Wings Meal when ordering through the Zaxby's app. The offer is valid all day long Friday, July 29, while supplies last. Zaxby's Boneless Wings Meal features five tender, tasty boneless wings tossed in one of eight different sauces and is served with Texas Toast, crinkle fries and Ranch sauce.
"Zaxby's is known for our signature sauces and Fingerz, but our wings are second to none. What better occasion than National Chicken Wing Day to celebrate with not one, but two Boneless Wings Meals," said Patrick Schwing, chief marketing & strategy officer at Zaxby's. "Given our obsession with serving great chicken to our guests, we want everyone to enjoy our wings this Friday. When you order a Boneless Wings Meal through the Zaxby's app or online, you'll get another boneless wing meal FREE."
From the famous Zax Sauce that started it all to Tongue Torch for those that appreciate heat with their wings, Zaxby's offers eight signature tossing sauce options to choose from.
To redeem the Boneless Wings Meal offer, customers have to download the app on Google Play or the App Store and place an order for two Boneless Wings Meals on July 29. Upon checkout, one will be discounted. The offer can be redeemed on the Zaxby's app or online and is valid on July 29 only.
Guests who want to experience Zaxby's nationally recognized loyalty program and redeem more rewards can sign up online at zaxbys.com.
Founded in 1990, Zaxby's is committed to serving delicious chicken fingers, wings, sandwiches and salads in a fun, offbeat atmosphere where customers are considered friends. For the second year in a row, Zaxby's iconic Signature Sandwich has won Thrillist's 2022 Fasties Award for Best Fried Chicken Sandwich. Zaxby's has grown to more than 900 locations in 18 states and is headquartered in Athens, Georgia. For more information, visit zaxbys.com or zaxbysfranchising.com.
Media Contact:
Jacob Teetzmann
Tombras
+1.423.494.3673
jteetzmann@tombras.com
View original content to download multimedia:
SOURCE Zaxby's | https://www.wlbt.com/prnewswire/2022/07/27/zaxbys-celebrates-national-chicken-wing-day-with-boneless-wings-meal/ | 2022-07-27T13:14:54Z | https://www.wlbt.com/prnewswire/2022/07/27/zaxbys-celebrates-national-chicken-wing-day-with-boneless-wings-meal/ | true |
ET Auto privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website.
You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website.
If you choose to ignore this message, we'll assume that you are happy to receive all cookies on ET Auto.
New Delhi: Auto component maker SKF India on Wednesday reported a 63% growth in its June quarter at INR 129 crore as against INR 79.12 crore in the corresponding quarter a year ago.
Meanwhile, the company's revenue from operations jumped to INR 1063.65 crore in Q1 FY23 from INR 693.53 crore in the same period a year ago.
According to Manish Bhatnagar, Managing Director, SKF India, the company delivered solid results in the first quarter of FY 2022-23 amidst a challenging cost and operating environment. "We continued to make progress on our new intelligent and clean growth strategy, prioritize high-growth business segments and drive customer centricity. While the operating environment remains volatile, strong demand and pricing actions enabled us to mitigate macro headwinds. Addressing the inflationary environment and advancing our strategy will require further pricing actions and ongoing cost controls over the year," Bhatnagar added.
On the outlook he said, the company remained well-positioned to further capitalize on the growth opportunities and accelerate progress across targeted high-growth business segments.
"The operating macroeconomic environment looks uncertain, but delivering growth remains our priority. Against this backdrop, we will continue to enhance our productivity and sharpen our cash flow momentum to deliver improved margins and create long-term value for all our stakeholders,” he added.
The company's Profit Before Tax for the quarter stood at INR 176 crore compared to INR 105.8 crore during the same year previous year. Cost of raw materials consumed surged 34% during the year under review to INR 263 crore in Q1 FY23 as against INR 196 crore in Q1 FY22.
Bosch Global Software Technologies (BGSW), a fully-owned engineering subsidiary of Bosch, is set to hire 5,500 engineers, the highest in a year, to tap the growing demand for software technologies and also to ride the megatrends like electrification and autonomous driving.
After facing a tough stance on its India entry and hanging on the edge for over two years, Chinese SUV maker Great Wall Motors (GWM) has finally called it quits by firing 11 Indian employees from its organisation. The company had initially proposed an investment of USD 1 billion (INR7000 crore) and had plans to start manufacturing in 2021. | https://auto.economictimes.indiatimes.com/news/auto-components/skf-india-q1-pat-rises-63-to-inr-129-crore/93165080 | 2022-07-27T13:15:24Z | https://auto.economictimes.indiatimes.com/news/auto-components/skf-india-q1-pat-rises-63-to-inr-129-crore/93165080 | false |
Senior loan officer ranked by the National Association of Hispanic Real Estate Professionals among the top 100 Latino originators in the Southeast region
MIDDLETOWN, R.I., July 27, 2022 /PRNewswire/ -- Embrace Home Loans, a top-ranked national mortgage lender, announces that Lisbeth Najarro, a senior loan officer at the company's Fairfax, Virginia office, has been named one of the top 100 Latino mortgage originators in the Southeast region by the National Association of Hispanic Real Estate Professionals (NAHREP).
The NAHREP Top 100 Latino Mortgage Originators Southeast is part of its Top 250 Latino Mortgage Originators Report, which celebrates leading originators whose exceptional hard work and dedication to homeownership led them to close billions of dollars in mortgages in 2021. The report ranks individual originators based on both number and dollar volume of transactions and represents $17.3 billion in combined mortgage sales in 2021. "NAHREP recognizes these top performing individuals for their contributions toward the association's mission of advancing sustainable Hispanic homeownership," the report stated.
Najarro closed 111 loans in 2021 totaling $39,980,889.
"Lisbeth's recognition by NAHREP is very well-deserved," said Steve Adamo, president of retail production at Embrace Home Loans. "She goes the extra mile for all of her clients, including Hispanic borrowers. We're proud to have Lisbeth on our team."
Najarro joined Embrace in 2016 as a loan officer assistant and became a loan officer in 2018. Her energy, positivity and determination also earned her a spot in the company's 2021 and 2022 President's Club for top-producing sales professionals.
"I'm delighted to be named a top Latino originator," said Najarro. "I'm always happy to help borrowers find the best mortgage program to fulfill their home financing goals."
About Embrace Home Loans
Founded in 1983, Embrace Home Loans is a prominent mortgage lender that provides borrowers and financial institutions with an exceptional mortgage experience. Licensed in all 50 states and the District of Columbia, Embrace has been recognized seven times as one of the Best Medium-sized Companies to Work for in America by Fortune and five times as one of the Fastest Growing Companies in America by Inc. The company has also been recognized more than a dozen times as one of the Best Places to Work in Rhode Island, as the Most Community Involved Company in Rhode Island, and with the Leadership Excellence Award by Providence Business News. The company is based in Middletown, Rhode Island. For more information, please visit www.embracehomeloans.com.
PRESS CONTACTS:
Henry Drennan
Strategic Vantage Marketing and Public Relations
(615) 497-8358
HenryDrennan@StrategicVantage.com
Mary McGarity
Strategic Vantage Marketing and Public Relations
(203)260-5476
MaryMcGarity@StrategicVantage.com
View original content to download multimedia:
SOURCE Embrace Home Loans | https://www.wflx.com/prnewswire/2022/07/27/embrace-home-loans-lisbeth-najarro-named-top-latino-mortgage-originator/ | 2022-07-27T13:15:52Z | https://www.wflx.com/prnewswire/2022/07/27/embrace-home-loans-lisbeth-najarro-named-top-latino-mortgage-originator/ | false |
CHICAGO (AP) — Willson Contreras drew a standing ovation in perhaps his last home game at Wrigley Field, then keyed an early burst as the Chicago Cubs beat the Pittsburgh Pirates 4-2 Tuesday for their season-high sixth straight win.
Contreras, one of three members left from the 2016 World Series title team, tipped his cap after being cheered at the plate his first time up. He hit a soft single to center field in a three-run first inning off Bryse Wilson (1-6).
“When I started hearing it the first at-bat, it was amazing,” said Contreras, who hugged his teammates and coaches on the field after the game. “I tried to enjoy it as much as I could and took it all in.”
Contreras, an All-Star catcher who can become a free agent after this season, has acknowledged this might be his last homestand as a member of the Cubs before the Aug. 2 trade deadline. He saluted the fans with a fist in his last at-bat in the seventh but struck out against reliever Tyler Beede.
“Getting traded to a team that’s going to compete is very good,” Contreras said. “If the Cubs get a good package for me to make this team better, they’re going to do it.
“I’d be more than happy to help a different team to get to the World Series. If it doesn’t happen, I’ll be more than happy to stay here with my teammates and try to find a way to make everyone better and keep being a nice leader on and off the field,” he said.
Representatives from the Blue Jays and White Sox were in attendance.
Seiya Suzuki, Ian Happ and Nico Hoerner hit consecutive doubles in the first to give Keegan Thompson (8-4) ample run support. Suzuki provided insurance with a homer in the eighth off reliever Will Crowe.
Thompson went a career-high seven innings.
“That was as good as we’ve seen Keegan,” manager David Ross said. “He continues to build.”
Mychal Givens pitched the ninth to earn his second save. Closer David Robertson wasn’t used for the second consecutive game after earning a win and save Saturday and Sunday at Philadelphia.
“He wasn’t an option,” said Ross, who informed Robertson of his intentions before the game.
The Cubs have (40-57) have their best winning streak since taking seven in a row last Aug. 31-Sept. 6.
The Pirates have lost four of five.
Thompson retired 16 of 18 batters before Hoerner committed a fielding error at shortstop with one out in the seventh, and 6-foot-7 rookie Oneil Cruz followed later with a two-run homer to center field.
Thompson completed the inning without further damage to top his previous high of 6 1/3 innings against the Reds on June 28.
Since the All-Star break, Cubs starters are 2-0 with a 2.03 ERA. Thompson has allowed two earned runs or fewer in five of his last seven starts.
After Hoerner’s double, Wilson retired 14 of the next 17 hitters.
THANKS FOR THE MEMORIES?
Ross acknowledged that Contreras looked distracted during Monday’s game, in which he shed tears later after being asked to reflect on his seven seasons with the team.
“When he came up, he was a happy young man, lot of smiling, fitting in very easily, showing off the absolute cannon he had all the time,” Ross said of Contreras, who made his debut midway through the 2016 title season.
That was Ross’ final season as a player, and he recalled Contreras taking over his specific duties of catching veteran left-hander Jon Lester.
“It was a big deal when he caught Jon,” Ross said. “I know that was something he took pride in and probably learned a ton. I think you learn in the moment as much as I’ve noticed a growth in him in being able to read the game.”
UP NEXT
The Pirates will send RHP Zach Thompson (3-7, 4.64 ERA) when they open a four-game series Thursday against the Phillies.
The Cubs will start LHP Justin Steele (4-6, 4.02) in the first game of a four-game series Thursday against the Giants. Steele allowed one run in five innings in a 15-2 win Friday over the Phillies.
___
More AP MLB: https://apnews.com/hub/MLB and https://twitter.com/AP_Sports | https://www.ksn.com/sports/ap-sports/contreras-salutes-fans-helps-cubs-win-6th-in-row-top-bucs/ | 2022-07-27T13:17:38Z | https://www.ksn.com/sports/ap-sports/contreras-salutes-fans-helps-cubs-win-6th-in-row-top-bucs/ | true |
Komainu is set to bring Digital Asset Custody Services to Institutional Clients in the Region
SAINT HELIER, JERSEY , July 27, 2022 /PRNewswire/ -- Komainu ["the Custodian"], a regulated digital asset custody provider built by institutions for institutions, today announced provisional regulatory approval from the Government of Dubai's Virtual Assets Regulatory Authority [VARA] to commence operational readiness even as the application goes through the warranted due diligence in accordance with VARA requirements, to enable Komainu to be amongst the first fully regulated digital asset custody services to institutional clients in the region.
Komainu acts as key gatekeeper to institutions gaining exposure to the digital asset industry with the provision of secure and regulated digital asset custody services for blockchain and beyond. Over the years, Komainu has established itself as one of the leading digital asset custody providers for institutional clients, providing the same safeguards and protections investors are accustomed to in traditional finance. The Custodian's industry-leading services have been designed by security, financial services and cryptocurrency experts and have been approved by external auditors.
Dubai and VARA are paving the way forward with their efforts to create a sophisticated and progressive regulatory framework, which will allow the region to become one of the world's most favourable jurisdictions for digital asset initiatives. Komainu has elected to base its regional HQ in Dubai and participate in this fast-evolving global virtual asset valley - in order to establish its leadership in the provision of institutional-grade digital asset services across the wider region.
H.E. Helal Saeed Almarri, Chairman of VARA, said, "Komainu's entry into VARA's regime is symbolic of the confidence and credibility that the Virtual Assets industry is gaining when backed by such strong endorsement from traditional finance leaders like Nomura. Such acceptance and active participation of tier 1 global institutional finance firms is not only an affirmation of Virtual Assets being integral to the future of finance, but also indicative of the potential that this industry can offer for economic empowerment. Dubai is pleased to welcome credible players like Komainu into VARA's virtual assets ecosystem."
The regulatory license once received, will establish Komainu as one of Dubai's first regulated crypto custody providers, bringing a much-needed service to the proliferating regional ecosystem. The endorsement from the Dubai Government strengthens the Custodian's fast-paced growth projections, in line with their core underpinning of doing so in a secure, robust and regulated manner. With the continued support of the Dubai regulators, Komainu is set to be a first mover in the MENA region.
Sebastian Widmann, Head of Strategy at Komainu, said, "Dubai and VARA are establishing a new hub for digital asset businesses and bringing like-minded companies into the country to help establish its growing crypto ecosystem and we look forward to contributing to these exciting developments. Komainu actively works with regulators, partners and our clients to make sure that our platform is held to the highest of standards and this latest endorsement by the Dubai Government is a further testament to that fact. By expanding into the MENA region, we are bringing a much-needed service to institutions operating within a regulated crypto marketplace. We are excited to bring Komainu Yield as well as the other new services set to launch in the near future to this marketplace and thereby serve a new demographic of institutions."
Komainu is the first hybrid custodian for institutional digital asset investors created by the Japanese investment bank Nomura, digital asset manager CoinShares and digital asset security company Ledger. Komainu is providing decentralized and secure digital asset custody services through a single application-based solution for institutions, offering multi-asset support and regulatory compliance. Headquartered in Jersey, Channel Islands, Komainu merges institutional financial services with leading security standards for the next generation of institutional custody.
Dubai Virtual Assets Regulatory Authority [VARA] is the world's first specialised regulator for the Virtual Assets sector. Established in March 2022, following the effect of Law No.4 of 2022, VARA is responsible by decree for licensing and regulating the Virtual Asset sector in the Emirate of Dubai and its free zone territories [excluding DIFC], and oversees all licensing requirements and applications for authorisation of Virtual Asset activities under UAE law. VARA plays a central role in creating Dubai's advanced legal framework to protect investors and establish international standards for Virtual Asset industry governance, while supporting the vision for a borderless economy.
Media Contact
Peter Padovano
M Group Strategic Communications [For Komainu]
646-859-5953
komainu@mgroupsc.com
View original content to download multimedia:
SOURCE Komainu | https://www.kold.com/prnewswire/2022/07/27/komainu-nomura-backed-crypto-custodian-granted-initial-provisional-regulatory-approval-operate-dubai/ | 2022-07-27T13:17:57Z | https://www.kold.com/prnewswire/2022/07/27/komainu-nomura-backed-crypto-custodian-granted-initial-provisional-regulatory-approval-operate-dubai/ | false |
New E-commerce Platform and Website Offers Technology to Help People of All Ages Live Independently
LOUISVILLE, Ky., July 27, 2022 /PRNewswire/ -- LogicMark, Inc., (Nasdaq: LGMK) (the "Company" or "LogicMark") (formerly Nxt-ID, Inc.), a provider of personal emergency response systems (PERS), health communications devices and remote care and activity monitoring technologies to create a connected care platform, today announces its new direct-to-consumer sales channel to broadly deliver its solutions to more people, including families and caregivers. The company is unveiling a new website and e-commerce platform which will facilitate its new direct-to-consumer distribution channel.
"For more than 10 years [LogicMark formed 12/6/2011], our company and technology have earned the trust of our customers by helping them live worry-free knowing we are there to help when they need it most," said Chia-Lin Simmons, CEO of LogicMark. "Technology has made life easier and more convenient in many ways, and now we are building solutions that can support freedom for the whole family -- from caregivers to those needing care. We are excited to finally make our products available directly to consumers who need them."
Today LogicMark is working to disrupt the care economy and help people of all ages live with greater peace of mind. The new company website offers a user-friendly experience with the opportunity for consumers to purchase products directly from the online store. The website includes a fresh look and feel as well as the company's updated branding, messaging, and mission.
Consumers can directly purchase the company's best-selling products via the new website, including the GuardianAlert911+, GuardianAlert911 and FreedomAlert. The simple, easy-to-use solutions provide safety and security for people both at home and on-the-go.
LogicMark's new website and e-commerce platform comes on the heels of the company's recent name change (from Nxt-ID to LogicMark) to reflect the company's enhanced focus on the care economy and technology.
"It's time for innovation in the care economy, allowing caregivers to confidently care for those they love, while helping their loved ones to continue to live independently," continued Simmons. "Peace of mind is priceless. Our new direct-to-consumer e-commerce platform is just the beginning of LogicMark's evolution."
To date, LogicMark has supplied more than 500,000 PERS devices to seniors, veterans and loved ones, providing them with the confidence to live independently at home for as long as possible. Through distribution via the Veterans Health Administration medical centers and outpatient clinics, LogicMark provides these devices to U.S. veterans at no charge. The U.S. government awarded LogicMark a GSA contract in July 2021, enabling the company to partner with federal, state and local governments to widen the distribution of its products.
To learn more about LogicMark, their products and services, visit www.logicmark.com.
LogicMark, Inc. (formerly Nxt-ID, Inc.) provides personal emergency response systems (PERS), health communications devices and remote care and activity monitoring technologies to create a connected care platform. The Company's devices give people the ability to receive care at home and confidence to age in place. LogicMark revolutionized the PERS industry by incorporating two-way voice communication technology directly into its medical alert pendant and providing this life-saving technology at a price point that everyday consumers could afford. LogicMark's PERS solutions are sold through the United States Veterans Health Administration and dealers/distributors. The Company was awarded a contract by the U.S. General Services Administration that enables the Company to distribute its products to federal, state and local governments. For more information on projects and services, visit LogicMark.com.
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements reflect LogicMark's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding LogicMark's successful execution of its business strategy. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target," "intend" and "expect" and similar expressions, as they relate to LogicMark or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to LogicMark and are subject to a number of risks, uncertainties, and other factors that could cause LogicMark's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Media Contact:
Erica Zeidenberg
Hot Tomato Marketing
erica@hottomato.net
925-518-8159 mobile
View original content to download multimedia:
SOURCE LogicMark Inc. | https://www.kold.com/prnewswire/2022/07/27/logicmark-launches-direct-to-consumer-sales-channel/ | 2022-07-27T13:18:16Z | https://www.kold.com/prnewswire/2022/07/27/logicmark-launches-direct-to-consumer-sales-channel/ | true |
- Submissions are supported by three Phase 3 clinical trials demonstrating upadacitinib achieved the co-primary endpoints of clinical remission and endoscopic response as induction and maintenance treatment1-4
- Safety results were generally consistent with the known safety profile of upadacitinib, with no new safety risks observed1-8
- Crohn's disease is a chronic, systemic disease that manifests as inflammation within the gastrointestinal tract, causing persistent diarrhea and abdominal pain9,10
NORTH CHICAGO, Ill., July 27, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted applications for a new indication to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for upadacitinib (RINVOQ®, 45 mg [induction dose] and 15 mg and 30 mg [maintenance dose]) for the treatment of adult patients with moderately to severely active Crohn's disease.4,11
"Crohn's disease can be debilitating and have a significant impact on a person's daily life," said Neil Gallagher, M.D., Ph.D., vice president, development, chief medical officer, AbbVie. "Those patients who are still suffering fuel our continued commitment to innovation in care for patients with IBD, and we look forward to potentially introducing a new treatment option for this disruptive condition."
The applications to the FDA and EMA are supported by data from three Phase 3 clinical trials, including two induction studies (U-EXCEED & U-EXCEL) and one maintenance study (U-ENDURE).1-4 Across all three studies, significantly more patients treated with upadacitinib achieved the co-primary endpoints of clinical remission and endoscopic response, with clinical remission measured by the Crohn's Disease Activity Index (CDAI) or by the patient-reported symptoms of stool frequency/abdominal pain (SF/AP).1-4 Additionally, more patients receiving upadacitinib 45 mg once daily at week 12 in the induction studies or 15 mg and 30 mg once daily at 52 weeks in the maintenance study achieved the secondary endpoint of corticosteroid-free clinical remission per CDAI and per SF/AP compared to placebo among patients taking corticosteroids at baseline.1-4
The safety results of upadacitinib in U-EXCEED, U-EXCEL and U-ENDURE were generally consistent with the known safety profile of upadacitinib, with no new safety risks observed.
About Crohn's Disease
Crohn's disease is a chronic, systemic disease that manifests as inflammation within the gastrointestinal tract, causing persistent diarrhea and abdominal pain.9,10 It is a progressive disease, meaning it gets worse over time in a substantial proportion of patients or may develop complications that require urgent medical care, including surgery.9,10 Because the signs and symptoms of Crohn's disease are unpredictable, it causes a significant burden on people living with the disease—not only physically, but also emotionally and economically.10
About the U-EXCEED and U-EXCEL Induction and U-ENDURE Maintenance Studies1,2,3
The three Phase 3 studies are multicenter, randomized, double-blind, placebo-controlled studies to evaluate the efficacy and safety of upadacitinib 45 mg once daily as induction therapy, and upadacitinib 15 mg and 30 mg once daily as maintenance therapy in adults with moderately to severely active Crohn's disease. Topline results from U-EXCEED and U-EXCEL induction studies were announced in December 2021 and February 2022, respectively, and topline results from the U-ENDURE maintenance study were announced in May 2022. These studies include assessments of efficacy, safety and tolerability of upadacitinib. More information on these trials can be found at www.clinicaltrials.gov (NCT03345836, NCT03345849, NCT03345823).
About upadacitinib (RINVOQ®)
Discovered and developed by AbbVie scientists, RINVOQ is a JAK inhibitor that is being studied in several immune-mediated inflammatory diseases.1–8 Based on enzymatic and cellular assays, RINVOQ demonstrated greater inhibitory potency for JAK-1 vs. JAK-2, JAK-3 and TYK-2. The relevance of inhibition of specific JAK enzymes to therapeutic effectiveness and safety is not currently known.12
Phase 3 trials of RINVOQ in rheumatoid arthritis, atopic dermatitis, psoriatic arthritis, axial spondyloarthritis, ulcerative colitis, giant cell arteritis and Takayasu arteritis are ongoing.4–8,11,13-18 The use of upadacitinib in Crohn's disease is not approved and its safety and efficacy have not been evaluated by regulatory authorities.
RINVOQ® (upadacitinib) U.S. Use and Important Safety Information12
RINVOQ is a prescription medicine used to treat:
- Adults with moderate to severe rheumatoid arthritis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated.
- Adults with active psoriatic arthritis when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
- Adults with moderate to severe ulcerative colitis when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
- Adults with active ankylosing spondylitis when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
It is not known if RINVOQ is safe and effective in children with juvenile idiopathic arthritis, psoriatic arthritis, ulcerative colitis, or ankylosing spondylitis.
- Adults and children 12 years of age and older with moderate to severe eczema (atopic dermatitis) that did not respond to previous treatment and their eczema is not well controlled with other pills or injections, including biologic medicines, or the use of other pills or injections is not recommended.
RINVOQ is safe and effective in children 12 years of age and older weighing at least 88 pounds (40 kg) with atopic dermatitis.
It is not known if RINVOQ is safe and effective in children under 12 years of age with atopic dermatitis.
What is the most important information I should know about RINVOQ?
RINVOQ may cause serious side effects, including:
- Serious infections. RINVOQ can lower your ability to fight infections. Serious infections have happened while taking RINVOQ, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Your healthcare provider (HCP) should test you for TB before starting RINVOQ and check you closely for signs and symptoms of TB during treatment with RINVOQ. You should not start taking RINVOQ if you have any kind of infection unless your HCP tells you it is okay. If you get a serious infection, your HCP may stop your treatment until your infection is controlled. You may be at higher risk of developing shingles (herpes zoster).
- Increased risk of death in people 50 years and older who have at least 1 heart disease (cardiovascular) risk factor.
- Cancer and immune system problems. RINVOQ may increase your risk of certain cancers. Lymphoma and other cancers, including skin cancers, can happen. Current or past smokers are at higher risk of certain cancers, including lymphoma and lung cancer. Follow your HCP's advice about having your skin checked for skin cancer during treatment with RINVOQ. Limit the amount of time you spend in sunlight. Wear protective clothing when you are in the sun and use sunscreen.
- Increased risk of major cardiovascular (CV) events, such as heart attack, stroke, or death, in people 50 years and older who have at least 1 heart disease (CV) risk factor, especially if you are a current or past smoker.
- Blood clots. Blood clots in the veins of the legs or lungs and arteries can happen with RINVOQ. This may be life-threatening and cause death. Blood clots in the veins of the legs and lungs have happened more often in people who are 50 years and older and with at least 1 heart disease (CV) risk factor.
- Allergic reactions. Symptoms such as rash (hives), trouble breathing, feeling faint or dizzy, or swelling of your lips, tongue, or throat, that may mean you are having an allergic reaction have been seen in people taking RINVOQ. Some of these reactions were serious. If any of these symptoms occur during treatment with RINVOQ, stop taking RINVOQ and get emergency medical help right away.
- Tears in the stomach or intestines and changes in certain laboratory tests. Your HCP should do blood tests before you start taking RINVOQ and while you take it. Your HCP may stop your RINVOQ treatment for a period of time if needed because of changes in these blood test results.
Do not take RINVOQ if:
- You are allergic to upadacitinib or any of the ingredients in RINVOQ.
What should I tell my HCP BEFORE starting RINVOQ?
Tell your HCP if you:
- Are being treated for an infection, have an infection that won't go away or keeps coming back, or have symptoms of an infection, such as:
- Have TB or have been in close contact with someone with TB.
- Are a current or past smoker.
- Have had a heart attack, other heart problems, or stroke.
- Have or have had any type of cancer, hepatitis B or C, shingles (herpes zoster), blood clots in the veins of your legs or lungs, diverticulitis (inflammation in parts of the large intestine), or ulcers in your stomach or intestines.
- Have other medical conditions, including liver problems, low blood cell counts, diabetes, chronic lung disease, HIV, or a weak immune system.
- Live, have lived, or have traveled to parts of the country, such as the Ohio and Mississippi River valleys and the Southwest, that increase your risk of getting certain kinds of fungal infections. If you are unsure if you've been to these types of areas, ask your HCP.
- Have recently received or are scheduled to receive a vaccine. People who take RINVOQ should not receive live vaccines.
- Are pregnant or plan to become pregnant. Based on animal studies, RINVOQ may harm your unborn baby. Your HCP will check whether or not you are pregnant before you start RINVOQ. You should use effective birth control (contraception) to avoid becoming pregnant during treatment with RINVOQ and for 4 weeks after your last dose.
- Are breastfeeding or plan to breastfeed. RINVOQ may pass into your breast milk. Do not breastfeed during treatment with RINVOQ and for 6 days after your last dose.
Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. RINVOQ and other medicines may affect each other, causing side effects.
Especially tell your HCP if you take:
- Medicines for fungal or bacterial infections
- Rifampicin or phenytoin
- Medicines that affect your immune system
If you are not sure if you are taking any of these medicines, ask your HCP or pharmacist.
What should I do or tell my HCP AFTER starting RINVOQ?
- Tell your HCP right away if you have any symptoms of an infection. RINVOQ can make you more likely to get infections or make any infections you have worse.
- Get emergency help right away if you have any symptoms of a heart attack or stroke while taking RINVOQ, including:
- Tell your HCP right away if you have any signs or symptoms of blood clots during treatment with RINVOQ, including:
- Tell your HCP right away if you have a fever or stomach-area pain that does not go away, and a change in your bowel habits.
What are other possible side effects of RINVOQ?
Common side effects include upper respiratory tract infections (common cold, sinus infections), shingles (herpes zoster), herpes simplex virus infections (including cold sores), bronchitis, nausea, cough, fever, acne, headache, increased blood levels of creatine phosphokinase, allergic reactions, inflammation of hair follicles, stomach-area (abdominal) pain, increased weight, flu, tiredness, lower number of certain types of white blood cells (neutropenia, lymphopenia), muscle pain, flu-like illness, rash, increased blood cholesterol levels, and increased liver enzyme levels.
A separation or tear to the lining of the back part of the eye (retinal detachment) has happened in people with atopic dermatitis treated with RINVOQ. Call your HCP right away if you have any sudden changes in your vision during treatment with RINVOQ.
These are not all the possible side effects of RINVOQ.
How should I take RINVOQ?
RINVOQ is taken once a day with or without food. Do not split, crush, or chew the tablet. Take RINVOQ exactly as your HCP tells you to use it. RINVOQ is available in 15 mg, 30 mg, and 45 mg extended-release tablets.
This is the most important information to know about RINVOQ. For more information, talk to your HCP.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
Globally, prescribing information varies; refer to the individual country product label for complete information.
Please click here for the Full Prescribing Information and Medication Guide.
About AbbVie in Gastroenterology
With a robust clinical trial program, AbbVie is committed to cutting-edge research to drive exciting developments in inflammatory bowel diseases (IBD), like ulcerative colitis and Crohn's disease. By innovating, learning and adapting, AbbVie aspires to eliminate the burden of IBD and make a positive long-term impact on the lives of people with IBD. For more information on AbbVie in gastroenterology, visit https://www.abbvie.com/our-science/therapeutic-focus-areas/immunology/immunology-focus-areas/gastroenterology.html.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, LinkedIn or Instagram.
Forward-Looking Statements
Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions, among others, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, failure to realize the expected benefits from AbbVie's acquisition of Allergan plc ("Allergan"), failure to promptly and effectively integrate Allergan's businesses, competition from other products, challenges to intellectual property, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry and the impact of public health outbreaks, epidemics or pandemics, such as COVID-19. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2021 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its subsequent Quarterly Reports on Form 10-Q. AbbVie undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.
References
- A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies. ClinicalTrials.gov. 2022. Available at: https://clinicaltrials.gov/ct2/show/NCT03345849. Accessed on June 3, 2022.
- A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy. ClinicalTrials.gov. 2022. Available at: https://clinicaltrials.gov/ct2/show/NCT03345836. Accessed on June 3, 2022.
- A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433. ClinicalTrials.gov. 2022. Available at: https://clinicaltrials.gov/ct2/show/NCT03345823. Accessed on June 3, 2022.
- RINVOQ [Summary of Product Characteristics]. AbbVie Deutschland GmbH & Co. KG; June 2022. Available at: https://www.ema.europa.eu/en/documents/product-information/rinvoq-epar-product-information_en.pdf.
- Cohen S., et al. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme. Ann Rheum Dis. 2020 Oct 28;80(3):304-11.
- Mease, P.J., et al. Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study. Rheumatol Ther. 2021 Apr 28. doi: 10.1007/s40744-021-00305-z. Online ahead of print.
- Guttman-Yassky E., et al. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate, double-blind, randomized controlled phase 3 studies. Lancet. doi:10.1016/s0140-6736(21)00588-2.
- Van der Heijde, D., et al. Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial. Lancet. 2019 Dec 7;394(10214):2108-2117. doi: 10.1016/S0140-6736(19)32534-6. Epub 2019 Nov 12.
- The Facts about Inflammatory Bowel Diseases. Crohn's & Colitis Foundation of America. 2014. Available at: https://www.crohnscolitisfoundation.org/sites/default/files/2019-02/Updated%20IBD%20Factbook.pdf. Accessed on June 3, 2022.
- Crohn's disease. Symptoms and Causes. Mayo Clinic. 2022. Available at: https://www.mayoclinic.org/diseases-conditions/crohns-disease/symptoms-causes/syc-20353304. Accessed on June 3, 2022.
- Pipeline – Our Science | AbbVie. AbbVie. 2022. Available at: https://www.abbvie.com/our-science/pipeline.html. Accessed on June 3, 2022.
- RINVOQ® (upadacitinib) [Package Insert]. North Chicago, Ill.: AbbVie Inc.
- A Study to Evaluate Efficacy and Safety of Upadacitinib in Adult Participants With Axial Spondyloarthritis (SELECT AXIS 2). ClinicalTrials.gov. 2022. Available at: https://clinicaltrials.gov/ct2/show/NCT04169373. Accessed on June 3, 2022.
- A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis. ClinicalTrials.gov. 2022. Available at: https://clinicaltrials.gov/ct2/show/NCT02819635. Accessed on June 3, 2022.
- A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis (Heads Up). ClinicalTrials.gov. 2022. Available at: https://clinicaltrials.gov/ct2/show/NCT03738397. Accessed on June 3, 2022.
- A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis (U-ACCOMPLISH). ClinicalTrials.gov. 2022. Available at: https://clinicaltrials.gov/ct2/show/NCT03653026. Accessed on June 3, 2022.
- A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis (SELECT-GCA). ClinicalTrials.gov. 2022. Available at: https://clinicaltrials.gov/ct2/show/NCT03725202. Accessed on June 3, 2022.
- A Study to Evaluate the Efficacy and Safety of Upadacitinib in Subjects With Takayasu Arteritis (TAK) (SELECT-TAK). ClinicalTrials.gov. 2022. Available at: https://clinicaltrials.gov/ct2/show/NCT04161898. Accessed on June 3, 2022.
View original content:
SOURCE AbbVie | https://www.valleynewslive.com/prnewswire/2022/07/27/abbvie-submits-regulatory-applications-fda-ema-upadacitinib-rinvoq-crohns-disease/ | 2022-07-27T13:22:34Z | https://www.valleynewslive.com/prnewswire/2022/07/27/abbvie-submits-regulatory-applications-fda-ema-upadacitinib-rinvoq-crohns-disease/ | false |
Staged in the atmospheric Opera House within Blackpool Winter Gardens, this touring production brings with it star names – Jason Donovan as Pharaoh is the headline and is absolutely nailed on with his gregarious Elvis-like comedy depiction of the Egyptian king.
But this staging of Tim Rice and Andrew Lloyd Webber’s classic musical is studded with less well-known star-turns, from the young children playing multiple roles to the enigmatic orchestra raising the roof from deep in the pit.
Since I last reviewed the show (this cynical old journalist has seen it dozens of times, performed in it as a child and knows every word) the arrangement has been re-jigged, the role of the children increased and The Narrator – played by the astonishing ( and Olivier-award nominated) Linzi Hately who held audience in the palm of her hand – has expanded.
She also plays multiple other roles, switching deftly from character to character with an elasticated beard or a shawl or a wink, her range is quite something alongside her pitch perfect singing voice – although she might want to rethink that Scouse accent. Only joking Linzi..
The titular role is played by newcomer Jac Yarrow who, from his first step on stage IS Joseph – young, handsome, and with a voice that resonated to every seat in the theatre - was clearly born for the role.
Alongside a multi-talented ensemble cast of professional dancers/singer and very confident children sometimes in fake beards, he pulls out the high notes, jumps around the stage, puppeteers and rides camels and carriages with aplomb and a twinkle in his eye.
A word for the staging which is remarkably versatile, the stage morphing from desert to Egyptian Palace to prison cell with clever lighting, curtains and moving scenery with the cast themselves taking on much moving and carrying, working this seamlessly into the choreography.
But the star of the show, and the sheer joy of Joseph, is the spirits-raising score which puts a smile back into 2022. | https://www.blackpoolgazette.co.uk/whats-on/things-to-do/joseph-and-the-amazing-technicolor-dreamcoat-an-absolute-joy-as-jason-donovan-joins-remarkable-cast-to-raise-the-rafters-at-blackpools-winter-gardens-3783760 | 2022-07-27T13:23:51Z | https://www.blackpoolgazette.co.uk/whats-on/things-to-do/joseph-and-the-amazing-technicolor-dreamcoat-an-absolute-joy-as-jason-donovan-joins-remarkable-cast-to-raise-the-rafters-at-blackpools-winter-gardens-3783760 | true |
MADRID (AP) — Colombian pop singer Shakira has opted to go to trial instead of accepting a deal offered by Spanish prosecutors to settle allegations she defrauded Spain's government of 14.5 million euros ($15 million) in taxes, her public relations team said Wednesday.
Shakira, 45, “trusts her innocence and chooses to leave the issue in the hands of the law," the PR firm Llorente y Cuenca said in a statement.
Spanish prosecutors charged the singer in 2018 with failing to pay 14.5 million euros in taxes on income earned between 2012 and 2014. She faces a possible fine and prison sentence, if found guilty of tax evasion.
There were no immediate details available on the deal prosecutors offered. No date for the trial has been set.
Shakira’s public relations firm said she has deposited the amount she is said to owe with the Spanish Tax Agency and has no pending tax debts.
The residence of the artist is at the core of the case. Prosecutors allege she lived mostly in Spain despite having an official residence in the Bahamas.
Shakira, whose full name is Shakira Isabel Mebarak Ripoll, has two children with Barcelona soccer star Gerard Pique. The couple used to live together in Barcelona but recently ended their 11-year relationship. | https://www.springfieldnewssun.com/nation-world/spain-shakira-rejects-prosecutors-offer-faces-tax-trial/YRVCEC2P5JCPRJHGR3B7AROIDU/ | 2022-07-27T13:24:34Z | https://www.springfieldnewssun.com/nation-world/spain-shakira-rejects-prosecutors-offer-faces-tax-trial/YRVCEC2P5JCPRJHGR3B7AROIDU/ | true |
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
Jason McLachlan, University of Notre Dame
(THE CONVERSATION) “Plant a tree” seems to be the go-to answer to climate change concerns these days. Booking a rental car online recently, I was asked to check a box to plant a tree to offset my car’s anticipated carbon dioxide emissions. In 2020, the governor of my state, Indiana, launched an initiative to plant a million of them within five years, and the state is a quarter of the way there.
The primary reason for this arboreal zeal is to capitalize on the power of trees to remove excess carbon dioxide from the atmosphere and turn it into wood, safely locking carbon away for decades to centuries.
That’s the theory, anyway.
The problem is that the fate of carbon stored in trees faces many challenges. Heat waves, logging, pests and wildfires can all destroy trees and release that carbon again. And most measurements of the carbon stored in forests’ woody biomass only extend back a few decades.
I lead the PalEON project, an initiative funded by the National Science Foundation that is working to reconstruct how the amount of carbon stored in U.S. trees ebbed and flowed over the past 10,000 years.
Our new reconstruction reveals in detail how forests in the upper Midwest gained almost a billion tons of carbon over the last 8,000 years, doubling their carbon storage. And then, in the span of just 150 years, almost all of that gain disappeared into the atmosphere.
The results offer lessons for today, particularly about the outsized role that a few tree species, human behavior and a changing climate can play.
How forests gained, then lost, a billion tons of carbon
Our forest story starts 10,000 years ago, after the massive Laurentide ice sheet that once covered much of North America retreated from the upper Midwest – what is now Michigan, Wisconsin, Minnesota and the northern edges of Illinois and Indiana. In this early period of natural warming, ice-age forests of needle-leaved trees shrank and were replaced by new tree species slowly spreading northward from southern refuges.
Forest growth rose and fell over the thousands of years that followed as the climate went through warm and cool periods, the frequency and intensity of wildfires changed, and Native American land management strategies shifted.
Previousstudies assumed that the amount of woody biomass – the carbon stored in trees – had been relatively stable over millennia before the industrial era. Instead, we were surprised to find that the Upper Midwest forests had steadily gained carbon for 8,000 years before Euro-American settlers began clearing large swaths of forest.
In much of the region, forests had become dominated by long-lived species that could store a lot of carbon as biomass. Two of those species stand out: American beech and eastern hemlock.
History in a grain of pollen
We know a lot of this thanks to tiny grains of ancient pollen and the Public Land Survey, a collection of highly detailed forest surveys conducted by government contractors in the mid-1800s, shortly before forest clearing took off.
Each year, trees release pollen, and some of that pollen falls into lakes, where it sinks into the mud and fossilizes. Scientists can study fossilized pollen in cross sections of lake bottom sediment to determine how old it is and the types of trees that were growing at the time. If a major fire came through, abrupt changes in the types of pollen in the sediment would give it away.
In a study recently published in the journal Science, Ann Raiho and other PalEON members mapped biomass changes in the Upper Midwest using a sophisticated statistical model based on the fossil pollen found in the sediment from a network of lakes. The Public Land Survey served as a sort of Rosetta Stone. The survey linked vegetation in the 1800s to the fossil pollen samples, allowing us to calibrate pollen levels with the amount of wood biomass.
Lessons from 10,000 years of forest growth and decline
Our maps of past biomass accumulation provide reason for optimism about the capacity of forests to sustainably store carbon for long periods, but also two warnings.
The optimistic take is that when forests dominated by old-growth species like American beech and eastern hemlock expanded, the forests stored large amounts of carbon in woody biomass for millennia. These two species contributed substantial carbon storage, particularly in the moister central and eastern parts of the region.
The first warning is that forests in the drier western part of our study area shrank when the climate became warmer and drier.
The second warning is that progress can quickly slip away. Although the Upper Midwest forests stored almost a billion tons more carbon than they lost over the last 8,000 years, that accumulation went back into the atmosphere over a short period of time as a result of logging and farming. We found the rate of woody biomass decline over the last 150 years was 10 times greater than in any other century in 10,000 years.
Looking ahead
So, what does this mean for tree planting efforts today?
If my rental car tree happened to be an American beech, and if it were allowed to mature and propagate an old-growth forest in the Upper Midwest, then future forests could replicate the processes that stored carbon for thousands of years.
But that future presumes that drought, pests and wildfires associated with a rapidly warming climate don’t undo those efforts. A recent study suggested that forests around the world may be losing resilience to climate warming.
The capacity of old-growth trees to store carbon can also be undone by other threats that can be exacerbated by the changing climate. For example, beech bark disease weakens trees, allowing fungus to kill them – and it’s now threatening the Upper Midwest’s beech populations.
Finally, communities will have to balance the value of carbon sequestered in old forests with other priorities.
From a conservation perspective, both the high-biomass, old-growth beech and hemlock forests and the lower-biomass oak savannas were important components of Midwestern vegetation over the last 10,000 years. However, open oak forests are now endangered, and the practices needed for their recovery, like controlled burns, are designed to keep competing species at bay – including American beech.
The past offers guidance for managing forest change in the future, but not easy answers.
This article is republished from The Conversation under a Creative Commons license. Read the original article here: https://theconversation.com/midwest-forests-lost-8-000-years-of-stored-carbon-in-just-150-years-new-animated-maps-track-the-changes-revealing-lessons-for-climate-projects-today-185686. | https://www.middletownpress.com/news/article/Midwest-forests-lost-8-000-years-of-stored-carbon-17331853.php | 2022-07-27T13:24:47Z | https://www.middletownpress.com/news/article/Midwest-forests-lost-8-000-years-of-stored-carbon-17331853.php | true |
BOGO deal is good through Zaxby's app all day long on July 29
ATHENS, Ga., July 27, 2022 /PRNewswire/ -- Zaxby's, the premium quick-service restaurant known for its Chicken Fingerz™, wings and signature sauces, is celebrating National Chicken Wing Day with a special 'Buy One, Get One' Boneless Wings Meal when ordering through the Zaxby's app. The offer is valid all day long Friday, July 29, while supplies last. Zaxby's Boneless Wings Meal features five tender, tasty boneless wings tossed in one of eight different sauces and is served with Texas Toast, crinkle fries and Ranch sauce.
"Zaxby's is known for our signature sauces and Fingerz, but our wings are second to none. What better occasion than National Chicken Wing Day to celebrate with not one, but two Boneless Wings Meals," said Patrick Schwing, chief marketing & strategy officer at Zaxby's. "Given our obsession with serving great chicken to our guests, we want everyone to enjoy our wings this Friday. When you order a Boneless Wings Meal through the Zaxby's app or online, you'll get another boneless wing meal FREE."
From the famous Zax Sauce that started it all to Tongue Torch for those that appreciate heat with their wings, Zaxby's offers eight signature tossing sauce options to choose from.
To redeem the Boneless Wings Meal offer, customers have to download the app on Google Play or the App Store and place an order for two Boneless Wings Meals on July 29. Upon checkout, one will be discounted. The offer can be redeemed on the Zaxby's app or online and is valid on July 29 only.
Guests who want to experience Zaxby's nationally recognized loyalty program and redeem more rewards can sign up online at zaxbys.com.
Founded in 1990, Zaxby's is committed to serving delicious chicken fingers, wings, sandwiches and salads in a fun, offbeat atmosphere where customers are considered friends. For the second year in a row, Zaxby's iconic Signature Sandwich has won Thrillist's 2022 Fasties Award for Best Fried Chicken Sandwich. Zaxby's has grown to more than 900 locations in 18 states and is headquartered in Athens, Georgia. For more information, visit zaxbys.com or zaxbysfranchising.com.
Media Contact:
Jacob Teetzmann
Tombras
+1.423.494.3673
jteetzmann@tombras.com
View original content to download multimedia:
SOURCE Zaxby's | https://www.ktre.com/prnewswire/2022/07/27/zaxbys-celebrates-national-chicken-wing-day-with-boneless-wings-meal/ | 2022-07-27T13:27:16Z | https://www.ktre.com/prnewswire/2022/07/27/zaxbys-celebrates-national-chicken-wing-day-with-boneless-wings-meal/ | false |
Hedge Fund Places Target Price at C$0.67 Per Share
VANCOUVER, BC, July 27, 2022 /PRNewswire/ - PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) ("PlantX" or the "Company") today announced that Capital Y Management, a New York-based hedge fund, has issued an independent research report on PlantX referring to PlantX as "a market leader with a disruptive business in an emerging industry with long term tailwinds''. Capital Y Management has established a 12-month price target of C$0.67 per common share, which would represent an enterprise value for PlantX of approximately C$68 million.
"The PlantX team is hard at work to make plant-based diets available to everyone, expanding our presence in this rapidly growing market," said PlantX CEO, Lorne Rapkin. "We are encouraged that this independent report has recognized that we are well-positioned. While we are not commenting on the specific projections, we are focused on achieving success similar to Capital Y's outlook."
The full report published in July 2022 and financial model can be viewed and downloaded from the PlantX website under Investors or by clicking here: https://investor.plantx.com/news/capital-y-report/
Any opinions, estimates or forecasts regarding the performance of PlantX and its management made by Capital Y Management are theirs alone and do not represent the opinions, estimates or forecasts of PlantX or its management. PlantX does not by this announcement or otherwise, imply that the Company endorses, analyzes or approves of such information, conclusions, or recommendations.
As the digital face of the plant-based community, PlantX's platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the Company offers customers across North America more than 5,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include a juice and coffee company – but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of likeminded consumers and, most importantly, to provide education. Its successful enterprise is being built and fortified on partnerships with the top nutritionists, chefs and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life.
Connect with PlantX: Email | Website | Facebook | LinkedIn | Twitter | Instagram | YouTube | TikTok
Forward-looking Information
This press release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may," "will," "expect," "likely", "should," "would," "plan," "anticipate," "intend," "potential," "proposed," "estimate," "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy. The forward-looking information contained herein includes, without limitation, statements regarding the valuation and target price of PlantX's common shares and the business and strategic plans of the Company.
By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: receiving sufficient demand for the Offering; the Company's ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; the conflict in eastern Europe; having a limited operating history; the ability of the Company to access capital to meet future financing needs; the Company's reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.
Additional risk factors can also be found in the Company's continuous disclosure documents, which have been filed on SEDAR and can be accessed at www.sedar.com. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
View original content to download multimedia:
SOURCE PlantX Life Inc. | https://www.wafb.com/prnewswire/2022/07/27/plantx-receives-bullish-research-valuation-capital-y-management/ | 2022-07-27T13:31:25Z | https://www.wafb.com/prnewswire/2022/07/27/plantx-receives-bullish-research-valuation-capital-y-management/ | true |
WILMINGTON, Del., July 27, 2022 /PRNewswire/ -- YorkTest has secured investment in its food sensitivity testing business as part of a $11 million investment by Private Equity backers, NVM.
YorkTest is a leading health and wellness company with over 40 years of expertise in the provision of home-to-laboratory tests in the US and the UK, with a focus on food sensitivity testing. The company operates in a rapidly growing market with revenues having grown significantly over the last two years, reflecting a growing awareness of health, nutrition and wellbeing and the trend towards increased home health testing.
The investment from NVM will enable YorkTest to expand its current product range in the US, together with further investment in laboratory equipment. Each food sensitivity test comes with a 30-minute consultation with an expert nutritional therapist and are HSA and FSA accepted.
As part of the transaction Richard Millman will join the Board as Non-Executive Chair. Having worked with a number of established retail businesses, Richard is the former Managing Director of a PC World group business, part of the Dixon's Retail Group and the former CEO of Total Fitness, the PE backed gym chain. He also chairs Protein Works, a global direct to consumer sports nutrition business and Vivify Venues, a tech enabled sports and leisure venue marketplace.
CEO of YorkTest, Richard Dawson, said:
"It's an exciting time for the food sensitivity testing market, as consumers look to take more control of their own health and nutrition, following the challenges of the pandemic.
"YorkTest is well positioned to continue its growth in the food sensitivity testing market and expand its range of health tests.
"Alongside NVM, we'll be at the forefront of positive change for the US home-to-laboratory health testing market."
Richard Millman, adds:
"I am delighted to be joining YorkTest as Non-Executive Chair. It's an exciting time for the sector, as people take more ownership of their own health, particularly following the challenges of the pandemic. The business is already seeing a shift in consumer behavior and the rise in online sales across its portfolio of home health tests. With significant investment in cloud-based technology, laboratory expertise and strong scientific credentials at its core, YorkTest is well positioned to achieve significant growth over the coming years."
The transaction has been led by Andy Leach, Mauro Biagioni and Oliver Wildig. Mauro and Andy will represent NVM's interest on the Board.
Mauro Biagioni, added:
"Under the leadership of CEO, Richard Dawson, the management team has built a robust business which is extremely well regarded in the food sensitivity testing market. We are confident that with today's investment the business is now suitably capitalized to enable the team to deliver their vision and we are delighted to be able to support them on that journey."
For more information about YorkTest, visit www.yorktest.com/us.
Photo - https://mma.prnewswire.com/media/1867412/YorkTest_CEO_Richard_Dawson.jpg
View original content to download multimedia:
SOURCE YorkTest | https://www.wafb.com/prnewswire/2022/07/27/yorktest-laboratories-inc-secures-investment-its-food-sensitivity-testing-business/ | 2022-07-27T13:34:05Z | https://www.wafb.com/prnewswire/2022/07/27/yorktest-laboratories-inc-secures-investment-its-food-sensitivity-testing-business/ | true |
An Exclusive Human Milk Diet with Prolacta's Fortifiers Reduces Risk of BPD, Late-Onset Sepsis, NEC, and ROP While Improving Neurological Development, Clinical Data Demonstrate
DUARTE, Calif., July 27, 2022 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants, reports that data from a growing body of peer-reviewed clinical studies show a reduced risk of several comorbidities among premature infants who received Prolacta's 100% human milk-based fortifiers as part of Exclusive Human Milk Diet (Prolacta's EHMD), compared to premature infants fed cow milk-based fortifiers.1-13
"Premature infants are susceptible to life-threatening complications that risk not only their very survival but also their long-term health and development," said Melinda Elliott, MD, FAAP, and chief medical officer of Prolacta. "Multiple peer-reviewed studies found that Prolacta's nutritional fortifiers, when used as part of an EHMD, play an integral role in helping reduce rates of the most common comorbidities in these fragile infants while also improving their long-term neurodevelopment."1-13
Neonatal intensive care units (NICUs) worldwide are working to reduce complications in premature infants. Mounting clinical evidence shows that replacing cow milk-based fortifiers with Prolacta's EHMD delivers the concentrated nutrition premature infants need to promote adequate growth and development,10 increases feeding tolerance,8 and reduces several of the most serious complications, including bronchopulmonary dysplasia (BPD),5,7,8 late-onset sepsis,5-7 necrotizing enterocolitis (NEC),9,11,13 and retinopathy of prematurity (ROP).5,8,10
An infant's lungs are among the last organs to fully develop inside the womb, leaving many premature infants at high risk of developing BPD. BPD is also called chronic lung disease (CLD) of prematurity. It is one of the most serious complications of prematurity and can cause respiratory morbidity, longer hospital stays, and long-term neurodevelopmental impacts. The longer a premature infant receives supplemental oxygen or mechanical ventilation, the higher the risk of developing BPD.14
Several studies have reported significant decreases (weighted average of 9.7%) in the incidence of BPD in premature infants fed Prolacta's EHMD compared to those fed cow milk-based nutritional products.5,7,8 Another study revealed that time is of the essence: Early fortification with Prolacta's fortifiers as part of an EHMD led to a 15% reduction in the incidence of BPD, compared with late fortification.2
Late-onset sepsis is a dangerous systemic infection with subsequent inflammatory response and the leading cause of mortality in NICUs. It is estimated that premature infants have up to a 26% chance of developing this serious complication.5-7 Late-onset sepsis is associated with several potential complications, including increased ventilation use, neurodevelopmental disabilities, predisposition to other comorbidities like BPD and ROP, longer NICU stays, and higher NICU costs.2,5,7,12
Several studies show that premature infants fed Prolacta's EHMD are less likely to develop late-onset sepsis than those fed cow milk-based fortifiers.5-7
NEC is a serious intestinal disease among extremely preterm infants (those born < 28 weeks gestational age) and is one of the leading causes of mortality among these very fragile, young patients.12 NEC is especially prevalent in premature infants who are fed cow milk-based fortifiers. Mortality for premature infants with NEC requiring surgical intervention can be as high as 34.9%, and 20.3% mortality in infants with medical NEC.15
Several studies have reported that premature infants who received Prolacta's EHMD instead of cow milk-based fortifiers have a reduced incidence of medical NEC or surgical NEC.7-9,11,13,16
ROP is an eye disease primarily affecting premature infants that results in abnormal development of retinal blood vessels. Between 40% and 80% of preterm infants develop ROP, making it a leading cause of blindness and decreased vision in children worldwide with a direct impact on neurodevelopment.17-20
Multiple studies have shown that infants fed Prolacta's EHMD have lower incidence and/or severity of ROP than those who are fed cow milk-based fortifiers.5-8
"The significant body of clinical evidence supporting short- and long-term health benefits with the use of an EHMD with Prolacta's fortifiers is encouraging and positively impacts not only the infants but also their families, communities, and the health system as a whole," said Scott Elster, president and CEO of Prolacta. "Addressing premature infant complications through nutrition in the NICU means getting these babies home sooner and healthier, and ultimately reducing hospital costs."8,12,21
In addition to reducing the risk of life-threatening comorbidities, Prolacta's EHMD has been clinically shown to:
- Lower mortality and morbidity7-9,11
- Achieve adequate growth2,4,9,10,22
- Shorten stays in the NICU8
- Reduce hospital costs8,12,21
- Improve long-term outcomes such as neurological development1,3
- Reduce feeding intolerance8
The major difference between cow milk-based and human milk-based products is the composition — notably, the bioactive components that are unique to human milk. These include immunoglobulins, lactoferrin, milk fat globule membrane, and the wide spectrum of prebiotics known as human milk oligosaccharides (HMOs), which are not easily manufactured and thus are greatly decreased or missing from cow milk-based nutritional products.23 Bioactivity is thought to support infants' immunity, development, growth, and long-term health.24
Prolacta's 100% human milk-based nutritional products have the highest bioactivity in the human milk industry.25 Prolacta's nutritional products are vat pasteurized using profiles defined by the U.S. Food and Drug Administration (FDA) to ensure pathogen inactivation and the highest level of safety while retaining as much of the natural bioactivity of the milk as possible.25 Prolacta's vat pasteurized products retain higher bioactivity than products processed using other methods, including retort sterilization and ultra-high-temperature (UHT) processing.26,27
Prolacta Bioscience® Inc. is a privately held, global life sciences company dedicated to Advancing the Science of Human Milk® to improve the health of critically ill, premature infants. Prolacta's 100% human milk-based nutritional products have been evaluated in more than 20 clinical studies published in peer-reviewed journals. More than 80,000 premature infants have benefited from Prolacta's nutritional products worldwide to date.* Established in 1999, Prolacta is the world's leading provider of human milk-based nutritional products for hospital use and is also exploring the therapeutic potential of human milk across a wide spectrum of diseases. Prolacta maintains the industry's strictest quality and safety standards for screening, testing, and processing human donor milk. Operating the world's first pharmaceutical-grade human milk processing facilities, Prolacta uses vat pasteurization and a patented, U.S. Food and Drug Administration-reviewed manufacturing process to ensure pathogen inactivation while protecting the nutritional composition and bioactivity of its human milk-based products. Prolacta is a global company with headquarters in Duarte, California, and can be found online at www.prolacta.com, on Twitter, Instagram, Facebook, and LinkedIn.
*Estimated number of premature infants fed Prolacta's products from January 2007 to December 2021; data on file.
Media Contact:
Loren Kosmont
Lkosmont@prolacta.com
310-721-9444
1. Bergner EM, Shypailo R, Visuthranukul C, et al. Growth, body composition, and neurodevelopmental outcomes at 2 years among preterm infants fed an exclusive human milk diet in the neonatal intensive care unit: a pilot study. Breastfeed Med. 2020. 15(5):304-311. doi:10.1089/bfm.2019.0210
2. Huston R, Lee M, Rider E, et al. Early fortification of enteral feedings for infants <1250 grams birth weight receiving a human milk diet including human milk-based fortifier. J Neonatal Perinatal Med. 2020;13(2):215-221. doi:10.3233/NPM-190300
3. Rahman A, Kase J, Murray Y, et al. Neurodevelopmental outcome of extremely low birth weight infants fed an exclusive human milk diet is not affected by growth velocity. Breastfeed Med. 2020;15(6):362-369. doi:10.1089/bfm.2019.0214
4. Lucas A, Boscardin J, Abrams SA. Preterm infants fed cow's milk-derived fortifier had adverse outcomes despite a base diet of only mother's own milk. Breastfeed Med. 2020;15(5):297-303. doi:10.1089/bfm.2019.013
5. Delaney Manthe E, Perks PH, Swanson JR. Team-based implementation of an exclusive human milk diet. Adv Neonatal Care. 2019;19(6):460-467. doi:10.1097/ANC.0000000000000676
6. O'Connor DL, Kiss A, Tomlinson C, et al. Nutrient enrichment of human milk with human and bovine milk-based fortifiers for infants born weighing <1250 g: a randomized clinical trial [published corrections appear in Am J Clin Nutr. 2019;110(2):529 and Am J Clin Nutr. 2020;111(5):1112] Am J Clin Nutr. 2018;108(1):108-116. doi:10.1093/ajcn/nqy067
7. Hair AB, Peluso AM, Hawthorne KM, et al. Beyond necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk-based diet [published correction appears in Breastfeed Med. 2017;12(10):663] Breastfeed Med. 2016;11(2):70-74. doi:10.1089/bfm.2015.0134
8. Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168
9. Abrams SA, et al. Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products. Breastfeed Med. June 2014. 9(6): 281-0285. doi:10.1089/bfm.2014.0024. This cohort study included 260 extremely preterm infants born weighing less than 1,250 g who received a diet that ranged from 100% cow milk to 100% human milk.
10. Hair AB, Hawthorne KM, Chetta KE, et al. Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Res Notes 2013;6:459. doi:10.1186/1756-0500-6-459.
11. Cristofalo EA, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. December 2013. 163(6):1592-1595. doi: 10.1016/j.jpeds.2013.07.011.
12. Ganapathy V, et al. Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants. Breastfeed Med. February 2012. 7(1):29-37. doi: 10.1089/bfm.2011.0002. This cost-effectiveness analysis of 2,560 extremely premature infants less than 28 weeks gestational age in 257 hospitals nationwide compared the impact of an exclusive human milk diet composed of mother's milk fortified with a human milk-based fortifier versus mother's milk fortified with cow milk-based fortifier.
13. Sullivan S, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. April 2010. 156(4):562-567. doi: 10.1016/j.jpeds.2009.10.040.
14. Learn about bronchopulmonary dysplasia. American Lung Association. Accessed March 6, 2020. https://www.lung.org/lung-health-diseases/lung-disease-lookup/bronchopulmonary-dysplasia/learn-about-bpd.
15. Han SM, Hong CR, Knell J, et al. Trends in incidence and outcomes of necrotizing enterocolitis over the last 12 years: A multicenter cohort analysis. J Pediatr Surg. 2020;55(6):998-1001. doi:10.1016/j.jpedsurg.2020.02.046
16. Huston RK, et al. Decreasing necrotizing enterocolitis and gastrointestinal bleeding in the neonatal intensive care unit: the role of donor human milk and exclusive human milk diets in infants <1,500 g birth weight. Infant Child Adolesc Nutr. 10 January 2014. 13:127. doi: 10.1177/1941406413519267.
17. Dutta S, Raghuveer T, Vinekar A, Dogra MR. Can we stop the current epidemic of blindness from retinopathy of prematurity? Indian Pediatr. 2016;53(Suppl 2):S80-S84.
18. Kong L, Fry M, Al-Samarraie M, Gilbert C, Steinkuller PG. An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J AAPOS. 2012;16(6):501-507. doi:10.1016/j.jaapos.2012.09.004
19. Raghuveer TS, Zackula R. Strategies to prevent severe retinopathy of prematurity: a 2020 update and meta-analysis. NeoReviews. 2020;21(4):e249-e263. doi:10.1542/neo.21-4-e249
20. Molloy CS, Anderson PJ, Anderson VA, Doyle LW. The long-term outcome of extremely preterm (<28 weeks' gestational age) infants with and without severe retinopathy of prematurity. J Neuropsychol. 2016;10(2):276-294. doi:10.1111/jnp.12069
21. Iskersky V. Use of an exclusive human milk diet in preterm infants to lower healthcare costs – short-term and long-term perspectives. Neonatal Intensive Care. 2020:37-39.
22. Huston RK, Markell AM, McCulley EA, Gardiner SK, Sweeney SL. improving growth for infants ≤1250 grams receiving an exclusive human milk diet. Nutr Clin Pract. 2018;33(5):671-678. doi:10.1002/ncp.10054.
23. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am. 2013 Feb;60(1):49-74. doi: 10.1016/j.pcl.2012.10.002. PMID: 23178060; PMCID: PMC3586783.
24. Gila-Diaz A, Arribas SM, Algara A, Martín-Cabrejas MA, López de Pablo ÁL, Sáenz de Pipaón M, Ramiro-Cortijo D. A review of bioactive factors in human breastmilk: a focus on prematurity. Nutrients. 2019;11(6):1307. doi:10.3390/nu11061307
25. Internal data.
26. Lima HK, Wagner-Gillespie M, Perrin MT, Fogleman AD. Bacteria and bioactivity in Holder pasteurized and shelf-stable human milk products. Curr Dev Nutr. 2017;1(8):e001438. doi:10.3945/cdn.117.001438
27. Meredith-Dennis L, Xu G, Goonatilleke E, Lebrilla CB, Underwood MA, Smilowitz JT. Composition and variation of macronutrients, immune proteins, and human milk oligosaccharides in human milk from nonprofit and commercial milk banks. J Hum Lact. 2018;34(1):120-129. doi:10.1177/0890334417710635
View original content to download multimedia:
SOURCE Prolacta Bioscience | https://www.wkyt.com/prnewswire/2022/07/27/multiple-peer-reviewed-studies-show-prolactas-100-human-milk-based-nutritional-fortifiers-reduce-risk-life-threatening-comorbidities-premature-infants-compared-cow-milk-based-nutrition/ | 2022-07-27T13:34:52Z | https://www.wkyt.com/prnewswire/2022/07/27/multiple-peer-reviewed-studies-show-prolactas-100-human-milk-based-nutritional-fortifiers-reduce-risk-life-threatening-comorbidities-premature-infants-compared-cow-milk-based-nutrition/ | false |
CombiSet SMARTECH™ Offers Innovative New Design and Simplifies Use
WALTHAM, Mass., July 27, 2022 /PRNewswire/ -- Fresenius Medical Care North America's (FMCNA) Renal Therapies Group today announced the availability of the CombiSet SMARTECHTM, the first available single-use bloodline with an integrated Crit-Line® blood chamber (CLiC™) that simplifies use by reducing the number of manual connections required. The CLICTM Blood Chamber is built into the bloodline itself and is designed to provide optimal performance with the 2008® series hemodialysis machines.
Crit-Line technology is designed to continuously monitor the percent change in blood volume, plasma refill, oxygen saturation and other key parameters during the hemodialysis treatment. This data can guide the clinician to intervene, if necessary, by adjusting the ultrafiltration rates to provide a more effective dialysis treatment. Fluid overload, or hypervolemia, is a common complication of kidney disease, particularly in patients with end-stage renal disease (ESRD) on hemodialysis. It is often associated with adverse outcomes including hypertension, exacerbation of congestive heart failure (CHF), and increased risk of death.1
"By combining these two components into one bloodline, we are simplifying the set-up process which will hopefully encourage increased use of Crit-Line technology," said Dr. Mike Anger, SVP and Chief Medical Officer for FMCNA's Renal Therapies Group. "This new bloodline is designed to make fluid management even easier, providing insights that can help better manage the fluid status of dialysis patients."
The CombiSet SMARTECH offers key advantages when providing hemodialysis to patients in outpatient or acute settings:
- Increased Ease of Use: Less product to manage at point of care; less inventory to maintain.
- Fewer Connections: The new integrated bloodline line has only one connection, eliminating the need for additional components and simplifying the connection process.
"This introduction of this new bloodline is part of our commitment to bring innovations to market that improve patient care, making the dialysis process simpler and safer for our patients," said Pat McCarthy, SVP of FMCNA's Renal Therapies Group. "This new integrated system is a step forward within our already trusted and reliable bloodline product offerings."
For more information about CombiSet SMARTECH, along with the benefits and features of the Crit-Line technology, visit https://fmcna.com/combiset-smartech.
About Fresenius Medical Care North America
Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities and outpatient cardiac and vascular labs, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world's largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com/.
Disclaimer
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.
Media Contact:
Fresenius Medical Care North America
Scott Sayres
Corporate Communications
scott.sayres@freseniusmedicalcare.com
(940) 297-5678
1 Arneson TJ, et al., Hospital treatment for fluid overload in the Medicare hemodialysis population. Clin J Am Soc Nephrol. 2010;5(6):1054-1063.
Indication for Use:
Crit-Line Technology is designed to non-invasively measure hematocrit, oxygen saturation and percent change in blood volume. The technology employs a sensor clip which emits multiple wavelengths of light to trans-illuminate the blood in the Crit-Line blood chamber. The differences in light absorption between blood constituents allow for the identification and measurement of the hematocrit. The measurement of hematocrit, percent change in blood volume and oxygen saturation in real-time during hemodialysis is intended to provide a more effective treatment for both the dialysis patient and the clinician. Based on the data that the monitor provides, the clinician/nurse, under physician direction, can intervene (i.e., by increasing or decreasing the rate at which fluid is removed from the blood) to remove the maximum amount of fluid from the dialysis patient without the patient experiencing the common complications of dialysis which include nausea, cramping and vomiting. The technology is available as a stand-alone device (Crit-Line IV Monitor) or as an optional module on the 2008T hemodialysis machine series (CLiC™ device).
CombiSet SMARTECH Hemodialysis Blood Tubing Set
- The Blood Tubing Set is a sterile, single use, disposable indicated for use with a prescribed hemodialyzer. The suitability of a particular bloodline/hemodialyzer configuration is the responsibility of the physician.
- The Blood Tubing Set is intended for acute and chronic hemodialysis therapy.
- The Blood Tubing Set is intended to be used with Fresenius Medical Care 2008® Series K, K2, and T Hemodialysis Machines equipped with Crit-Line hardware.
- The Crit-Line Blood Chamber is an optical cuvette designed for use with the Crit-Line monitor's sensor clip during acute and chronic hemodialysis therapy to noninvasively measure hematocrit, percent change in blood volume, and oxygen saturation.
Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.
Note: Read the Instructions for Use for safe and proper use of these devices. For a complete description of hazards, contraindications, side effects and precautions, see full package labeling at www.fmcna.com.
© 2021 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, Fresenius Renal Technologies, 2008, Crit-Line CLiC, CombiSet, and CombiSet SMARTECH are trademarks of Fresenius Medical Care Holdings, Inc., or its affiliated companies. All other trademarks are the property of their respective owners.
View original content to download multimedia:
SOURCE Fresenius Medical Care Holdings, Inc. | https://www.wafb.com/prnewswire/2022/07/27/fresenius-medical-care-north-america-introduces-first-single-use-integrated-bloodline-support-fluid-management-dialysis/ | 2022-07-27T13:35:03Z | https://www.wafb.com/prnewswire/2022/07/27/fresenius-medical-care-north-america-introduces-first-single-use-integrated-bloodline-support-fluid-management-dialysis/ | false |
Presnel Kimpembe has made a huge decision surrounding his future at PSG, according to reports. The 26-year-old was linked with a move to Chelsea this summer as the Blues look to rebuild their defensive ranks in the transfer window, but it appears as though a deal may not go through.
It comes as Thomas Tuchel struggles to find a suitable option to bolster his centre-back options at the club. The loss of Antonio Rudiger and Andreas Christensen over the summer has only seen Kalidou Koulibaly join so far.
When the Blues have looked at other targets so far, they haven't quite managed to land them. Matthijs de Ligt made the switch to Bayern Munich, talks over Nathan Ake's return broke down and as it stands, Barcelona are poised to win the race for Sevilla's Jules Kounde.
READ MORE: Bayern Munich chief gives Cristiano Ronaldo and Harry Kane update amid Chelsea transfer links
Chelsea are now considering making a move for Leicester City centre-back Wesley Fofana, football.london understands, with contact expected to be made some time this week. The Blues are still monitoring the situation surrounding Milan Skriniar, Josko Gvardiol and Kimpembe should they need to switch to another target.
The latter was heavily linked with a reunion with Tuchel earlier in the window, but talk surrounding a move have since grown quieter, with PSG said to be willing to let the Frenchman leave but only if he wishes to. If the west London club were waiting for the answer to that question, it appears they may have received an answer.
Le10Sport reports that Kimpembe has decided to stay in the French capital rather than leave, making himself available to new boss Christophe Galtier. The 26-year-old has two-years left on his deal with PSG, meaning there may still be doubts over his near future.
However, it appears as though that future won't currently involve a regular appearance at Stamford Bridge next season.
READ MORE:
Denzel Dumfries benched, Presnel Kimpembe signs - Chelsea’s best back four with three transfers
Chelsea news and transfers LIVE: All the latest updates and rumours from Stamford Bridge
Full Chelsea Premier League fixture list for 2022/23
Denzel Dumfries Chelsea transfer signals Thomas Tuchel's most troubling Kai Havertz problem
Denzel Dumfries, Jules Kounde and Chelsea stars left in limbo as wait for 3rd transfer continues | https://www.football.london/chelsea-fc/transfer-news/presnel-kimpembe-chelsea-psg-transfer-24600450 | 2022-07-27T13:36:16Z | https://www.football.london/chelsea-fc/transfer-news/presnel-kimpembe-chelsea-psg-transfer-24600450 | true |
Exclusive product, coupled with company's existing RateShield program that locks mortgage interest rates for 90 days during home shopping, brings confidence to consumers
DETROIT, July 27, 2022 /PRNewswire/ -- Rocket Mortgage, America's largest mortgage lender and a part of Rocket Companies (NYSE: RKT), today announced the introduction of Rate Drop Advantage – an exclusive program that brings confidence to homebuyers by covering a significant portion of closing costs of a refinance transaction if interest rates drop and they refinance within three years of purchasing a home.
Through Rate Drop Advantage, when clients refinance within the allotted timeframe, Rocket Mortgage will waive the fees for appraisal, credit report pulls, processing, underwriting and several other costs for an average savings of approximately $2,000. Rate Drop Advantage gives buyers confidence in the midst of a rising rate environment by knowing if rates decrease within the three-year period after closing on their original purchase, they can easily and affordably refinance.
"Rocket Mortgage is committed to creating more ways to make the financing process easier and more affordable for homebuyers and maintain the excitement that should come along with this huge milestone in their life," said Bob Walters, CEO of Rocket Mortgage. "Innovation comes in many different forms – Rocket Mortgage is known for both our revolutionary technology and the creativity we bring to help meet the needs of our clients, like Rate Drop Advantage, RateShield and our Verified Approval. We are constantly listening to our clients, implementing their feedback and developing programs that meet and exceed their needs."
Homebuyers benefit in both the short- and long-term with the combination of Rate Drop Advantage and Rocket Mortgage's existing RateShield program. For the past four years, Rocket Mortgage clients have used RateShield to gain confidence and stability while shopping for a home. Interest rate increases can cause your home purchase budget to change from day to day.
With RateShield, however, American homebuyers get access to a powerful two-way benefit. A buyer will have the ability to lock in current rates for up to 90 days while home shopping, providing a hedge against rising rates. If rates have fallen by the time the purchase agreement is signed – the buyer will receive the lower rates. This option has been wildly popular with prospective homebuyers in today's volatile rate environment.
Rocket Mortgage also takes an innovative approach to mortgage approvals. Buyers can receive an exclusive Verified Approval to know the exact amount they qualify for and the assurance that their finances are ready to close on a mortgage. Far beyond a prequalification or a preapproval, a Verified Approval is based on an underwriter's comprehensive analysis of a buyer's credit, income, employment status, assets and debt. Homebuyers with a Verified Approval Letter from Rocket Mortgage are nearly twice as likely to close on their mortgage.
Innovative programs like Rate Drop Advantage, RateShield and Verified Approval are examples of Rocket Companies' mission to simplify life's most complex moments to help clients live their American dream.
For more information on these programs, visit RocketMortgage.com/Learn/RateShield-Rate-Drop-Advantage.
Detroit-based Rocket Mortgage, the nation's largest home mortgage lender and part of Rocket Companies (NYSE: RKT), enables the American Dream of homeownership and financial freedom through its obsession with an industry-leading, digital-driven client experience. In late 2015, it introduced the first fully digital, completely online mortgage experience. Rocket Mortgage closed $351 billion dollars of mortgage volume across all 50 states in 2021.
Rocket Mortgage moved its headquarters to downtown Detroit in 2010. The company generates loan production from web centers located in Detroit, Cleveland and Phoenix and operates a centralized loan processing facility in Detroit.
Rocket Companies, Rocket Mortgage's parent company, ranked #7 on Fortune's list of the "100 Best Companies to Work For" in 2022 and has placed in the top third of the list for 19 consecutive years.
For more information and company news visit RocketMortgage.com/PressRoom.
Founded in 1985, Rocket Companies is a Detroit-based FinTech platform company consisting of personal finance and consumer technology brands including Rocket Mortgage, Rocket Homes, Amrock, Rocket Auto, Rocket Loans, Rocket Money (formerly known as Truebill), Rocket Solar, Rocket Mortgage Canada (formerly known as Edison Financial), Lendesk, Core Digital Media, Rocket Central and Rock Connections.
Rocket Companies' mission is to be the best at creating certainty in life's most complex moments so that its clients can live their dreams. The Company helps clients achieve the dream of home ownership and financial freedom through industry-leading client experiences powered by its simple, fast and trusted digital solutions. Rocket Companies ranked #7 on Fortune's list of the "100 Best Companies to Work For" in 2022 and has placed in the top third of the list for 19 consecutive years. For more information, please visit our Corporate Website or Investor Relations Website.
View original content to download multimedia:
SOURCE Rocket Mortgage | https://www.wkyt.com/prnewswire/2022/07/27/rocket-mortgage-introduces-rate-drop-advantage-giving-homebuyers-confidence-when-purchasing-rising-rate-environment/ | 2022-07-27T13:36:25Z | https://www.wkyt.com/prnewswire/2022/07/27/rocket-mortgage-introduces-rate-drop-advantage-giving-homebuyers-confidence-when-purchasing-rising-rate-environment/ | true |
This is a carousel. Use Next and Previous buttons to navigate
KHIMKI, Russia (AP) — American basketball star Brittney Griner testified Wednesday at her drug trial in Russia that a language interpreter provided during her questioning translated only a fraction of what was said and officials instructed her to sign documents without providing an explanation.
Griner was arrested at a Moscow airport in February. She acknowledged in court earlier this month that she had vape cartridges containing cannabis oil when she arrived in Russia but contends she had no criminal intent and the cartridges ended up in her luggage inadvertently.
During her testimony, the Phoenix Mercury standout described making a grueling 13-hour flight to Moscow from Arizona while recovering from COVID-19. Griner said she still does know how the cannabis oil for which she had a doctor's recommendation ended up in her bag but explained she had packed in haste while under great stress.
She recalled how her luggage was checked upon her Feb. 17 arrival in Moscow and getting pulled aside after inspectors found the cartridges.
Along with the interpreter provided an incomplete translation, Griner said she was offered neither an explanation of her rights nor access to lawyers and was instructed to sign documents without receiving an explanation of what they implied.
After hours of proceedings she did not understand, she was allowed to hand over her personal belongings to a lawyer before being led away in handcuffs, Griner said. She said she received only a cursory translation of the allegations at her during a Feb. 19 hearing where a court sanctioned her arrest.
Griner faces up to 10 years in prison if convicted of transporting drugs. Her trial started July 1. and the five previous court sessions so far were short, some lasting only about an hour.
It is unclear how long the trial will last, but a court has authorized Griner's detention until Dec. 20. She went to Russia to play for a Russian team in the WNBA's off-season.
During Tuesday’s court session of about 90 minutes, a Russian neuropsychologist testified about worldwide use of medicinal cannabis, which remains illegal in Russia. Griner’s defense team has submitted a U.S. doctor’s letter recommending the basketball player use medical cannabis to treat pain.
Griner testified Wednesday that she was suffering from pain from injuries sustained during her basketball career. She emphasized that cannabis oil is widely used in the United States for medicinal purposes and has less negative effects than some other painkillers
A Russian Foreign Ministry spokesperson said last week that the legalization of cannabis for medical and recreational use in parts of the U.S. had no bearing on what happens in Russia.
The slow-moving trial and Griner's five months of detention have raised strong criticism among teammates and supporters in the United States, which has formally declared her to be “wrongfully detained,” a designation sharply rejected by Russian officials.
Griner was arrested in February amid high U.S.-Moscow tensions ahead of Russia sending troops into Ukraine later that month. Some supporters contend she is being held in Russia as a pawn, possibly for a prisoner swap. American soccer notable Megan Rapinoe last week said “she’s being held as a political prisoner, obviously.”
Russian media have speculated that Griner could be exchanged for prominent Russian arms trader Viktor Bout, who is imprisoned in the United States, and that Paul Whelan, an American imprisoned in Russia for espionage, may also figure in an exchange.
U.S. officials have not commented on the prospects for such a trade. Russian officials have said no exchange could be discussed until the conclusion of the legal proceedings against Griner. | https://www.ourmidland.com/news/article/Griner-testifies-at-Russia-drug-trial-about-17331940.php | 2022-07-27T13:37:40Z | https://www.ourmidland.com/news/article/Griner-testifies-at-Russia-drug-trial-about-17331940.php | true |
QUETTA, Pakistan (AP) — Rescuers backed by troops used boats and helicopters Wednesday to evacuate hundreds of marooned people from the country's southwest, where floods triggered by monsoon rains have killed 104 people.
Since June 14, the downpours have damaged bridges, roads and about 4,000 homes in Baluchistan province, according to the National Disaster Management Authority.
It said 337 people have died in rain-related incidents across impoverished Pakistan.
Akram Bugti, a rescue official, said hundreds of people were stranded just in Lasbella, a district in Baluchistan province, after floodwater inundated several villages.
He said the Baluchistan government is providing food, tents and other essential items to flood-affected people.
In a statement, Pakistan’s military said the previous day that troops were assisting local authorities in Baluchistan to evacuate people from flood-affected areas.
It said the military had set up medical camps in deluged areas, where the World Health Organization this week launched an anti-cholera vaccination campaign to prevent the spread of the water-borne disease.
Cholera has caused 28 deaths and sickened thousands of people in Baluchistan in recent months.
The disease is endemic and seasonal in Pakistan, where many people don’t have access to clean drinking water. Health officials said the anti-cholera vaccination campaign began on July 25 and will continue until Friday.
The monsoon season runs from July through September in Pakistan. | https://www.ourmidland.com/news/article/Pakistan-uses-boats-helicopters-to-evacuate-17331936.php | 2022-07-27T13:38:23Z | https://www.ourmidland.com/news/article/Pakistan-uses-boats-helicopters-to-evacuate-17331936.php | false |
WFO PENDLETON Warnings, Watches and Advisories for Saturday, July 30, 2022
_____
EXCESSIVE HEAT WARNING
URGENT - WEATHER MESSAGE
National Weather Service Pendleton OR
620 AM PDT Wed Jul 27 2022
...EXCESSIVE HEAT WARNING REMAINS IN EFFECT UNTIL 11 PM PDT
SATURDAY...
* WHAT...Dangerously hot conditions with temperatures 105 to 112.
* WHERE...Portions of central, south central and southeast
Washington and central, north central and northeast Oregon.
* WHEN...Until 11 PM PDT Saturday.
* IMPACTS...Extreme heat will significantly increase the
potential for heat related illnesses, particularly for those
working or participating in outdoor activities.
PRECAUTIONARY/PREPAREDNESS ACTIONS...
Drink plenty of fluids, stay in an air-conditioned room, stay out
of the sun, and check up on relatives and neighbors. Young
children and pets should never be left unattended in vehicles
under any circumstances.
Take extra precautions if you work or spend time outside. When
possible reschedule strenuous activities to early morning or
evening. Know the signs and symptoms of heat exhaustion and heat
stroke. Wear lightweight and loose fitting clothing when
possible. To reduce risk during outdoor work, the Occupational
Safety and Health Administration recommends scheduling frequent
rest breaks in shaded or air conditioned environments. Anyone
overcome by heat should be moved to a cool and shaded location.
Heat stroke is an emergency! Call 9 1 1.
* WHAT...Dangerously hot conditions with temperatures up to 105.
* WHERE...East Slopes of the Washington Cascades.
_____
Copyright 2022 AccuWeather | https://www.ourmidland.com/weather/article/WA-WFO-PENDLETON-Warnings-Watches-and-Advisories-17331988.php | 2022-07-27T13:39:56Z | https://www.ourmidland.com/weather/article/WA-WFO-PENDLETON-Warnings-Watches-and-Advisories-17331988.php | true |
ASHGABAT, Turkmenistan (AP) — The Central Asian nation of Turkmenistan says if you’re trying to smuggle its prized native dog breed out of the country, you’re barking up the wrong tree.
The government is now requiring that its celebrated Alabay dogs receive a passport before they can leave the country.
A law that took effect Tuesday requires that all puppies of the breed, which is also known as the Central Asian shepherd dog, be marked in the government’s pedigree book and register of pedigreed dogs. Passports will be issued including data on the dog’s sex, date of birth, color, as well as details about the owner. Special government export permission will be required.
Turkmenistan, an isolated desert country of 6 million people, prides itself on its horses and dogs, honoring centuries-old herding traditions. Alabay, traditionally used for guarding livestock herds, are among the world’s largest dogs, weighing as much as 80 kilograms (175 pounds).
In 2020, then-President Gurbanguly Berdymukhamedov established a holiday honoring the dogs, and last year unveiled a 15-meter (50-foot)-tall golden statue of them in the nation’s capital, Ashgabat. The Turkmen leader extolled the Alabay for years. He published a book and wrote a song about the breed and presented Russian President Vladimir Putin with an Alabay puppy in 2017.
Gurbanguly Berdymukhamedov’s son, Serdar, who was elected president this year, heads the international association of Alabays. | https://www.beaumontenterprise.com/news/article/Turkmenistan-restricts-export-of-its-local-Alabay-17331982.php | 2022-07-27T13:40:22Z | https://www.beaumontenterprise.com/news/article/Turkmenistan-restricts-export-of-its-local-Alabay-17331982.php | false |
A tourist has promised to never come back to the UK after a member of the Queen's guard screamed at her for getting too close to his horse.
TikTok user Ethan (@_phigs) shared the video of his step-mum being screamed at, and then vowed he would never come back.
The video showed Ethan's step-mum going over to the soldier, who was riding a tall, black horse outside Buckingham Palace, after she had queued to pose for a photo.
Just as the photo was being taken, the woman reaches to hold the horse's reigns.
The animal gets quite visibly distressed, causing the solider to shout at her.
"Stand back from the Queen's lifeguard, don't touch the reins!" he yelled.
The incident garnered mixed reactions, with many people feeling sorry for the woman, who they said didn't realise she was doing anything wrong.
One TikTok user wrote: "He was a rather angry little man."
"Is this a new trend to get shouted at by the queen's guard?" another said.
That said, others didn't feel such sympathy for the woman, and said she shouldn't have just touched the reins as she did.
One person said: "It’s not Disney they are working horses and serving army."
A second commented: "They really don’t care if you’re going back I promise you", and a third remarked: "Serves her right you aren’t allowed to touch the guard."
One person in the comments section recalled being allowed to grab the reins for a picture after asking permission from a soldier.
An Army spokesperson said: “We take all incidents like this seriously and want to ensure all those who visit Horse Guards have an enjoyable time.
"This area is particularly busy with tourists and on occasions the soldiers undertaking Guard duty need to shout loudly to alert members of the public if they get too close to the horses, which happened in this case.
“We have signs placed alongside the horse boxes, stating that the horses bite and would always encourage the public not to get close to horses, as after all, they are animals and can be unpredictable.”
Read More
Read More | https://www.mirror.co.uk/news/uk-news/tourist-vows-never-return-uk-27591070 | 2022-07-27T13:43:47Z | https://www.mirror.co.uk/news/uk-news/tourist-vows-never-return-uk-27591070 | true |
BERLIN (AP) — The German government plans to reduce incentive payments for buyers of electric cars and end subsidies for buying plug-in hybrids at the end of this year.
The government had announced shortly after taking office in December that, starting in 2023, it would only provide payments for electric vehicles that “demonstrably have a positive climate-protection effect.” It unveiled details of the new system late Tuesday.
At present, buyers of electric-only cars are eligible for government incentives of up to 6,000 euros ($6,100) and people who buy plug-in hybrids can get up to 4,500 euros ($4,570).
The economy and climate ministry said the number of electric cars on the road is rising fast, with the total expected to near 2 million this year. They “are becoming ever more popular and will need no state subsidies in the foreseeable future,” minister Robert Habeck said.
Starting in January, government incentives for electric and fuel-cell cars will be cut to 4,500 euros apiece for vehicles with a list price up to 40,000 euros and to 3,000 euros ($3,045) for cars costing 40,000-65,000 euros.
Beginning in September next year, the incentives will be limited to private individuals, although the government is considering allowing small businesses and charitable organizations to remain eligible.
Starting in January 2024, the government incentives will be cut to 3,000 euros for vehicles priced up to 45,000 euros and scrapped for more expensive cars.
The funding will also be capped. Finance Minister Christian Lindner said Wednesday that the government incentives will end when a final 2.5 billion euros is exhausted and after that, only tax advantages for buying climate-friendly cars will remain.
“And I would like to add that in view of auto companies’ billions in profits, such subsidization is no longer necessary — I’m counting on an impetus coming via the market to make electric vehicles cheaper, through competition,” he said.
The government wants to have at least 15 million fully electric cars on the road by 2030. It also aims to step up efforts against climate change by expanding the use of renewable energy and bringing Germany’s exit from coal-fired power forward from 2038, “ideally” to 2030.
___
Follow AP’s coverage of climate change at https://apnews.com/hub/climate-and-environment | https://www.cbs42.com/news/business/germany-to-reduce-financial-incentives-to-buy-electric-cars/ | 2022-07-27T13:43:50Z | https://www.cbs42.com/news/business/germany-to-reduce-financial-incentives-to-buy-electric-cars/ | false |
Justice Dept. investigating Trump, fake elector scheme allegations, reports say
(CNN) - The Justice Department is apparently looking closer at the so-called fake elector scheme in the 2020 election.
The Justice Department is investigating actions by former President Donald Trump in its criminal investigation into efforts to overturn the 2020 election, according to a new report from the Washington Post.
A source close to the investigation told CNN prosecutors are focusing in on the fake elector scheme and the role of lawyers Rudy Giuliani and John Eastman along with meetings that were part of a pressure campaign to convince then-Vice President Mike Pence to disrupt the certification of electoral votes.
“The Justice Department has from the beginning been moving urgently to learn everything we can about this period,” Attorney General Merrick Garland said.
In an interview with NBC’s Lester Holt, Garland deflected criticism that the Department of Justice is not moving fast enough.
“We have a huge number of prosecutors and agents working on these cases,” Garland said. “It is inevitable in this kind of investigation that there will be speculation about what we are doing, who we are investigating, what our theories are. The reason there is this speculation and uncertainty is that it’s a fundamental tenet of what we do as prosecutors and investigators is to do it outside of the public eye. We do that for two important reasons. One is to protect the civil liberties people and events that we’re investigating and the second is to ensure the success and the integrity of our investigation.”
When it comes to charging Trump and others, he’s not ruling that out.
“We pursue justice without fear or favor. We intend to hold everyone -- anyone -- who is criminally responsible for the events surrounding January 6 or any attempt to interfere with the lawful transfer of power from one administration to another accountable,” Garland said. “That is what we do. We don’t pay any attention to other issues with respect to that.”
And asked whether a 2024 presidential bid from Trump would change that, Garland reiterated, “I will say again that we will hold accountable anyone who is criminally responsible for attempting to interfere with the legitimate, lawful transfer of power from one administration to the next.”
On Capitol Hill, in newly released audio, former acting Defense Secretary Chris Miller is heard telling the House Select Committee that Trump never gave an order to have troops ready to be deployed to the Capitol on Jan. 6.
“I was never given any direction order or knew of any plans of that nature,” he said. “There was no direct, there was no order from the president.”
Trump has said that he requested National Guard troops to be ready that day, saying that he “suggested and offered” 20,000 National Guard troops.
Newly obtained emails obtained by the New York Times show that Trump allies knew that their electoral scheme was fake.
In an email sent to Trump campaign adviser Boris Epshteyn from a Phoenix-based lawyer, the lawyer wrote, “We would just be sending in ‘fake’ electoral votes to pence so that ‘someone’ in Congress can make an objection when they start counting votes and start arguing the ‘fake’ votes should be counted.”
In a follow up email, the lawyer said, “PPS, ‘alternative’ votes is probably a better term than ‘fake’ votes,” adding a smiley face emoticon.
For the first time since leaving office, Trump returned to Washington to speak about Republican policies and air some grievances at the America First Policy Institute’s two-day summit.
“I ran for president. I won, and I won a second time, much better the second time,” Trump said.
Copyright 2022 CNN Newsource. All rights reserved. | https://www.kbtx.com/2022/07/27/justice-dept-investigating-trump-fake-elector-scheme-allegations-reports-say/ | 2022-07-27T13:44:45Z | https://www.kbtx.com/2022/07/27/justice-dept-investigating-trump-fake-elector-scheme-allegations-reports-say/ | true |
Amazon hikes Prime subscription in five European countries
While the price hikes are much higher than inflation, analysts believe that the service costs Amazon much more than it charges and is used to lure and keep customers.
Amazon Prime customers in five European countries learned Tuesday that they face double-digit price increases for the platform's expedited delivery service.
Amazon said the rises were due to increased operating costs as fuel prices have jumped higher.
Beginning in mid-September, customers in France will have to pay 43 percent more for an annual subscription. Italians face a 38.6-percent hike, Spaniards 30.3 percent, and Britons and Germans 20 percent.
The rises take the price of Prime, which in addition to rapid delivery includes access to its Prime Video service, to 49.90 euros in Italy and Spain. It will be 89.90 euros in France and Germany, and 95 pounds (around 112 euros) in Britain.
That leaves the service less costly than in the United States, where it rose by 17 percent in February to $139 per year (137 euros).
While the price hikes are much higher than inflation, analysts believe that the service costs Amazon much more than it charges and is used to lure and keep customers.
Market intelligence firm Foxintelligence estimated last year that European members of Prime bought on average twice as much on Amazon than non-members.
A handful of angry customers announced their intention to cancel the service on Twitter.
However, Amazon representatives in France were unfazed.
"What we could see in the United States was there wasn't an opt-out surge because more and more services are offered via Prime and it still allows consumers to realise very considerable savings," said the firm.
© Copyright AFP 2022. All rights reserved. | https://www.ibtimes.co.uk/amazon-hikes-prime-subscription-five-european-countries-1702683 | 2022-07-27T13:46:28Z | https://www.ibtimes.co.uk/amazon-hikes-prime-subscription-five-european-countries-1702683 | false |
Justice Dept. investigating Trump, fake elector scheme allegations, reports say
(CNN) - The Justice Department is apparently looking closer at the so-called fake elector scheme in the 2020 election.
The Justice Department is investigating actions by former President Donald Trump in its criminal investigation into efforts to overturn the 2020 election, according to a new report from the Washington Post.
A source close to the investigation told CNN prosecutors are focusing in on the fake elector scheme and the role of lawyers Rudy Giuliani and John Eastman along with meetings that were part of a pressure campaign to convince then-Vice President Mike Pence to disrupt the certification of electoral votes.
“The Justice Department has from the beginning been moving urgently to learn everything we can about this period,” Attorney General Merrick Garland said.
In an interview with NBC’s Lester Holt, Garland deflected criticism that the Department of Justice is not moving fast enough.
“We have a huge number of prosecutors and agents working on these cases,” Garland said. “It is inevitable in this kind of investigation that there will be speculation about what we are doing, who we are investigating, what our theories are. The reason there is this speculation and uncertainty is that it’s a fundamental tenet of what we do as prosecutors and investigators is to do it outside of the public eye. We do that for two important reasons. One is to protect the civil liberties people and events that we’re investigating and the second is to ensure the success and the integrity of our investigation.”
When it comes to charging Trump and others, he’s not ruling that out.
“We pursue justice without fear or favor. We intend to hold everyone -- anyone -- who is criminally responsible for the events surrounding January 6 or any attempt to interfere with the lawful transfer of power from one administration to another accountable,” Garland said. “That is what we do. We don’t pay any attention to other issues with respect to that.”
And asked whether a 2024 presidential bid from Trump would change that, Garland reiterated, “I will say again that we will hold accountable anyone who is criminally responsible for attempting to interfere with the legitimate, lawful transfer of power from one administration to the next.”
On Capitol Hill, in newly released audio, former acting Defense Secretary Chris Miller is heard telling the House Select Committee that Trump never gave an order to have troops ready to be deployed to the Capitol on Jan. 6.
“I was never given any direction order or knew of any plans of that nature,” he said. “There was no direct, there was no order from the president.”
Trump has said that he requested National Guard troops to be ready that day, saying that he “suggested and offered” 20,000 National Guard troops.
Newly obtained emails obtained by the New York Times show that Trump allies knew that their electoral scheme was fake.
In an email sent to Trump campaign adviser Boris Epshteyn from a Phoenix-based lawyer, the lawyer wrote, “We would just be sending in ‘fake’ electoral votes to pence so that ‘someone’ in Congress can make an objection when they start counting votes and start arguing the ‘fake’ votes should be counted.”
In a follow up email, the lawyer said, “PPS, ‘alternative’ votes is probably a better term than ‘fake’ votes,” adding a smiley face emoticon.
For the first time since leaving office, Trump returned to Washington to speak about Republican policies and air some grievances at the America First Policy Institute’s two-day summit.
“I ran for president. I won, and I won a second time, much better the second time,” Trump said.
Copyright 2022 CNN Newsource. All rights reserved. | https://www.mysuncoast.com/2022/07/27/justice-dept-investigating-trump-fake-elector-scheme-allegations-reports-say/ | 2022-07-27T13:48:04Z | https://www.mysuncoast.com/2022/07/27/justice-dept-investigating-trump-fake-elector-scheme-allegations-reports-say/ | false |
ALBUQUERQUE, N.M. (KRQE) – The Albuquerque Police Department are investigating a deadly shooting in northeast Albuquerque. Tuesday night APD responded to shots fired on the 400 block of Rhode Island St., near Copper Ave. and Rhode Island St.
Officials say when officers arrived they would find a vehicle that had been shot up. “Right next to the vehicle they located one male who appeared to be struck by at least one gunshot wound. That man was declared deceased on scene,” APD Lieutenant Ray DelGreco.
The identity of the man has not been released. No other details are available. APD is asking anyone with information on the incident to reach out to them. | https://www.krqe.com/news/crime/shooting-in-southeast-albuquerque-leaves-one-dead/ | 2022-07-27T13:53:54Z | https://www.krqe.com/news/crime/shooting-in-southeast-albuquerque-leaves-one-dead/ | true |
WASHINGTON (AP) — The federal government hopes a new website can help people and local governments beat the increasingly deadly heat of an ever-warming world.
Days after nearly half the country — 154.6 million people — sweated through a blistering heat wave, which for the West, hasn’t quite finished,the Biden Administration Tuesday unveiled heat.gov, which includes maps, forecasts and health advice. The government can’t lower temperatures in the short-term, but it can shrink heat’s death toll, officials said.
“July 2021 was the hottest month ever recorded on Earth and summers are getting hotter and deadlier,” said National Oceanic and Atmospheric Administration chief Rick Spinrad. “The annual average temperature of the contiguous U.S. has already warmed over the past few decades and is projected to rise by 5 to 9 degrees Fahrenheit (2.8 to 5 degrees Celsius) by the end of this century.”
But officials said even though heat is the No. 1 weather killer, and warming is worsening, deaths can still be prevented. That’s the purpose of the website.
“We don’t have to accept” heat deaths, Commerce Secretary Gina Raimondo said Tuesday. “This doesn’t have to be this way.”
The new website is aimed both at local planners to help them decide whether it is too hot for road work, at farmers for planting and harvesting advice, and even “a mom trying to decide this summer: Is it safe for your kids to play outside or to go to summer camp?” Raimondo said.
Pat Breysse, director of environmental health at the Centers for Disease Control and Prevention, said the predictions the new website offers can help authorities plan for extreme heat in advance and protect people who are most at risk, by setting up cooling centers and providing water, for example.
“There’s a host of things that we can do with this advance warning from the data that NOAA provides us, particularly from a health standpoint,” Breysse said. He pointed to earlier efforts by Rhode Island, Maine, New Hampshire and Vermont to change weather service heat warnings to make them more effective for New England residents.
The new website could be put to use immediately because record-breaking temperatures are forecast for Spokane, Washington, and Boise, Idaho — heat in the low to mid 100s, Spinrad said.
The website follows other Biden Administration action on heat, including financial aid to help on air conditioning for low-income residents, grants to build new cooling centers, upcoming rules for workers outside in the heat and help for cities to cool urban heat islands with more tree cover. Calling climate change “an emergency,” but stopping short of invoking emergency measures, President Biden last week promised more action to fight global warming.
Outside experts said the multi-agency website and action are overdue.
“This is an important step for elevating the risks of heat,” said University of Georgia meteorology professor Marshall Shepherd, past president of the American Meteorological Society. “For too long, heat has been one of the deadliest weather hazards, but has languished from an urgency standpoint,” ignored by the public, media and decision-makers. Shepherd said people scamper inside at the threat of lightning or tornado, but exert themselves when the heat index is 100 or higher.
North Carolina state climatologist Kathie Dello said, “extreme heat is one of our greatest challenges as a county and I’m glad to see the interagency cooperation.”
It’s important that the website shows that heat isn’t just a problem for today “but in the future,” Dello said.
Given warming trends, this summer with its widespread heat waves “is likely to be one of the coolest summers of the rest of our lives,” Raimondo said. “That’s a pretty scary thing.”
——
Wildeman reported from Hartford, Connecticut.
___
Follow AP’s climate and environment coverage at https://apnews.com/hub/climate-and-environment
___
Follow Seth Borenstein on Twitter at @borenbears
and Mary Katherine Wildeman at @mkwildeman
___
Associated Press climate and environmental coverage receives support from several private foundations. See more about AP’s climate initiative here. The AP is solely responsible for all content. | https://www.kxnet.com/news/national-news/feds-hope-new-website-can-prevent-deaths-from-worsening-heat/ | 2022-07-27T13:56:12Z | https://www.kxnet.com/news/national-news/feds-hope-new-website-can-prevent-deaths-from-worsening-heat/ | true |
It’s not yet a done deal, but the City of Milwaukee took a major step forward toward hosting the 2024 Republican National Convention last week when it gained the endorsement of the GOP site selection panel.
RNC Senior Advisor Richard Walters said the selection committee’s vote was “a testament to the forthright and professional behavior embraced by Milwaukee’s city leaders throughout the process.”
That came in part because the pursuit of the convention was a bipartisan one with both Republicans and Democrats laying out the welcome mat for the event. That was reflected again in the round of applause it got from local officials immediately after the vote was announced.
“Today’s news is great for our region, especially as workers and businesses continue to recover from the devastating economic impacts of the pandemic. We are ready to show the world what Milwaukee has to offer,” said Milwaukee County Executive David Crowley.
People are also reading…
His comments were echoed by Milwaukee Mayor Cavalier Johnson who said, “I want Milwaukee to hold a prominent position as a convention city. This is about future conventions and future business, trade shows, major membership organizations, sports and entertainment activities happening right here in the city of Milwaukee.”
It’s a second chance for the city which had planned to host the 2020 Democratic National Convention until it was upended by the coronavirus that left it as a “virtual” convention. Still, that experience allowed city and state leaders to push the city as a “turnkey” site for the GOP convention since it had just gone through the massive planning needed to host such an event.
It didn’t hurt, either, that Nashville, the other top contender for the GOP nod, balked down the stretch when there was local opposition to hosting and backers withdrew a proposed agreement about how to host the event. Still a final decision has not been made, but that is expected to come from the full Republican National Committee when it meets in early August.
Make no mistake, the economic impact is likely to be immense and long-lasting. The Republican host committee plans on raising $65 million for the event and it is projected to bring 50,000 convention attendees and visitors to the area in July and August. The economic impact on southeastern Wisconsin has been estimated at $200 million.
Beyond that, it will also give the city a chance to prove its bona fides as a convention host and showcase the Fiserv Forum and the Wisconsin Center, which is currently undergoing an expansion, and which are expected to be main venues for the gathering.
Yes, there will be concerns about security and – as most political conventions do – there will likely be some protests. We hope proper safeguards are in place. And, yes, there are political naysayers, in this political battleground state, who would rather not see Republicans gathering here and, perhaps, boosting their chances in the fall elections.
But it’s also a chance to showcase all the charms of Wisconsin and Milwaukee as a sparkling gem on the Great Lakes, to demonstrate our generous hospitality and put out a welcome mat for all visitors for years to come. That will endure long after the convention has come and gone. | https://www.kenoshanews.com/opinion/editorial/kenosha-news-editorial-milwaukee-gets-boost-in-gop-convention-bid/article_ca1a9e7e-0c5d-11ed-9ea5-4336a962613c.html | 2022-07-27T13:56:41Z | https://www.kenoshanews.com/opinion/editorial/kenosha-news-editorial-milwaukee-gets-boost-in-gop-convention-bid/article_ca1a9e7e-0c5d-11ed-9ea5-4336a962613c.html | false |
In 1998, as nations around the world agreed to cut carbon emissions through the Kyoto Protocol, America’s fossil fuel companies plotted their response, including an aggressive strategy to inject doubt into the public debate.
“Victory,” according to the American Petroleum Institute’s memo, “will be achieved when average citizens ‘understand’ (recognize) uncertainties in climate science… Unless ‘climate change’ becomes a non-issue… there may be no moment when we can declare victory.”
The memo, later leaked to The New York Times that year, went on to outline how fossil fuel companies could manipulate journalists and the broader public by muddying the evidence, by playing up “both sides” of the debate and by portraying those seeking to reduce emissions as “out of touch with reality.”
Nearly 25 years later, the reality of a changing climate is now clear to most Americans, as heatwaves and wildfires, rising sea levels and extreme storms become more common.
Last week, President Joe Biden announced moves intended to expand offshore wind, though he stopped short of declaring a national climate emergency. A Supreme Court ruling last month limited the federal government’s ability to regulate carbon emissions from power plants, meaning it will be up to a divided Congress to pass any meaningful limits on emissions.
Even as surveys show the public generally has become more concerned about climate change, a sizeable number of Americans have become even more distrustful of the scientific consensus.
“The tragedy of this is that all over social media, you can see tens of millions of Americans who think scientists are lying, even about things that have been proven for decades,” said Naomi Oreskes, a historian of science at Harvard University who has written about the history of climate change disinformation. “They’ve been persuaded by decades of disinformation. The denial is really, really deep.”
And persistent. Just last month, even with record heat in London, raging wildfires in Alaska and historic flooding in Australia, the Science and Environmental Policy Project, a pro-fossil fuel thank tank, said all the scientists had it wrong.
“There is no climate crisis,” the group wrote in its newsletter.
Years before COVID-19 set off a wave of misinformation, or former President Donald Trump’s lies about the 2020 election helped spur an insurrection at the U.S. Capitol, fossil fuel companies spent big in an effort to undermine support for emissions reductions.
Now, even as those same companies promote investments in renewable energy, the legacy of all that climate disinformation remains.
It’s also contributed to a broader skepticism of scientists, scientific institutions and the media that report on them, a distrust reflected by doubts about vaccines or pandemic-era public health measures like masks and quarantines.
“It was the opening of a Pandora’s Box of disinformation that has proven hard to control,” said Dave Anderson of the Energy and Policy Institute, an organization that has criticized oil and coal companies for withholding what they knew about the risks of climate change.
Starting in the 1980s and 1990s, as public awareness of climate change grew, fossil fuel companies poured millions of dollars into public relations campaigns denouncing the accumulating evidence supporting the idea of climate change. They funded supposedly independent think tanks that cherrypicked the science and promoted fringe views designed to make it look like there were two legitimate sides to the dispute.
Since then, the approach has softened as the impact of climate change has become more apparent. Now, fossil fuel companies are more likely to play up their supposedly pro-environmental record, touting renewables like solar and wind or initiatives designed to improve energy efficiency or offset carbon emissions.
Aggressive approaches to address climate change are now dismissed not on scientific grounds but on economic ones. Fossil fuel companies talk about lost jobs or higher energy prices — without mentioning the cost of doing nothing, said Ben Franta, an attorney, author and Stanford University researcher who tracks fossil fuel disinformation.
“We are living within an extended multi-decade campaign executed by the fossil fuel industry,” Franta said. “The debate (over climate change) was manufactured by the fossil fuel industry in the 1990s, and we are living with that history right now.”
The impact of that history is reflected in public opinion surveys that show a growing gap between Republicans and other Americans when it comes to views on climate change.
While the percentage of overall Americans who say they’re concerned about climate change has risen, Republicans are increasingly skeptical. Last year, Gallup found that 32% of self-identified Republicans said they accepted the scientific consensus that pollution from humans is driving climate change, down from 52% in 2003.
By comparison, the percentage of self-identified Democrats that say they accept that human activities are leading to climate change increased from 68 to 88 over the same time period.
Fossil fuel companies deny any intent to mislead the American public and point to investments in renewable energy as evidence that they take climate change seriously.
ExxonMobil CEO Darren Woods told members of Congress last fall that his company “has long acknowledged the reality and risks of climate change, and it has devoted significant resources to addressing those risks.” ExxonMobil’s public claims about climate change, he said, “are and have always been truthful, fact-based … and consistent” with mainstream science.
Asked about its role in spreading climate misinformation, a spokesman for the Southern Company pointed to recent expansions in renewable energy and initiatives meant to offset carbon emissions.
The 1998 “victory memo” laying out the industry’s strategy was created by the American Petroleum Institute. In a statement emailed to The Associated Press, API spokesperson Christina Noel said the oil industry is working to reduce emissions while also ensuring access to reliable, affordable energy.
“That’s exactly what our industry has been focused on for decades,” Noel said. “Any suggestion to the contrary is false.”
The 1998 memo is one of several documents cited by climate activists and some Democratic lawmakers who say they could be used to hold them legally responsible for misleading ratepayers, investors or the general public.
“It’s time for these companies to answer for the harm they have caused,” said Rep. Ro Khanna, D-California.
Republicans, however, have said Democrats want to focus on climate misinformation to distract from failed environmental policies that are driving up gas and energy costs. | https://www.kxnet.com/news/politics/ap-politics/climate-disinformation-leaves-lasting-mark-as-world-heats/ | 2022-07-27T13:57:39Z | https://www.kxnet.com/news/politics/ap-politics/climate-disinformation-leaves-lasting-mark-as-world-heats/ | false |
WASHINGTON (AP) — The week before the Jan. 6, 2021, attack on the U.S. Capitol, Missouri’s Josh Hawley became the first Republican senator to announce he would object to the certification of the 2020 election.
Texas’ Ted Cruz came next, dashing off his own plan on a flight from Houston to Washington days before the joint session of Congress to certify the election results.
In all, a dozen GOP senators initially planned to challenge Joe Biden’s victory. But unlike their House GOP counterparts who have been subpoenaed for testimony before the Jan. 6 committee, the Republican senators have largely escaped the reach of the investigation.
While the committee did share highlights about the senators, including Hawley’s raised-fist salute to the rioters that day — an image seared in history, and now on coffee mugs the senator sells — it has made the surprising, if pragmatic, decision not to call the senators for testimony. One dramatic video showed Hawley sprinting from the Senate chamber later that day as rioters swarmed.
Amid wider public scrutiny of Jan. 6, the senators have been left to explain their actions on their own terms, and have often done so defiantly.
“I do not regret it,” Hawley said to applause at Turning Point USA’s Student Action Summit in Tampa, Florida, after he strode to the stage Friday to a standing ovation.
As the summer hearings of the Jan. 6 committee come to a close, Chairman Bennie Thompson has indicated that the panel is looking elsewhere. As work continues, the investigation is moving closer to the top ranks of the White House and the defeated president’s inner circle.
“We continue to receive new information every day,” Thompson, D-Miss., said last week, announcing the next round of hearings in September. “We are pursuing many additional witnesses for testimony.”
The House committee is investigating not only the grisly attack on the Capitol, but Trump’s extraordinary effort to overturn the presidential election by submitting “fake” slates of electors from the battleground states to vote for him, not Biden, when Congress convened Jan. 6 to tally the 2020 presidential election results.
The senators could provide information about the run-up to Jan. 6, including any conversations they may have had with Trump and his lawyers who were putting together the plan for the fake electors, said Norm Eisen, a senior fellow at Brookings and former top adviser to Democrats on the House Judiciary Committee.
In one dramatic screenshot of a text exchange, the committee told the story of how a top aide for GOP Sen. Ron Johnson of Wisconsin attempted to hand off a slate of false, pro-Trump electors to then-Vice President Mike Pence as he was presiding in his ceremonial role of certifying the election. Johnson has said he was not involved in that effort.
But having interviewed more than 1,000 witnesses and having issued rare subpoenas to fellow House lawmakers, Eisen said the panel is trying to preserve its political capital by declining to compel senators to testify in what would be seen as an unusual House challenge to the upper chamber.
The Jan. 6 committee’s decision to issue subpoenas to House Minority Leader Kevin McCarthy of California and Reps. Jim Jordan of Ohio, Scott Perry of Pennsylvania, Andy Biggs of Arizona and Mo Brooks of Alabama was a show of force by the nine-member panel. And it came after much deliberation among the lawmakers, who for weeks considered whether taking the unprecedented step of subpoenaing members of their own chamber would be worth further inflaming partisan tensions over the 2021 attack.
“They only have so much committee time,” said Eisen.
Cruz declined to say Tuesday if he would have appeared had the Jan. 6 panel asked for his testimony. Hawley’s office has similarly said he wouldn’t want to address a hypothetical situation.
But in recent conversations, the Republicans have stood by their efforts to challenge Biden’s victory.
“This country would have been much better off” if Congress had taken up his plan, Cruz recently told The Associated Press.
Cruz had proposed forming a commission to audit voter fraud in the disputed states, even though Trump’s own Justice Department said there was no voter fraud on a scale that could have tipped the 2020 election. Dozens of court cases claiming fraud had been rejected or gone unheard.
Cruz said he did not recall conversations with Trump ally John Eastman, the conservative lawyer who was the architect of the alternative electors plan. Last month, federal authorities seized Eastman’s phone and issued subpoenas to electors in states nationwide allegedly involved in the scheme.
“I wrestled for a long time with what was the best approach to take with regard to the certification on Jan. 6,” Cruz said. He said he alone drafted the statement he put out with 11 senators, which he said he dashed off on the flight back to Washington.
Hawley has brushed off questions about the committee’s work, and declined last month to comment about Eastman’s plans for the alternative electors.
One police officer testified to the committee that Hawley’s raised fist on Jan. 6 “riled up the crowd” that day, said Rep. Elaine Luria, D-Va. During last week’s hearing, she played the video showing how Hawley “fled after those protesters he helped to rile up stormed the Capitol.”
Johnson has downplayed his aide’s attempt to pass a fake slate of electors to Pence. The handoff never took place, but the moment showed how close the plan came to fruition. If it had been successful, the electoral votes for Michigan and Wisconsin could have gone to Trump, not Biden, the rightful winner in those states.
After police cleared the Capitol of rioters that night, seven Republican senators led by Cruz and Hawley stuck with the plan to challenge the election results. Several of the other GOP senators who had initially signed on backed out.
At least one Republican who voted to challenge the election results after the rioting, Sen. Tommy Tuberville of Alabama, said Tuesday he would talk to the committee if they asked for his testimony,
“I’d go,” said Tuberville, who took a phone call from Trump as senators were being swept to safety. Tuberville was also among senators who had received a voicemail from Trump lawyer Rudy Giuliani that night, the committee has said.
Tuberville said he hasn’t been watching the hearings. “There’s nothing, anything, that I’ve seen that would change my mind on anything that I’ve voted on,” he said.
___
Associated Press writer Jill Colvin in Tampa, Florida, contributed to this report. | https://www.kxnet.com/news/politics/ap-politics/hawley-cruz-escape-jan-6-probe-have-no-regrets-over-role/ | 2022-07-27T13:58:08Z | https://www.kxnet.com/news/politics/ap-politics/hawley-cruz-escape-jan-6-probe-have-no-regrets-over-role/ | true |
Singer-songwriter Stevie Nicks is starting a new chapter as a comic book star
Singer-songwriter Stevie Nicks is starting a new chapter as a comic book star
You can see the singer's animated story come to life in the 22-page book Female Force: Stevie Nicks. Rumors are she's being reimagined in her signature witchy style and long blond hair. | https://www.npr.org/2022/07/27/1113889997/singer-songwriter-stevie-nicks-is-starting-a-new-chapter-as-a-comic-book-star | 2022-07-27T13:59:50Z | https://www.npr.org/2022/07/27/1113889997/singer-songwriter-stevie-nicks-is-starting-a-new-chapter-as-a-comic-book-star | false |
Western Washington is rarely associated with wildfires, but hotter, dryer summers have pushed the region to brace itself for the growing dangers of climate change.
On Tuesday, King County released its first-ever Wildfire Risk Reduction Strategy, a 12-point plan to bolster the region’s ability to prepare for, respond to and recover from large burns.
“We’re seeing the global impact of climate change with unprecedented fires,” King County Executive Dow Constantine told reporters Tuesday morning, standing at a podium under thinning shade at Mirrormont Park south of Issaquah as temperatures climbed toward 95 degrees.
With just over 4,000 residents, Mirrormont is located in unincorporated King County, one of the urban pockets that meet rural forest and farmland. This means it falls under the state’s wildland-urban interface, a designation for residents and buildings considered at greater risk of fire.
More than 350,000 people — or about 15% of King County residents — live under these potential risks.
The Wildfire Risk Reduction Strategy released Tuesday is part of the county’s Strategic Climate Action Plan, announced in 2020, which details a roadmap to better prepare the community for summers with less precipitation and more extreme temperatures.
The twelve recommended actions defined in the strategy call for, among other things, an increase in support for small forest landowners, the development of community preparedness, monitoring invasive species that increase fire risk and implantation of countywide training standards for emergency response.
Officials said lack of preparedness and population growth are major concerns.
Many neighborhoods have only one access road and most communities don’t have a wildfire response or evacuation plan, said Lara Whitely Binder, King County’s Climate Preparedness Program Manager.
Not only is infrastructure not ready, Binder said, but 85% of wildfires in Washington were caused by people.
The Puget Sound Regional Council projected in 2018 that the population of the central Puget Sound region will grow from 4 million to 5.8 million by 2050.
A growing population means more people will be at risk as heatwaves like the one Seattle entered Tuesday dry the land and produce fuel for potential fires in the future.
“The challenge we face is that, for those of us living in western Washington, our reference point for wildfire is defined by what we see happening in eastern Washington and California,” she said.
The Pacific Northwest has suffered expansive burns in recent years across central Washington, Oregon and California. But in King County and other regions west of the Cascades, it won’t take a massive fire to cause significant damage, Binder said.
“We just need to shift the reference point,” she said. | https://www.seattletimes.com/seattle-news/king-county-isnt-prepared-for-wildfire-executive-says-but-needs-to-be/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_seattle-news | 2022-07-27T14:02:00Z | https://www.seattletimes.com/seattle-news/king-county-isnt-prepared-for-wildfire-executive-says-but-needs-to-be/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_seattle-news | true |
Project designed to enhance service reliability for nearly 2,300 customers
READING, Pa., July 27, 2022 /PRNewswire/ -- Met-Ed, a subsidiary of FirstEnergy Corp. (NYSE: FE), recently completed a project to upgrade its distribution system in southern Monroe County to help prevent or minimize the length of service disruptions, particularly during severe summer storms. The work included rebuilding existing power lines to provide a second source of electricity to a substation near Snydersville and installing automated equipment on the local network to help prevent service disruptions and restore power faster for nearly 2,300 customers.
The upgrades are part of Met-Ed's Long Term Infrastructure Improvement Plan, a $153 million initiative to accelerate capital investments to the company's electric distribution system over five years to help ensure continued electric service reliability for customers.
"We've reconstructed three power lines to add a second source of electricity for the substation, providing redundancy that allows us to keep the lights on for many of our customers in Snydersville and Hamilton and Stroud Townships when our crews must make repairs or perform maintenance," said Scott Wyman, president of FirstEnergy's Pennsylvania Operations. "This substation had been fed by a single power line that traverses dense forest, steep hillsides and swamps, increasing the potential for lengthy tree-related outages in hard-to-access areas."
Met-Ed created the new 34.5 kilovolt (kV) source line that runs four miles along South Easton Belmont Pike and Middle Easton Belmont Pike by:
- Rebuilding a single-wire, 34.5-kV power line as a three-wire line with more electrical capacity
- Converting part of a lower voltage electric line to a 34.5-kV line with taller poles, new wire, transformers and fuses
- Installing new 55-foot poles on a lower voltage line to accommodate both the existing line and a new 34.5-kV line positioned overhead on the same poles
This new 34.5-kV power line parallels the roadway, providing easy access for crews to use bucket trucks to repair and maintain equipment.
Two devices enabled with supervisory control and data acquisition (SCADA) technology were installed in the substation, with two others placed on key spots along the line. SCADA conveys real-time information about voltage and electric current conditions to distribution system operators. Based on conditions, operators can control the devices remotely to quickly isolate damage and transfer customer load from one substation source to the other, helping to keep the lights on for customers when problems occur.
The devices have smart capability that will allow them to sense conditions on the system and operate automatically in several years when Met-Ed installs more automated equipment on the local network.
Met-Ed serves approximately 580,000 customers within 3,300 square miles of eastern and southeastern Pennsylvania. Follow Met-Ed on Twitter @Met Ed and on Facebook at www.facebook.com/MetEdElectric.
FirstEnergy is dedicated to integrity, safety, reliability and operational excellence. Its 10 electric distribution companies form one of the nation's largest investor-owned electric systems, serving customers in Ohio, Pennsylvania, New Jersey, West Virginia, Maryland and New York. The company's transmission subsidiaries operate approximately 24,000 miles of transmission lines that connect the Midwest and Mid-Atlantic regions. Follow FirstEnergy online at www.firstenergycorp.com and on Twitter @FirstEnergyCorp.
Editor's Note: A photo of line workers replacing a utility pole and cross arms is available on Flickr.
View original content to download multimedia:
SOURCE FirstEnergy Corp. | https://www.wbay.com/prnewswire/2022/07/27/met-ed-completes-upgrade-electric-system-monroe-county/ | 2022-07-27T14:03:49Z | https://www.wbay.com/prnewswire/2022/07/27/met-ed-completes-upgrade-electric-system-monroe-county/ | false |
BEIJING, July 27, 2022 /PRNewswire/ -- "The Dulong ethnic group has been lifted out of poverty!"
At the end of 2018, the thrilling news spread across China via various media reports. It was not only a historic milestone for the isolated ethnic group of the Dulong, but also a reflection of the outcome of China's poverty eradication work under the leadership of the CPC.
The Dulong people, who had been mysterious to many along with their ancient face-tattoo custom, are one of the ethnic minorities that directly transitioned from an antiquated society to a socialist society in the early days of the founding of the New China in 1949.
Located in Southwest China's Yunnan Province bordering Myanmar, Dulongjiang township is the Dulong ethnic minority's ancestral home. It is a group that had long endured extreme poverty and was isolated from the outside world.
Since the start of the poverty alleviation battle, thanks to the firm leadership of the CPC, with the unremitting efforts of the Dulong cadres and masses, the Dulong people have shaken off poverty as a whole.
Only those who have experienced the process would understand the true hardship and value of this victory.
Kong Yucai is one of them. "People here have benefited from improved infrastructure and connectivity to eliminate poverty," Kong, now head of Dulongjiang township of Gongshan county in Yunnan's Nujiang Lisu Autonomous Prefecture, told the Global Times.
A 'miracle' for the Dulong
Kong, now 42 and a locally born and bred Dulong man, has witnessed the changes in his hometown through his time growing up and working as a local civil servant, especially the stunning achievements in the past decade.
The Dulong people had long endured extreme poverty in history. They live in the mountainous areas nestled along the deep undeveloped forests that isolated them from the outside world.
This geographic remoteness has inadvertently made the area one of the least developed parts of China, as transportation would routinely be cut off for at least half a year from November to May due to heavy snowfall in the mountains, as Kong explained.
The Chinese know too well that development holds the master key to all problems. As the Chinese saying goes, building the road is the first step to become prosperous. For Dulong township and people in most of the impoverished areas in China, rural highways are the key to communicating with a modern world.
"However, this wasn't easy," Kong said.
With the launch of the poverty alleviation program in the village, the weakest link was determined to be poor transportation. "While relocating and resettling impoverished households along the Dulong river, transportation in the rugged mountains has been the biggest obstacle," Kong Said.
Moreover, the region would face seasonal water shortages, which would cause electricity outages, along with bad satellite signals, leading to slow construction progress. Construction workers would routinely quit their job because of such poor conditions.
Under such a difficult situation, in 2014, the first highway tunnel linking Dulongjiang township and Gongshan county was finally completed, which enabled the villagers to get timely healthcare services, education opportunities, and more conveniences.
The road became a lifeline, and it showcased the long-hidden village to the world. The Dulong people even grasped the opportunity the road had created for them and opened homestays for tourists.
In 2018, the total rural economic income of Dulongjiang Township hit 28.599 million yuan ($4.23 million), and rural per capita net income was 6,122 yuan which was up 23.5 percent year-on-year. A total of 2,297 people from 611 households were lifted out of poverty. The entire Dulong ethnic group achieved the goal of poverty alleviation, according to official statistics.
There are more than 1,100 households in the Dulongjiang township, and they all now live in new and better homes. The six administrative villages are all connected by paved roads, with radio, TV, and 4G coverage. Every villager is covered by the serious illness insurance policy. Aside from that, the younger generation enjoys 14 years of free education from pre-school to high school, the Xinhua News Agency reported.
"Our development path has become wider, people's income has also been greatly increased, and our life is getting sweeter," Kong said.
Dreams and dedication
Winning the battle against poverty in rural China reflects a people-centered philosophy, which would be absolutely impossible without the leadership and efforts of the CPC.
"The founding of New China on October 1, 1949, allowed our Dulong people to stand up and become the true masters of our land. I learned from my father and grandfathers how they had changed from an antiquated situation, and how the CPC united and led the Dulong people to strive to build our homeland with strong determination and concerted effort," Kong said.
Convinced of the strength of role models, strong will, and determination from the older generations, the 42-year-old Party official dedicated himself to helping impoverished Dulong villagers shake off poverty by providing extensive support.
"When I was a student in the university, joining the CPC was always an aspirational life goal. I joined the Party in 2011 and worked for the village Party committee in Dulongjiang in the following years," Kong said.
"To 'serve the people' wholeheartedly is an invariable promise that is implanted in my heart and soul. So I dedicated myself to the country's poverty reduction campaign with the aims of building a path to prosperity and ensuring people to have sufficient food and clothing, as well as access to proper education, basic medical services, and safe housing conditions. These are basic conditions for a quality life, and we have managed to attain them," he believes.
Poverty relief work has been put under the unified leadership of the CPC with more than 90 million members. Party chiefs at all levels were required to assume primary responsibility. Over 2.9 million public sector officials were sent from cities and towns to villages to fight poverty "on the front line."
To meet the anti-poverty deadline, since 2012, over 10 million people have had to be lifted out of poverty every year. This equates to about 1 million people every month or 20 people every minute.
Encouragement and inspiration
Shortly before of the New Year's Day in 2014, people from Gongshan county, where most of the Dulong people live, wrote to President Xi Jinping to report that the Gaoligong Mountains-Dulongjiang River highway tunnel was about to be completed
Xi, also the General Secretary of the CPC Central Committee and chairman of the Central Military Commission, replied to their letter.
Xi said he was glad to hear of the good news about the tunnel and congratulated the community. "I have always been concerned about the well-being of the Dulong people as you used to live harsh lives."
In 2018, the six administrative villages in Dulongjiang township, Gongshan county, eradicated poverty.
People in the township wrote another letter to inform Xi that they had been lifted out of poverty as a whole and were enjoying a better life.
Xi replied he was very glad to hear the good news and congratulated the Dulong people on their success.
"Poverty alleviation must have genuine effects that can win the approval of the people and stand the test of practice and history," Xi said.
Over the past eight years, the final 98.99 million impoverished rural residents living under the current poverty line have all been lifted out of poverty. All the 832 impoverished counties and 128,000 impoverished villages have been removed from the poverty list in China, Xi said in February 2021 while addressing a grand gathering held in Beijing to mark the country's accomplishments in poverty alleviation and honor its model poverty fighters.
View original content:
SOURCE Global Times | https://www.wibw.com/prnewswire/2022/07/27/global-times-dulong-people-achieve-miracle-eradicating-poverty-embracing-better-life-under-firm-leadership-cpc/ | 2022-07-27T14:03:51Z | https://www.wibw.com/prnewswire/2022/07/27/global-times-dulong-people-achieve-miracle-eradicating-poverty-embracing-better-life-under-firm-leadership-cpc/ | true |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.